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Chapter 1  
Introduction1 
 
Amyloids are ubiquitous 
 In 1894, Dr. Rudolf Virchow first used the word “amyloid” to describe aggregated 
material in brain tissue samples. Virchow noted that the observed aggregates stained 
with iodine, a characteristic of starch. Virchow named the aggregates “amyloid” for the 
Latin amylum and Greek amylon meaning starch. It was later demonstrated by Friedrich 
and Kekule that these iodine-staining aggregates were composed of protein, not starch 
(1). Amyloids have since been intensely studied for decades as they have been found to 
be hallmarks of many human illnesses including Alzheimer’s, Parkinson’s and 
Huntington’s diseases"(2-5). More recently, a new class of amyloids—the so-called 
‘functional’ amyloids—has been described, and new members of this class are rapidly 
being discovered (6, 7). Functional amyloids were first discovered in Escherichia coli as 
part of the extracellular matrix important to promote biofilm formation (8). Functional 
amyloids are now believed to be ubiquitous and they perform an enormous diversity of 
biological functions"(8-12).  
Microbial functional amyloids often mediate self and non-self interactions during biofilm 
formation. Loosely defined, biofilms are communities of bacteria encased in an 
extracellular matrix of proteins and polysaccharides (13). Amyloids are the major 
proteinaceous component in many biofilms (10). Amyloid fibers are well suited to serve 
as protein scaffolds in the biofilm matrix as they are remarkably strong can help 
aggregate individual cells together providing resistance to a variety of environmental 
___________________ 1 Portions of this chapter were published in Trends in Microbiology (6) and Biochemical 
Biophysical ACTA (180). Luz Blanco and Matthew Badtke contributed to writing the 
sections on microbial amyloids. Will DePas supplied the image in Figure 1.1B and Dan 
Smith designed the model in Figures 1.2 and 1.5. 
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insults (14, 15). The assembly of amyloid fibers also does not require energy because 
amyloid proteins can ‘seed’ their own oligomerization (16).  
Functional amyloids are not just involved in bacterial biofilm formation. 
Throughout this chapter I discuss the assembly of microbial amyloids and how these 
molecules participate in biofilm formation, persistence, and other cellular functions. I 
also illustrate, with an emphasis on curli, the many mechanisms that have evolved in 
functional amyloid systems that discourage potential amyloid-induced cytotoxicity. 
 
Functional Amyloids in Biofilms and Flocs 
 A variety of microbes including bacteria and fungi are capable of biofilm 
formation. Gram-negative bacteria such as Salmonella and E. coli produce a complex 
extracellular matrix that contributes to the formation of biofilms (17, 18). This matrix 
includes cellulose, exopolysaccharides such as colonic acid, and curli (18, 19). Curli are 
critical determinants of biofilm formation as they can mediate initial surface attachment 
and also provide a scaffold that contributes to biofilm integrity (17, 20-23). Accordingly, 
curliated bacteria better colonize plant tissues, stainless steel and glass (23-26). 
Rationally designed, small, peptidomimetic molecules that are able to interfere with curli 
assembly also prevent biofilm formation, supporting a key role for curli in biofilm 
formation (27).  
Amyloids have been identified in the natural environment in biofilms produced by 
Proteobacteria, Bacteriodetes, Chloroflexi and Actinobacteria (10). Amyloids have also 
been identified in organisms involved in water treatment processes, where the critical 
bioremediation step is mediated by biofilm-like structures called flocs: aggregative 
clusters of microbes in a network of polysaccharides and protein. Amyloids have been 
characterized in the matrix of activated sludge-derived flocs containing a broad variety 
of microbes (28). In this context, amyloids likely play diverse roles in adhesion and as a 
scaffold important for biofilm formation, integrity and persistence. However, amyloids 
may also help to act as physical barriers, scavengers of toxins, moisture regulators, or 
as toxins that kill other microbial species. Specific examples of these possible amyloid 
functions during biofilm development are discussed below.  
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Pseudomonas fluorescens and Bacillus subtilis produce identifiable functional 
amyloids in their biofilm matrix (20, 29, 30). FapC, originally characterized in P. 
fluorescens, is a highly conserved amyloid protein found in many Pseudomonas 
species. FapC has 3 repeat motifs and forms an extracellular amyloid matrix that 
contributes to the aggregative properties of Pseudomonas species (29). Biofilm integrity 
and persistence in B. subtilis are also influenced by the amyloid-forming protein TasA 
(11). TasA forms extracellular amyloid fibers that are anchored to the peptidoglycan 
layer of the cell wall by TapA (30). When biofilms age or D-amino acids are elevated, 
TapA is shed from the membrane releasing TasA fibers from the cell surface and 
allowing for dispersal from the biofilm (30). Although unrelated at the primary sequence 
level, TasA and FapC together with CsgA serve similar functions in biofilm formation 
demonstrating a common function for these amyloids in biofilms. 
 
Functional Amyloids as Adhesins  
Amyloids also function as adhesins, as is the case with Mycobacterium 
tuberculosis (31). Electron microscopic analysis of the M. tuberculosis pili (MTP) shows 
fibers that are strikingly similar to curli fibers. These fibers have also been reported in 
aged and carbon starved M. tuberculosis cultures (32, 33). Additionally, MTP are 
sodium dodecyl sulfate (SDS)-insoluble and bind Congo red (CR), suggesting that MTP 
are in fact amyloid fibers. MTP fibers have recently been shown to contain the protein 
product of the Rv3312a reading frame (31). The significance of MTP fibers for the 
pathogenesis of M. tuberculosis is unclear; however, MTP have been shown to bind 
laminin, a human extracellular matrix protein. MTP are conserved only in pathogenic 
mycobacterial species; a recent study showed that tuberculosis patients produce serum 
antibodies against to MTP (31). These data suggest that MTP are amyloid fibers that 
may be involved in M. tuberculosis cellular adherence and pathogenesis. 
Amyloids produced by fungi also play a role in adhesion. Candida albicans 
produces Als adhesins, which are involved in host tissue adherence and self-
aggregation (34-38). Als5p was shown to be important in surface changes that resulted 
in yeast aggregation when expressed heterologously in Saccharomyces cerevisiae or in 
C. albicans (39). Als5p was shown to undergo changes in protein secondary structure 
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and bind to CR. Short peptides from Als were also shown to form amyloids in vitro, 
demonstrated by CR binding, ThT fluorescence and electron microscopy (36). 
Intriguingly, oral infections in humans occur more prevalently with C. albicans when 
there is a higher amount of ferritin in the oral cavity. This observation led to the 
discovery that Als3 adhesin expression in the hyphae morphotype of C. albicans allows 
binding and utilization of iron sequestered in ferritin (40). Hence, in this yeast, 
expression of functional amyloid leads key events for fungal survival and virulence.  
 
Functional Amyloids as Surface Property Modifiers 
There are several examples of amyloids modifying the surface properties of 
microbes. One example, chaplins, are produced by the soil-derived bacteria 
Streptomyces coelicolor. S. coelicolor produce aerial hyphae in order to dispense 
spores. While underground, the hyphae are hydrophilic, whereas the aerial hyphae and 
spores are hydrophobic (41), and the formation of aerial hyphae requires a change in 
the surface hydrophobicity. This change in surface property is concomitant with the 
formation of an SDS-insoluble surface layer in the aerial hyphae and spores. The 
formation of this layer requires chaplin proteins, which are encoded by chpA-H (42). 
Chaplin proteins assemble into a network of amyloid fibers and cellulose on the surface 
of the aerial hyphae (43). The chaplins also self-assemble into β-sheet-rich fibers in 
vitro and bind CR and ThT (42). The amyloid properties of chaplins provide the dramatic 
hydrophobicity change to the surface layer that results in decreased surface tension at 
the air–water interface. The hyphae are then freed from the soil and continue to rise into 
the air (44).  
The individual contributions of the eight chaplin proteins to the amyloid network 
are starting to be elucidated. Recently, five of them (ChpD-H) have been shown to form 
amyloid fibers in vitro (45). Remarkably, addition of crude cell extracts containing 
chaplins restores formation of aerial hyphae to mutant S. coelicolor lacking some of the 
chp genes. This observation is similar to the interbacterial complementation phenotype 
of E. coli csgA and csgB mutants where the individual strains are unable to produce 
curli, but when grown in close proximity to each other csgA and csgB mutants are able 
to make curli (42, 46). Further, there may be temporal regulation influencing the 
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expression of the chaplin genes suggesting that a coordinated biosynthesis pathway is 
at work in chaplin amyloid assembly (42). How chaplin assembly is controlled on the 
molecular level remains undefined. Several of the chp genes are not essential for fiber 
formation and could function as accessory factors for preventing inappropriate 
amyloidogenesis (45, 47). In addition, the importance of cellulose in chaplin formation 
could be another control mechanism, preventing chaplin fiber formation until the 
subunits contact cellulose on the cell surface (48). 
Hydrophobins are another class of small, secreted proteins of about 100 amino 
acids that are produced by fungi. Hydrophobins play a similar role to that of chaplins in 
spore and fruiting body formation, but also play a role in attachment to host surfaces 
and protection against the host innate immune response during infection (49, 50). 
Hydrophobins can be divided into class I and II. The better-characterized class I 
hydrophobins are functionally related and can complement each other. Hydrophobins 
self-assemble at the hydrophilic-hydrophobic interface (reviewed in (49)). Strikingly, the 
hydrophobin polymerization process is most efficient over interfaces with high surface 
tension while agents that reduce this property slow down the rate of hydrophobin 
polymerization in vitro (51). The layer that forms from class I hydrophobins is SDS-
insoluble, and can only be disassembled with formic acid (FA) treatment (52). Amino 
acid sequences among the hydrophobins are diverse, but they all have eight conserved 
cysteine residues. The SC3 hydrophobin is β-sheet rich and forms a helical intermediate 
at the hydrophilic–hydrophobic interface (53). This β-sheet rich structure forms stable 5-
12 nm wide rodlets (rod-shaped structures) that fluoresce when mixed with ThT and can 
bind CR. Therefore, the rodlets appear to share many properties with amyloids. 
Ustilago maydis is a fungal plant pathogen that produces proteins called 
repellents, which are involved in aerial hyphae formation and attachment to host cells. 
In U. maydis, these repellents perform a similar function to hydrophobins; however, 
these two classes of proteins are unrelated at the amino acid level. The rep1 gene 
encodes a pre-pro-peptide that is processed into the 10 peptides that are collectively 
referred to as repellents. Teertstra and colleagues have shown that the peptide Rep1-1 
is able to form filaments both in vitro and in vivo with amyloid characteristics (54). 
Microarray analysis conducted comparing a rep1 mutant with a wild type strain found 
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induction of a small subset of genes encoding secreted cysteine rich proteins that are 
predicted to form amyloids (55, 56). Thus, these amyloids may be functionally 
redundant in order to ensure that proper fungal development occurs. This redundancy 
supports an essential role of functional amyloids in fungi. 
 
Functional Amyloids as Toxins 
One way many functional amyloids bypass the toxicity associated with amyloid 
formation is through separation of nucleator and major subunit functionalities. However, 
some functional amyloids capitalize on the inherent cytotoxicity of the amyloid fold. 
Microcin E492 is a bactericidal peptide produced by Klebsiella pneumoniae that 
assembles into oligomeric pores within the cytoplasmic membrane of neighboring 
bacteria, particularly Enterobacteriaceae species (57). Other microcins have also been 
described with similar antimicrobial functions (58). Microcin E492 is imported across the 
bacterial outer membrane in a receptor-mediated fashion (59), and has been shown to 
form voltage independent ion channels in planar lipid bilayers (57). The toxicity of the 
peptide changes during the growth cycle of the K. pneumonia. The toxicity is greatest 
during exponential phase and lowest during stationary phase, and this change in 
microcin E492 toxicity is associated with the formation of mature amyloid fibers (60). 
The assembly of amyloid fibers can also be observed in vitro, and corresponds to a loss 
of toxicity (60). Therefore, the toxic pore forming microcin E492 is presumably a 
transient pre-amyloid oligomer intermediate. It has been speculated that the toxic 
microcin E492 species may have structural similarity with the transient oligomeric 
species formed by disease-associated amyloids. Microcin E492 has been shown to 
trigger apoptosis in some human cell lines, reminiscent of the toxic effect observed for 
disease-associated preamyloid oligomers (61). Microcin E492 is currently being 
explored as a method to eliminate malignant cells (62). The mechanisms for promoting 
oligomeric pore formation, but preventing aggregation into fibers, requires further study. 
Harpins are proteins secreted by bacteria that elicit a hypersensitive immune 
response in plants, some of which might include the toxic aspect of amyloid formation 
intermediates. The hypersensitive response is characterized by localized cell death in 
plant tissue, which is a mechanism to prevent the spread of plant pathogens. Several 
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pathogens including Xanthomonas, Erwinia and Pseudomonas species secrete harpins 
as virulence factors to assist in movement through plant hosts (63, 64). Harpins from 
several bacterial species form amyloid-like fibers in vitro (65). The amyloid forming 
ability of HpaG, a harpin from Xanthomonas, directly correlates with hypersensitive 
response. A mutant form of HpaG that is unable to form amyloid also fails to elicit the 
hypersensitive response. Interestingly, size exclusion chromatography and visualization 
by electron microscopy suggests that a tetrameric oligomer is present when a 
hypersensitive response is observed (65). These results raise intriguing questions about 
how the bacteria avoid the toxicity associated with oligomer formation. 
 
Functional Amyloids in Epigenetic Inheritance 
Prions have been shown to cause many diseases, including transmissible 
spongiform encephalopathies (reviewed in (66)). The cause of the prion diseases is a 
normally soluble protein, PrPc that misfolds and forms an amyloid aggregate, PrPsc. The 
prion form can then convert other soluble PrPc proteins into insoluble aggregates that 
propagate the misfolded protein conformation and cause cellular damage (67). 
However, several prions can be categorized as “functional” in yeast because a definable 
advantage is gained upon their formation (68). In addition, many of these proteins form 
a cytoplasmic amyloid that is passed on to progeny during cellular division. These 
prions are examples of an epigenetic, non-Mendelian type of inheritance. Sup35p is the 
best-studied example of how particular protein folds can impart heritable changes. 
Sup35 is a translation termination factor that prevents protein synthesis past stop 
codons in S. cerevisiae. This regulation is lost when Sup35p assembles into an amyloid 
in [PSI+] S. cerevisiae leading to C-terminal extensions on some proteins and therefore 
greater protein diversity (69). Similarly, through aggregation, Ure2p can regulate Gln3p 
activity. Gln3p is a transcription factor that regulates expression of DAL5, which 
encodes an ureidosuccinate and allantoate transporter. Aggregation of Ure2p in 
[URE3+] strains of yeast causes Gln3p to be constitutively active and DAL5 expression 
is upregulated. This effectively eliminates nitrogen catabolite repression and enables 
yeast to utilize ureidosuccinate in the presence of ammonium (70). Rnq1p, a 
glutamine/asparagine rich protein with unknown function in S. cerevisiae, can also 
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polymerize into the prion form [PIN+] and has been shown to promote the formation of 
[PSI+], another prion phenotype (71, 72). Collectively, the transition to and from the 
amyloid form of these multi-domain proteins impacts cellular physiology. 
Lastly, fungal hyphae from adjacent colonies can fuse to form heterokaryons, 
genetically different nuclei coexisting in a common cytoplasm, and this process is 
mediated by the specific interactions that occur between amyloidogenic proteins. A well-
characterized protein named HET-s regulates heterokaryon formation in Podospora 
anserine by prion formation. The prion form of HET-s results in heterokaryon 
incompatibility of genetically similar fungi (73). This is a currently expanding field, with 
several new examples of functional yeast prions reported including Swi1p, a part of the 
SWI/SNF chromatin-remodeling complex that is involved in regulation of 6% of the 
genes in S. cerevisiae. Aggregation of Swi1p alters the regulation of the complex, and is 
transmitted to offspring by the cytoplasm (74, 75). Therefore amyloid aggregation can 
significantly impact fungal physiology, while also imparting inheritable changes. 
 
Curli are Functional Amyloids 
Curli, the first identified functional amyloid, are extracellular protein fibers 
produced by many enteric bacteria including Escherichia coli and Salmonella species 
(Fig. 1.1A) (18, 76-78). Curli are the major proteinaceous component of E. coli biofilms 
and are important for surface colonization and interacting with host factors and the host 
immune system (19, 77, 79-85). Curli production is easily scored in the lab by plating 
cells on agar plates containing Congo red (CR) (82, 86). Like all amyloids, the major 
curli subunit CsgA is capable of self-polymerizing in vitro into β-sheet-rich amyloid fibers 
that bind to the amyloid binding fluorescent dye Thioflavin T (ThT) and can be visualized 
using transmission electron microscopy (TEM) (8, 87, 88). In vitro assembled CsgA 
amyloid fibers are indistinguishable from fibers formed in vivo (88).  
The ability of curli to act as a strong scaffolding agent in biofilm formation stems 
from properties inherent to all amyloids. Curli are highly stable 6-12 nm wide non-
branching fibers (Fig. 1.1A) that are resistant to degradation by proteases and 
denaturation by detergents (8). Pretreatment with a strong denaturant such as formic 
acid (FA) or hexafluoroisopropanol (HFIP) is required to depolymerize curli fibers so that 
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monomers of the major subunit protein, CsgA, can be resolved on an SDS-PAGE gel 
(8). CsgA amyloids, like other amyloids, are β-sheet rich and assemble into a highly 
stable cross-β structure stabilized in large part by tight “steric zipper” interactions 
between side-chains on adjacent β-sheets (8, 89-91). The amyloid characteristics of 
curli fibers are clearly important for their biological function and afford many useful 
techniques for rapid in vivo and in vitro study of curli biogenesis, biofilm formation and 
integrity, and amyloid assembly (27, 92). 
 
Curli expression is highly coordinated.  
Curli gene expression is a highly regulated and coordinated event both on the 
cellular level and within a biofilm community. Curli are the major protein component of 
E. coli biofilms yet the production of curli within a biofilms is restricted to a distinct 
subpopulation (14, 19, 93-95). Expression is controlled by several environmental signals 
and chemical gradients including temperature, osmolarity and oxygen (96-98). Within a 
rugose, or rough, colony biofilm (Fig. 1.1B) curliated cells localize to the air-colony 
interface (14, 95). This bimodal population development can be triggered by oxidative 
stress, and in turn, rugose biofilms are protected from oxidative damage resulting from 
exposure to hydrogen peroxide (14). Bacteria within Salmonella enterica curli- and 
cellulose-dependent rugose colonies are also protected from desiccation and are more 
resistant to sodium hypochlorite treatment (or bleach) when compared to non-curliated 
colonies or planktonic cells, respectively (15). Successful biofilm formation requires 
spatial and temporal regulation of curli assembly, which relies on elaborate coordination 
of gene expression and protein production (Table 1.1). 
The curli specific genes (csg) are found in two divergently transcribed operons, 
the intergenic region of which is the 7th largest in E. coli and subject to extensive 
regulation (82, 99, 100). The csgDEFG promoter is recognized as one of the most 
complexly regulated promoters in E. coli (101). Curli are primarily expressed during 
stationary phase and at low temperature (below 30°C), although some clinical isolates 
can express curli at 37°C (18, 77, 97, 102). Both curli promoters are regulated by the 
stationary phase alternative sigma factor σS, which is assisted by the thermo-sensitive 
protein Crl (Table 1.1) (77, 102-104). Stationary phase expression of the csgDEFG 
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promoter is likewise positively regulated by the stationary phase transcription factor 
MlrA (Table 1.1) (105, 106). Curli expression is also internally regulated by the first gene 
product of the csgDEFG operon: CsgD (Table 1.1). CsgD is a member of the FixJ/LuxR 
family of transcriptional regulators that coordinates the expression of multiple biofilm 
components including curli and cellulose, while repressing expression of flagellar genes 
(82, 107-109). CsgD activity and stability is modulated by phosphorylation of an N-
terminal aspartic acid residue (DNA binding is decreased by in vitro phosphorylation) 
(110). Several additional transcriptional regulators modulate expression of the csgDEFG 
promoter: the catabolite repressor/activator protein Cra, the cAMP receptor protein 
CRP, and the recently identified protein RcdA (Table 1.1) (105, 111-114). At least two 
known two-component systems negatively regulate the csgDEFG operon (CpxA/R and 
RcsA/B) and one positively (OmpR/EnvZ) (Table 1.1) (22, 115-119). The two global 
DNA organization protein complexes IHF and H-NS impact curli gene expression 
inversely: IHF contributes to promote curli gene expression while H-NS represses curli 
expression in E. coli (Table 1.1) (111, 120, 121). Both positive and negative regulation 
involves simultaneous binding of regulatory proteins as well as competitive binding 
between positive and negative regulators. For instance, H-NS and IHF act in 
competition for binding upstream of the csgDEFG promoter while CpxR and H-NS can 
bind simultaneously to negatively regulate the csgDEFG promoter and OmpR and RstA 
can bind simultaneously with IHF to positively regulate the csgD promoter (111). Finally, 
the csgDEFG transcript is also subject to negative post-transcriptional regulation by five 
small regulatory RNAs: OmrA, OmrB, McaS, GcvB and RprA (Table 1.1) (122-125). The 
small RNAs ArcZ and SdsR also positively regulate csgD in S. enterica, but whether this 
is a direct effect has yet to be determined (Table 1.1) (126). For a more comprehensive 
review of the role of small RNAs in regulating the transition between biofilm and sessile 
growth see Mika and Hengge, 2013 (127). 
 
CsgA amyloid assembly by design 
A striking aspect of curli biogenesis is that, despite the propensity of CsgA to 
aggregate, amyloid formation is so faithfully restricted to the cell surface. The major and 
minor curli subunits, CsgA and CsgB, respectively, are encoded by the csgBAC operon 
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(82, 99, 128). CsgA is secreted across the outer membrane as an unstructured soluble 
protein (Fig. 1.2 and Fig. 1.3) (129). Soluble CsgA is then templated into an amyloid on 
the cell surface by the nucleator and minor curli subunit CsgB (Fig. 1.2 and Fig. 1.3) 
(46, 130). This mechanism of secretion is termed nucleation-precipitation or Type VIII 
secretion (131). A third, and less well understood, gene csgC is located downstream of 
csgA. CsgC is a small periplasmic protein that is proposed to play a role in subunit 
secretion and is the focus of Chapter 3 (129, 132). CsgC is a β-sheet rich protein with 
an immunoglobulin-like fold and a conserved CxC motif that shares a high degree of 
structural similarity with the N-terminus of the redox-active DsbD (132). Whether the 
other curli proteins are redox substrates of CsgC still unclear; the curli pore protein 
CsgG, however, is an attractive substrate candidate as it is the only other curli protein 
that contains a solvent exposed cysteine residue (132). Additionally, the presence of 
CsgC renders the csgBA mutant more sensitive to bile salts compared to the csgBAC 
mutant suggesting that CsgC may keep the pore open or ungated (132). Furthermore, 
an S. enteritidis csgC mutant produces wider curli fibers (~20nm) suggesting that CsgC 
may also function in CsgA folding and curli fiber structure (129). The csgE, csgF and 
csgG genes encode the proteins that comprise the unique outer membrane curli 
secretion apparatus (Fig. 1.3). CsgG assembles into a pore-like structure in the outer 
membrane while CsgE and CsgF play chaperone-like functions assisting in secretion 
and cell surface attachment of the curli fibers (Fig. 1.3) (133-136). CsgD is a positive 
regulator that promotes biofilm formation by positively regulating curli and cellulose 
production (Table 1.1) (82, 107-109).  
CsgA is the major subunit of the curli fiber and is secreted across the outer 
membrane as an unstructured and soluble peptide (Fig. 1.3) (8, 82, 129, 137, 138). The 
mature CsgA protein is comprised of an N-terminal 22 amino acids (N-term22) required 
for outer membrane secretion, and a C-terminal amyloid core domain (Fig. 1.4AB) (89, 
91, 136). The amyloid core of CsgA is composed of five imperfect repeating units: R1 
through R5 (Fig. 1.4AB) (88, 137). Each repeating unit contains a Ser-X5-Gln-X-Gly-X-
Gly-Asn-X-Ala-X3-Gln motif and forms a β-sheet-turn-β-sheet secondary structure with 
an overall β-helical, cross-β structure (Fig. 1.4AB) (89, 91). The arrangement of the 
repeating units in the cross-β structure aligns the Gln and Asn residues in each 
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repeating unit in stacks that stabilize the amyloid fold (Fig. 1.4AB) (139). It is also worth 
noting that the placement and stacking of the Gly and Ala residues in the consensus 
sequence is highly conserved in Gammaproteobacteria and likely play an important role 
in amyloid assembly (76). 
Purified CsgA self-assembles into amyloid fibers that bind ThT and can be 
visualized by TEM in vitro (Fig. 1.5A). CsgA polymerization in vitro is very robust: CsgA 
polymerizes into indistinguishable amyloid fibers over large pH (3.0-9.0) and ionic (0-
500mM NaCl) ranges (87). CsgA polymerization is concentration dependent and can be 
divided into three phases: a lag phase, an elongation phase and a stationary phase 
(Fig. 1.5AB). At CsgA concentrations between 5 and 30 µM, the lag phase is 
approximately 2 hours (87, 88). During the lag and elongation phases, a CsgA folding 
intermediate that is conserved in most amyloid-forming proteins can be detected with a 
conformation-specific antibody, A11 (88, 140). Although purified CsgA readily forms 
amyloid in vitro, CsgA amyloid formation in vivo requires the nucleator protein CsgB (46, 
130). CsgB nucleated polymerization of CsgA can be recapitulated in vitro in a process 
called “seeding”. When added to soluble CsgA, preformed CsgB or CsgA fibers (also 
referred to as seeds) accelerate the polymerization of CsgA by eliminating the lag 
phase (139). Interestingly, curli subunits from closely related species exhibit a cross-
seeding promiscuity. Curli subunits from E. coli and the closely related bacteria 
Citrobacter koseri and Salmonella enterica are capable of cross-seeding both in vivo 
and in vitro (141).  
The molecular features of both CsgA and CsgB that contribute to amyloid 
formation and nucleation have been thoroughly dissected. The repeating units of CsgA 
have distinct characteristics that either promote or temper amyloid formation (Fig. 
1.4AB) (139, 142). Repeating units R1, R3, and R5 are amyloidogenic, while R2 and R4 
are non-amyloidogenic: synthetic peptides of R1, R3 and R5 rapidly assemble into 
amyloid fibers in vitro while R2 and R4 do not (88, 143). Furthermore, CsgA ΔR1 and 
ΔR5 do not assemble into curli fibers in vivo and cannot be seeded by either CsgA or 
CsgB in vitro (143). R1 and R5 are therefore not only important for amyloid assembly, 
but are also the domains that mediate CsgA-CsgA and CsgA-CsgB interactions. The 
Gln and Asn residues in R1 and R5 (at positions 49, 54, 139 and 144) are critical for 
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amyloid formation (Fig. 1.4A) (139). Mutation of the Gln and Asn in R1 and R5 results in 
a CsgA variant, aptly named CsgAslowgo, that polymerizes with a significantly extended 
(~100x longer) lag phase compare to WT CsgA (88, 139). While R1, R3 and R5 
synthetic peptides all polymerize into amyloids in vitro, R3 polymerizes more slowly 
(139). R1 and R5 are interchangeable with one another (R12341 and R52345 CsgA 
chimeras produce WT curli in vivo), while replacement of either R1 or R5 with R3 
(R32345 or R12343) results in little to no curli (143).  
Certain residues in the CsgA repeating units appear to temper or slow CsgA 
aggregation into amyloid (142). Asp residues at positions 91 and 104 within R3 have 
been identified as “gatekeeper” residues that reduce the amyloidogenicity of R3 (Fig. 
1.4A) (142). Mutations to either of these Asp residues in such a way that the peptide 
more closely resembles R1 or R5 restore curli assembly of the R12343 chimera in vivo 
and polymerization in vitro (142). Conversely, substitution of Asn136 and His149 within 
R5 for Asp, thus rendering R5 more similar to R3, abolishes curli assembly in vivo 
(142). The non-amyloidogenic repeating units R2 and R4 also contain “gatekeeper” 
residues (Fig. 1.4A). Mutating Gly78/Asp80/Gly82 in R2 and Gly123/Asp127 in R4 to 
the corresponding amino acids in R1 and R5, respectively, restored curli assembly to 
the CsgA ΔR1 and ΔR5 truncations in vivo (142). Mutation of all of the “gatekeeper” 
residues in R2, R3 and R4 to the corresponding residues in R1 or R5 in full-length CsgA 
results in a variant (CsgA*) that polymerizes without a lag phase in vitro (142). 
Furthermore, CsgA* is capable of forming curli in vivo in a CsgB/CsgF-independent 
manner and exhibits a toxic effect when overexpressed (142). These “gatekeeper” 
residues enable a level of intramolecular control over CsgA amyloid assembly that is 
important in avoiding amyloid-associated cytotoxicity. 
 
Amyloid assembly is nucleation-dependent in vivo 
In addition to keeping CsgA polymerization in check with intramolecular 
“gatekeeping” residues, curli assembly is also controlled by dividing the tasks of 
nucleation and polymerization between two proteins, CsgB and CsgA, respectively. 
CsgB is dispensable for polymerization of CsgA in vitro but is required for curli assembly 
on the cell surface in vivo"(8, 46, 88, 130, 139, 144). In the absence of the surface-
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associated CsgB, CsgA is secreted away from the cell and remains SDS-soluble (130, 
145, 146). However, soluble CsgA either supplemented exogenously or from a nearby 
csgB mutant donor cell can be engaged on the surface of cells presenting CsgB in a 
process referred to as interbacterial complementation (Fig. 1.6) (8, 130, 139). Donor 
and recipient strains streaked on an agar plate as far apart as three millimeters can still 
participate in interbacterial complementation, owing to the incredible efficiency of the 
nucleation-precipitation mechanism of curli (Fig. 1.6) (130). 
Like CsgA, CsgB is a glutamine and asparagine-rich protein comprised of a Sec 
secretion signal sequence, an N-terminal domain and a core domain (Fig. 1.4C). CsgB 
shares 30% sequence identity with CsgA and has an amyloid-like core similar to CsgA 
(46, 147). Each of the first four repeating units of CsgB contains an Ala-X3-Gln-X-Gly-
X2-Asn-X-Ala-X3-Gln motif similar to the repeat motif of CsgA. Repeating unit 5, 
however, lacks several of these residues and instead contains four positively charged 
amino acids that are absent in the other CsgB repeating units: Lys133, Arg140, Arg147 
and Arg151 (Fig. 1.4C). Deletion of repeating unit 5 results in a truncated version of 
CsgB (CsgBtrunc) that is no longer cell surface associated (144). Moreover, CsgBtrunc 
self-assembles into amyloid fibers in vitro and can seed the polymerization of CsgA 
consistent with the hypothesis that CsgB also assembles into an amyloid core (46). 
Repeating units 1-3 appear to be largely dispensable for in vitro polymerization and 
localization, leaving R4 and R5 of primary importance for localization and nucleation of 
CsgA (144). It is also possible, however, that some of the CsgB repeating units function 
redundantly. These observations suggest a model where CsgB associates with the cell 
membrane via the fifth repeating unit while R1-R4 assume an amyloid fold that can 
template soluble CsgA into amyloid fibers. How CsgB is associated with the outer 
membrane is still largely unknown. CsgB localization, however, requires at least one 
component of the curli secretion apparatus, CsgF (134). 
 
Curli are secreted by a dedicated outer membrane secretion apparatus 
The curli system possesses a unique outer membrane secretion apparatus 
comprised of at least three proteins: CsgG, CsgE and CsgF (Fig. 1.3) (8, 82, 133, 146). 
CsgG is a lipoprotein that spans the outer membrane and assembles into an oligomeric 
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annular-shaped structure with an inner diameter of approximately 2 nm (132, 136, 146). 
The crystal structure of CsgG has been solved and reveals the pore to be a nonameric 
β-barrel pore (133). CsgE interact with CsgG in the periplasm assembling into a cap like 
structure (133). Overexpression of CsgG results in increased sensitivity to the small 
antibiotic erythromycin (740 Da) but not the larger vancomycin (1440 Da) suggesting 
that CsgG has a pore-like activity (136). Overexpression of CsgE suppresses the 
erythromycin sensitivity phenotype of a CsgG overexpressing strains (93, 135). CsgE 
may therefore act, in part, by gating CsgG to prevent the influx of environmental 
chemicals and molecules through the pore.  
The CsgG oligomers are not uniformly distributed around the cell but are instead 
spatially restricted to discrete regions of the cell that co-localize with what appears to be 
the primary curli fiber attachment site (93). The mechanism of CsgG localization, 
however, and how the curli secretion apparatus is spatially localized to discrete spots 
around the cell remains unknown. Because subcellular localization is important for 
many biological functions, including macromolecular organelle assembly in bacteria, it is 
not unreasonable to hypothesize that spatial restriction of the curli secretion apparatus 
is also important for curli assembly (148, 149). Diffusion of protein subunits into the 
environment is a significant challenge of the nucleation-precipitation/Type VIII secretion 
system (131, 150). Localized secretion of CsgA may lead to high local concentrations 
that promote efficient curli formation on the cell surface. Interestingly, CsgA and CsgB 
are both required for stable oligomerization of CsgG suggesting that either subunit 
secretion or active curli polymerization on the cell surface somehow facilitates stable 
pore assembly (93).  
Stable oligomerization of CsgG is dependent on both of the major and minor curli 
subunits, CsgA and CsgB, as well as the accessory proteins CsgE and CsgF (93). 
Conversely, CsgG is required for the stability and secretion of CsgA, CsgB and CsgF 
across the outer membrane (134, 146). CsgG interacts with CsgE and CsgF as well as 
fusion proteins in which the N-term22 of CsgA has been fused to the N-terminus of a 
substrate protein (136). CsgF is extracellular and interacts with CsgG on the cell surface 
where it stabilizes and localizes CsgB to cell-surface (134). In the absence of CsgF, 
both CsgB and CsgA remain predominately SDS-soluble and are secreted away from 
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the cell (134). Overexpression of CsgB in a csgF mutant restores the cell-surface 
localization of CsgB but it does not restore WT cell-surface associated curli fibers (134). 
CsgF therefore may play a more important role in remodeling CsgB into an amyloid-
templating conformation rather than actually anchoring CsgA fibers.  
Ensuring that curli amyloid assembly occurs at the correct time and place is a 
feat that is at least in part achieved by molecular chaperones (135, 151). Nenninger et 
al. described CsgF as having chaperone-like activity: CsgF appears to assist in directing 
the assembly of CsgA into an amyloid on the cell surface (134). CsgE, on the other 
hand, functions earlier in the curli biogenesis pathway by inhibiting premature amyloid 
formation within the periplasm, but also by directing CsgA subunits to CsgG for 
secretion (135). CsgE inhibits CsgA amyloid formation and interacts with CsgA amyloid 
fibers in vitro (135, 152). Two lines of evidence using fusion protein constructs with the 
N-terminal domain of CsgA implicate the N-terminal 22 amino acids of CsgA as the 
interacting domain with both CsgE and CsgG (135, 136). First, the large periplasmic 
protein PhoA coimmunoprecipitated with CsgG when PhoA was fused to the N-terminal 
42 amino acids of CsgA (including the Sec secretion signal sequence) (136). Second, 
expression of CsgE specifically permits the secretion of the second domain of PapD 
and CpxP only when C-terminally fused to the N-terminal 22 amino acids of CsgA (135). 
However, overexpression of CsgG results in unchecked secretion of CsgA indicating 
that secretion through CsgG doesn’t necessarily require CsgE (135, 136). Together, 
these results suggest a coordinated chaperone/delivery and secretion mechanism. 
CsgE putatively has three functions: 1) bind to CsgG and gate the outer membrane 
secretion pore, 2) bind to and inhibit amyloid formation of curli subunits within the 
periplasm, and 3) deliver these subunits to CsgG for secretion.  
 
The curli system can be exploited for studying other amyloids 
Other bacteria may have also adapted the CsgG-like amyloid secretion pore. The 
Caulobacter crescentus holdfast protein HfaA shares the amyloid-like characteristics of 
being resistant to heat and SDS denaturation (153). Like CsgA, the secretion and 
stability of HfaA depends on an outer membrane lipoprotein, HfaB, which shares 31% 
identity and 42% similarity with CsgG (154). It is attractive to hypothesize that the curli 
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secretion mechanism is representative of a distinct class of apparatuses for secreting 
amyloid subunits across membranes.  
The unique curli secretion apparatus may be ideally suited for transporting 
generic unfolded amyloid proteins across the outer membrane. Secreted CsgA is 
unstructured. The CsgG pore is only about 2 nm (or 20 Å) wide and not large enough to 
secrete CsgA in its folded conformation, suggesting that CsgA is maintained in an 
unstructured and soluble conformation prior to secretion (129, 136, 137). The N-terminal 
22 amino acids of the mature CsgA not only direct its secretion across the outer 
membrane, but when fused to unrelated amyloid proteins, can also direct their secretion 
(92, 135, 136, 155). E. coli expressing fusions of unrelated amyloids with the N-terminal 
domain of CsgA produce Congo red binding colonies on agar plates and SDS-insoluble 
fibers (92, 155). Harnessing the curli secretion system to assemble heterologous 
amyloids on the bacterial cell surface may pave the way for new high throughput 
screening methods for modulators of amyloid assembly.  
 
Amyloid assembly can be modulated and probed with antibodies, small 
molecules and protein folding factors  
Folding intermediates can be probed using antibodies and small molecules  
The discovery of conformation specific antibodies has contributed immensely to 
our understanding of amyloid assembly (140, 156, 157). We now have the tools to 
detect intermediate oligomeric and fibrillar species during the amyloid assembly 
process. The conformation-specific antibody A11 was raised against an oligomeric 
intermediate of Aβ, the amyloid protein associated with Alzheimer’s disease, and reacts 
with the oligomeric intermediates of many other disease-associated amyloids (140). 
CsgA is also transiently recognized by A11 in vitro indicating that CsgA functional 
amyloid formation proceeds by the same mechanism of assembly as disease-
associated amyloids in vitro (88). Antibodies have also been raised that specifically 
recognize the amyloid fiber conformation and also broadly react with unrelated amyloid 
fibers (156, 157). Conformation specific antibodies have motivated the development of a 
new class of antibodies, gammabodies (for grafted amyloid motif antibodies), which not 
only react specifically with the fiber conformation, but also have a high degree of 
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specificity for protein sequence (158, 159). Gammabodies have been demonstrated to 
act in distinct mechanisms, depending on the grafted sequence, to inhibit amyloid 
formation of several disease-associated amyloids (158). Gammabodies have been 
engineered against each repeating unit of CsgA and have been show to exhibit the 
same sequence and conformation specificity as gammabodies designed to interact with 
disease-associated amyloids (152, 159). It has yet to be determined if similar inhibitory 
interactions are possible between gammabodies and functional amyloids.  
Peptidomimetic compounds are also attractive candidates for modulating protein-
protein interactions and amyloid formation. A screen of compounds originally designed 
to inhibit the elaboration of E. coli P pili yielded a set of small molecules capable of 
inhibiting amyloid formation of Aβ (160, 161). These compounds have since been 
subject to extensive chemical modification and assayed for biological activity against 
several amyloid substrates including curli (27, 152, 162). This extensive library of 2-
pyridone compounds, or curlicides, exhibit varying degrees of CsgA amyloid inhibition 
and curli-dependent biofilm inhibition (27, 152, 162). Interestingly, the compound FN075 
inhibits both Aβ and CsgA amyloid formation but accelerates amyloid formation of the 
Parkinson’s Disease-associated protein α-synuclein (162). FN075 promotes the 
oligomerization of both CsgA and α-synuclein; however, the α-synuclein oligomers are 
competent for amyloid formation (on-pathway) while the CsgA oligomers are not (off-
pathway) (162). These provocative results suggest that the 2-pyridone compounds may 
be used as tools for probing and distinguishing between on- and off-pathway protein 
folding intermediates. Andersson et al. have now identified other 2-pyridone compounds 
that are capable of accelerating CsgA polymerization (152). Further analysis of curli 
assembly in the presence of these curlicide and accelerator compounds may be 
instrumental in dissecting early stages of function amyloid assembly.  
 
Chaperones can modulate amyloid assembly 
One major question that remains in the functional amyloid field is how organisms 
ensure that functional amyloids assemble only at the right time and in the right place so 
as to avoid the cytotoxic effects traditionally associated with amyloid assembly and 
amyloid intermediates. Proteostatic dysfunction is frequently, if not always, associated 
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with protein misfolding and amyloid-associated diseases"(163). A class of molecular 
chaperones called small heat shock proteins (sHSP) has been found to be associated 
with many types of amyloid aggregates in vivo. The small heat shock proteins Hsp27 
and αB-crystallin are induced in Alzheimer’s disease and the heat shock response is 
induced in patients with Familial Amyloidotic Polyneuropathy resulting in increased 
expression of Hsp70 and Hsp27 (164-167). The chaperones Hsp20 and HspB2 
colocalize with senile plaques in brain samples from patients with Alzheimer’s disease 
and TorsinA (a homolog of the yeast Hsp104), Hsp70, Hsp27, Hsp40 and Hsp110 
colocalize with α-synuclein in Lewy bodies in brain tissue samples from patients with 
Parkinson’s disease (168-170).  
Heat shock proteins have also been shown to inhibiting disease-associated 
amyloid assembly and amyloid-related cytotoxicity in vitro and in vivo (163). For 
instance, the heat shock protein Hsp70 inhibits amyloid assembly of the Alzheimer’s 
Disease-associated protein Aβ and the Parkinson’s Disease-associated protein α-
synuclein in vitro (171-174). Overexpression of Hsp70 has also been found to reduce 
disease pathology in a murine model of Alzheimer’s Disease (175). Similarly, 
overexpression of the small heat shock protein Hsp16.2 in a Caenorhabditis elegans 
model of Alzheimer’s Diseases resulted in decreased amyloid deposits and toxicity 
(176). Modulating the protein folding environment as a means to ameliorate amyloid-
associated diseases is an area of intense research focus (177-179). 
 
Dissertation Goals 
The amyloid field has undergone a sea change since curli were characterized as an 
amyloid and the functional amyloid field was born. Curli biology is ideal for studying 
protein secretion, folding and amyloid biology. The goal of this dissertation is to identify 
and characterize factors that are involved in the controlled secretion and assembly of 
curli amyloid fibers. In Chapter 2 (published in Prion) I describe the ability of known 
molecular chaperones from the E. coli cytoplasm and periplasm to inhibit CsgA amyloid 
assembly. In Chapter 3 (accepted for publication in Molecular Cell) I report the 
discovery that the curli gene csgC encodes an efficient and selective inhibitor of CsgA 
and α-synuclein amyloid assembly. Finally, in Chapter 4, I report molecular details of 
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CsgE function as a curli secretory protein. My findings contribute exciting new 
knowledge to the functional amyloid field by refining some of the elaborate mechanisms 
that are in place to ensure that curli are assembled only at the right time and in the right 
place.  
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Figures and Tables 
 
 
 
Figure 1.1. Curli production contributes to E. coli biofilm formation. A. E. coli k-12 
strain BW25113 grown on a low salt agar plate at 26°C produce cell surface associated 
curli fibers that are visible by transmission electron microscopy. Scale bar is 500nm. B. 
The uropathogenic E. coli strain UTI89 develops a complex rugose colony morphology 
that is dependent on curli.  
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Figure 1.2. Model of curli biogenesis. Excluding CsgD, the master curli regulator, all 
Csg proteins have Sec-dependent signal sequences allowing their secretion into the 
periplasm. The lipoprotein CsgG forms a pore-like structure in the outer membrane. The 
major subunit protein CsgA and the nucleator CsgB are secreted to the cell surface in a 
CsgG- and CsgE-dependent manner. CsgF associates with the outer membrane and is 
required for cell association of the minor curli fiber subunit CsgB. Situated at the cell 
surface, CsgB nucleates soluble, unstructured CsgA into a highly ordered amyloid fiber. 
Curli production can be visualized by CR binding, which is absent in a csgA mutant, and 
by transmission electron microscopy (left inserts). Also shown are two CsgA subunits 
interacting in a cross-β conformation, with the R1–R5 interaction depicted (right inset).  
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Figure 1.3. The curli biogenesis system possesses a unique outer membrane 
secretion apparatus. The CsgG pore is composed of nine subunits with a 2 nm wide 
central pore. Both CsgE and CsgF interact directly with the CsgG pore. CsgE is 
periplasmic and required for directing soluble CsgA to the CsgG pore for secretion while 
CsgF is surface exposed and contributes to the assembly of CsgB into a surface 
associated, amyloid-templating conformation. Once outside the cell, CsgA interacts with 
CsgB and assembles into an amyloid fiber. 
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Figure 1.4. The molecular details of CsgA and CsgB. A. The mature CsgA protein is 
composed of an N-terminal 22 amino acids and 5 amyloid repeating units, each with a 
β-sheet-turn-β-sheet (indicated by the red arrows). Ser, Gln and Asn residues (boxes) in 
each repeating unit align in stacks that stabilize the amyloid conformation. The Gln 
residues at positions 49 and 139 and the Asn residues at positions 54 and 144 (circled) 
are essential for amyloid formation. Repeating unites R2, R3 and R4 contain 
“gatekeeper” residues (*) that temper amyloid formation. The conserved glycine and 
alanine residues are indicated in bold font. B. A cartoon representation of the predicted 
structure of CsgA shows the five repeating units assemble into a β-helical, cross-β 
structure (side view, left). The Gln, Asn and Ser residues of R1 (upper right) are shown 
as sticks and the overhead view of CsgA (lower right) shows the alignment of these 
residues within the predicted structure. C. The mature CsgB protein is composed of an 
N-terminal 22 amino acids and 5 amyloid repeating units with similarly conserved Gln 
and Asn stacks (boxes). The conserved glycine and alanine residues in R1-R4 are 
indicated in bold font. Repeating unit 5 lacks one of the Asn repeats, but instead 
contains four charged residues (indicated by +) that may be important for tethering 
CsgB to the cell surface via R5. 
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Figure 1.5. Schematic representation of amyloid polymerization. (a) Typical ThT 
fluorescence kinetics of soluble purified CsgA monomers polymerizing into curli [15]. 
The lag, growth and stationary phases are indicated. The blue arrow indicates the end 
of the lag phase. The insert shows a transmission electron micrograph of CsgA fibers 
formed when purified CsgA is allowed to polymerize in vitro as described by Wang et al. 
[8]. Scale bar, 500 nm. (b) The transition from soluble monomeric proteins to polymeric 
and insoluble amyloid fibers is characterized by distinguishable steps that result in loss- 
or gain-of-function properties for the protein. In the lag phase, soluble protein 
assembles into a common intermediate or nucleus that is proposed to be toxic to 
membranes [29,88]. The formation of the intermediate is proposed to be the rate- 
limiting step of amyloidogenesis. Once the nucleus is formed, monomers are templated 
into growing amyloid fibers causing an increase in ThT fluorescence. When the 
monomer population is depleted, elongation stops and enters the stationary phase. The 
green boxes below the schematic highlight properties of some of the functional 
amyloids, whereas the red boxes highlight some general properties of disease-
associated amyloids.  
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Figure 1.6. Interbacterial complementation. Curli subunit sharing between adjacent 
cells, or interbacerial complementation, is made possible by the nucleation-precipitation 
mechanism of curli fiber assembly. A csgB mutant (or csgA+ donor strain) secretes 
soluble CsgA into the extracellular milieu. CsgA from a csgB mutant can polymerize on 
a csgA mutant (or csgB+ acceptor) that is presenting CsgB on the cell surface when 
grown in close proximity to one another on a plate. The left panel shows a csgB mutant 
(top) streaked near a csgA mutant (bottom), and on the edge of the CsgB-expressing 
streak there is a Congo red staining region. 
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Table 1.1. Direct Regulators of the Curli Operons.  
Regulators of the csgBAC and csgDEFG promoters. Positive and negative regulation of 
each promoter is indicated by “+” or “-”, respectively. 
 
 
 
 Regulator PcsgBAC PcsgDEFG Evidence Reference(s) 
Transcriptional 
Regulators RpoS + + 
Expression analysis, 
consensus binding site 
(103, 104, 
121, 181) 
 
Crl + + 
Interacts with RpoS 
and stabilizes binding 
to csg promoters 
(102, 104) 
 CsgD + + Expression analysis, consensus binding site (82, 108) 
 MlrA  + Expression analysis, consensus binding site (105, 106) 
 Cra 
(FruR)  + 
Expression analysis, 
consensus binding site (112) 
 Crp  + Expression analysis  (114) 
 RcdA  + Expression analysis, consensus binding site  (113) 
DNA Modifying 
Enzymes IHF  + 
Expression analysis, 
consensus binding site (111, 120) 
 
H-NS  
-/+  
(E. coli/S. 
typhimurium) 
Expression analysis, 
consensus binding site (103, 111, 121) /(120) 
Two-Component 
Systems CpxA/R - - 
Expression analysis, 
consensus binding site 
(111, 115, 
118) 
 EnvZ/ 
OmpR  + 
Expression analysis, 
consensus binding site 
(111, 117-
120, 182) 
 RcsA/B - - Expression analysis (116, 118, 183) 
 
RstB/A  
-/+ 
(basic/acidic 
conditions) 
Expression analysis, 
consensus binding site (111, 184) 
 ArcA/B  + Expression analysis, consensus binding site (185) 
 BasS/R  + Expression analysis, consensus binding site (186) 
Small Regulatory 
RNAs OmrA/B  - 
Antisense binding to 
5’UTR (122) 
 McaS  - Antisense binding to 5’UTR (123, 125) 
 GcvB  - Antisense binding to 5’UTR (123) 
 RprA  - Antisense binding to 5’UTR (123, 124) 
 
ArcZ  + 
Expression analysis 
post-transcriptional 
regulation 
(126) 
 
SdsR  + 
Expression analysis, 
transcriptional 
regulation 
(126) 
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Chapter 2 
Escherichia coli Chaperones DnaK, Hsp33 and Spy Inhibit Bacterial Functional 
Amyloid Assembly2 
 
 
Abstract 
Amyloid formation is an ordered aggregation process, where β-sheet rich polymers are 
assembled from unstructured or partially folded monomers. How two Escherichia coli 
cytosolic chaperones, DnaK and Hsp33, and a more recently characterized periplasmic 
chaperone, Spy, modulate the aggregation of a functional amyloid protein, CsgA is 
examined in this chapter. DnaK, the Hsp70 homologue in E. coli, and Hsp33, a redox-
regulated holdase, potently inhibited CsgA amyloidogenesis. The Hsp33 anti-
amyloidogenesis activity was oxidation dependent, as oxidized Hsp33 was significantly 
more efficient than reduced Hsp33 at preventing CsgA aggregation. When soluble CsgA 
was seeded with preformed amyloid fibers, neither Hsp33 nor DnaK were able to 
efficiently prevent soluble CsgA from adopting the amyloid conformation. Moreover, 
both DnaK and Hsp33 increased the time that CsgA was reactive with the amyloid 
oligomer conformation-specific A11 antibody. The ability of the periplasmic chaperone 
Spy to inhibit CsgA polymerization was also investigated. Like DnaK and Hsp33, Spy 
also inhibited CsgA polymerization in vitro. Overexpression of Spy resulted in increased 
chaperone activity in periplasmic extracts and in reduced curli biogenesis in vivo. We 
propose that DnaK, Hsp33 and Spy exert their effects during the nucleation stages of 
___________________ 
2 A modified version of this chapter was published in Prion (86). Jens Schmidt, 
Marianne Ilbert and Shannon Doyal conducted the DnaK and Hsp33 experiments 
(Figures 2.1, 2.2, 2.3AB and 2.4). Shu Quan, from James Bardwell’s lab, and Ursula 
Jakob’s lab generously donated Spy, DnaK and Hsp33 protein. Sue Wickner 
contributed the DnaK V436F mutant. I contributed the experiments in Figures 2.3C, 2.5 
and 2.6.  
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CsgA fibrillation. Thus, both housekeeping and stress induced cytosolic and periplasmic 
chaperones may be involved in discouraging premature CsgA interactions during curli 
biogenesis. 
 
Introduction 
Amyloid formation is central to human ailments such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease, transmissible spongiform encephalopathies, 
and type II diabetes (1, 2). Proteins and peptides of various primary sequence 
signatures can assemble into amyloids, which are biophysically distinguished as 4-12 
nm wide, β-sheet rich fibers that are highly resistant to denaturation and bind to dyes 
such as thioflavin T (ThT) and Congo red (CR) (3). Amyloid subunits spontaneously 
polymerize into amyloid fibers in vitro after a defined lag phase, which is followed by 
rapid fiber growth (4-6). Although many proteins, if not all, can adopt the amyloid 
conformation in vitro, certain amino acid sequences or cellular environments 
significantly influence in vivo amyloidogenesis (1, 5, 7). 
A new class of ‘functional’ amyloids has been linked to important physiological 
processes in cells. Unlike disease-associated amyloid formation in vivo, which is 
sporadic and difficult to predict, the formation of ‘functional’ amyloids is a tightly 
regulated cellular process (8, 9). Functional amyloids have been identified in nearly all 
walks of life, from bacteria (10-13) to fungi (14-16) to mammals (17, 18). Understanding 
how functional amyloids can form without apparent cellular toxicity will provide new 
insights into the processes that break down during disease-associated amyloid 
formation.  
The first described functional amyloid was curli; extracellular organelles 
assembled by enteric bacteria such as Escherichia coli and Salmonella species (11). 
Curli fibers play an important roll in biofilm formation (19-21), cell adhesion (22), cell 
invasion (23, 24), and induction of the host inflammatory response (25-27). Curli 
biogenesis is highly regulated process and requires the products of two divergently 
transcribed operons (csgBAC and csgDEFG) (28). CsgD is a transcriptional activator of 
the csgBAC operon.(28, 29) CsgG forms an outer membrane lipoprotein required for the 
secretion of the major and minor curli subunits CsgA and CsgB, respectively (29, 30). 
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CsgA is secreted as a soluble, unstructured peptide and is nucleated into an 
extracellular amyloid fiber by the cell surface-associated CsgB (11, 31-33). CsgF assists 
in attachment of CsgA fibers to the cell surface and assists CsgB in its nucleation 
function (34). CsgE functions as a specificity factor in the periplasm for CsgG-mediated 
secretion of curli subunits and possesses chaperone activity in vitro (35). CsgC 
putatively collaborates with CsgG to regulate the passage of proteins and small 
molecules through CsgG (36, 37). Curli biogenesis must be a finely tuned system in 
order to prevent intracellular aggregation of CsgA.  
The primary amino acid sequence of CsgA features five imperfect repeating units 
that are predicted to form a β-helix with an overall cross β-strand structure (38, 39). 
Repeating units one and five are highly amyloidogenic and contain conserved glutamine 
and asparagine residues that promote amyloid formation (40). Repeating units two, 
three and four contain gatekeeper residues, which reduce the propensity to form 
amyloids on their own (41). The separation of the amyloidogenic regions of CsgA is 
believed to help reduce the occurrence of premature amyloid formation within the cell. 
CsgA also contains a Sec-secretion signal sequence and an N-terminal 22 amino acid 
sequence on the mature protein that is required for CsgG-mediated translocation across 
the outer membrane (30, 35). Both CsgA and CsgB proteins are at undetectable levels 
by western blot in the absence of CsgG (29). Whether this is due to proteolytic 
degradation of CsgA and CsgB or transcriptional repression remains to be established.  
During synthesis and export, CsgA may be exposed to the cytosolic and 
periplasmic chaperone machinery, which could modulate amyloidogenesis by 
preventing inappropriate amyloid fiber formation within the cell. How the cellular 
chaperone machinery engages amyloidogenic proteins, especially functional amyloids, 
is poorly understood. Recent studies have shown that the human chaperone Hsp70 
partially prevents amyloid formation of the disease-associated proteins Aβ(1-42) and α-
synuclein (42, 43). Hsp70 is an ATPase but can inhibit Aβ amyloidogenesis in the 
absence of ATP and its cochaperone Hsp40 (44). DnaK, the Hsp70 homologue in E. 
coli (45), has been shown to prevent protein aggregation and assist in the refolding of 
denatured proteins or remodeling of large protein aggregates (46, 47). DnaK is 
composed of two functional domains, the ATPase domain and the substrate-binding 
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domain (48). Substrate binding and release by DnaK is regulated by the nature of the 
nucleotide bound to the ATPase domain (49, 50). The ATP bound form of DnaK has a 
significantly lower substrate affinity than the ADP bound form (48). The ATPase cycle of 
DnaK is regulated by the co-chaperones DnaJ and GrpE (46). DnaJ stimulates the 
DnaK ATPase activity, while GrpE is a nucleotide exchange factor that stimulates the 
release of ADP from DnaK (51, 52). DnaJ, or a DnaJ homolog, and GrpE are essential 
for DnaK activity in vivo and in in vitro luciferase disaggregation assays (53). 
Hsp33 is a “holdase’ chaperone (54). Holdase chaperones are not thought to 
actively refold denatured substrates, but instead quench exposed hydrophobic regions 
of proteins during periods of transient cellular stress (54). Hsp33 expression is 
controlled by σ32, the heat shock transcription initiation factor, and is induced at elevated 
temperatures and other conditions that trigger protein denaturation (55). Hsp33 is 
activated at the protein level by oxidizing and denaturing conditions (54). Four cysteine 
residues located in Hsp33’s C-terminal redox-switch domain coordinate Zn2+ under 
reducing conditions (56, 57). When oxidized, these cysteine residues form two disulfide 
bonds and the Zn2+ is released from the protein (58). A second region on the C-terminal 
domain of Hsp33 senses denaturing conditions (59). The combination of oxidizing and 
denaturing conditions triggers full activation and dimerization of Hsp33, which then acts 
as a holdase with broad specificity (54). Hsp33 efficiently protects the cell from protein 
aggregation in the cytoplasm under aggregation inducing conditions (60). 
CsgA traverses the periplasmic space where it may be exposed to periplasmic 
proteostatic mediators that may play a role in maintaining CsgA in a soluble form prior 
to secretion across the outer membrane. The curli specific accessory protein CsgE 
exhibits chaperone activity towards CsgA in vitro by inhibiting polymerization.(35) Spy, a 
newly characterized periplasmic holdase (61), can prevent CsgA from polymerizing into 
an amyloid aggregate in vitro. Spy is under the regulation of the Cpx and Bae two-
component systems, both of which are induced by stresses that promote protein 
misfolding and aggregation (62-65). Interestingly, both of the curli operons are 
negatively regulated by the Cpx system (64). Whether the Cpx stress response is 
induced during curli biogenesis has yet to be determined.  
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 In this chapter Hsp33, DnaK and Spy are demonstrated to be potent inhibitors of 
CsgA fiber formation in vitro. Sub-stoichiometric amounts of DnaK transiently prevent 
CsgA polymerization in the absence of the co-chaperones DnaJ and GrpE, and without 
the addition of ATP. Hsp33 not only interfered with polymerization initiation, but also 
reduced the total amount of amyloid fibers formed. Spy, in addition to inhibiting CsgA 
polymerization in vitro, reduced curli biogenesis when overexpressed in vivo. The 
inhibition of CsgA fiber formation by DnaK, Hsp33 and Spy can be overcome by the 
addition of preformed CsgA fibers. Moreover, Hsp33 and DnaK did not prevent the 
formation of a structurally conserved transient CsgA intermediate that is also formed by 
disease-associated amyloids. These chaperones may be part of a control mechanism 
protecting the cell from inappropriate amyloid formation within the cell. 
 
Results 
DnaK inhibits CsgA amyloid formation.  
The conversion of soluble amyloidogenic monomeric proteins to an ordered 
amyloid fiber in vitro can be measured using the amyloid specific dye thioflavin T (ThT). 
When freshly purified CsgA was mixed with ThT, fluorescence emission increased 
rapidly after an approximately 2-hour lag phase (Fig. 2.1A). The rapid growth phase of 
CsgA fibers was followed by a stationary phase, consistent with previous findings (Fig. 
2.1A) (6). When comparing CsgA polymerization profiles in the presence or absence of 
chaperone proteins, two parameters were measured. The first kinetic parameter was 
calculated as the time period preceding rapid fiber growth, called lag phase. The second 
parameter, called the elongation phase, was calculated as the time period 
encompassing the fiber growth phase from initiation of rapid polymerization to its 
completion (6, 66).  
To determine if DnaK affects CsgA amyloid formation in vitro, ThT fluorescence 
was measured in the presence or absence of DnaK. DnaK increased the lag phase 3 
and 8 fold at molar ratios of 1:20 and 1:5 (DnaK:CsgA), respectively (Fig. 2.1A). 
However, once CsgA started to aggregate, neither the rate of fiber formation nor the 
maximal ThT fluorescence were affected by the presence of the chaperone (Fig. 2.1A). 
To determine if the ability of DnaK to inhibit CsgA polymerization was dependent on the 
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intact DnaK substrate-binding domain, the DnaKV436F mutant was tested in the ThT 
assay. The DnaKV436F mutant has reduced substrate affinity, but similar substrate 
specificity (67). When added to soluble CsgA, DnaKV436F was significantly less efficient 
at inhibiting CsgA fiber formation compared to wild type DnaK (Fig. 2.1B). Wild type 
DnaK prevented CsgA polymerization for greater than 30 hours, while an equivalent 
concentration of DnaKV436F only increased the lag phase from 2 hours to 7 hours (Fig. 
2.1B).  
To verify that the observed effect was due to the inhibition of CsgA 
polymerization, and not due to an indirect effect such as interference of the chaperone 
with ThT fluorescence CsgA solubility was measured in the presence and absence of 
DnaK. As an amyloid, curli are highly resistant to denaturation and require treatment 
with a harsh denaturant such as formic acid (FA) or hexafluoro-2-propanol (HFIP) to 
liberate the monomeric species (11). After 13 hours of incubation, polymerization 
reactions were centrifuged to separate the soluble and insoluble CsgA prior to analysis 
by SDS-PAGE. Duplicate samples were treated with 80% (w/w) FA to depolymerize 
CsgA aggregates (11, 68). CsgA was present only in the FA treated pellet samples after 
13 hours of incubation in the absence of DnaK indicating that CsgA was entirely in the 
polymerized form (Fig. 2.1C lanes 1-4). After 13 hours in the presence of DnaK, 
however, CsgA was still detected in the non-FA treated supernatant samples 
suggesting that DnaK maintains CsgA in a soluble state (Fig. 2.1C lanes 5-8). These 
results were in agreement with transmission electron micrograph (TEM) images. CsgA 
formed unbranched fibers in the absence of DnaK; however, no such fibers were 
observed when CsgA was incubated in the presence of DnaK for 13 hours (Fig. 2.1D, 
1E). 
 
Oxidized Hsp33 inhibits CsgA polymerization in vitro.  
Hsp33 is a homodimeric molecular chaperone which, when activated by oxidative 
stress, functions as a potent holdase. To determine if Hsp33 influences amyloid 
formation, CsgA fiber formation was monitored in vitro using ThT fluorescence (69, 70). 
Reduced, chaperone-inactive, Hsp33red, and oxidized, chaperone-active, Hsp33ox, 
were assayed for the ability to inhibit CsgA polymerization in vitro.(54) The presence of 
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Hsp33ox at a 1:80 (Hsp33ox dimer:CsgA) molar ratio increased the lag phase of CsgA 
fiber formation to 8 hours (Fig. 2.2A). The presence of Hsp33ox at a molar ratio of 1:20 
increased the lag phase by 13 hours, while a molar ratio of 1:4 prevented CsgA 
polymerization for a time that was greater than the duration of the experiment (Fig. 
2.2A). To verify that Hsp33 interfered with CsgA fiber formation and not with the ThT 
fluorescence, a CsgA solubility assay was conducted. All CsgA-containing samples had 
one band corresponding to CsgA in the pellet fraction treated with FA (Fig. 2.2B, lane 
4). The majority of CsgA was present in the supernatant fraction of samples that 
contained Hsp33ox and CsgA at a 1:2 molar ratio signifying that CsgA was maintained 
in an SDS-soluble form (Fig. 2.2B, lanes 5-6). Fibers were observed by TEM in samples 
containing only CsgA, while no fibers were observed in samples containing both CsgA 
and Hsp33ox (Fig. 2.2C and 2D). 
In contrast to Hsp33ox, Hsp33red had only marginal effects on CsgA 
polymerization in vitro (Fig. 2.2E). Consistent with the ThT results, CsgA was mostly 
present in the pellet fraction of samples containing Hsp33red and CsgA at a 1:2 molar 
ratio (Fig. 2.2F lane 8). Significantly smaller amounts of CsgA were present in the 
supernatant fraction along with large quantities of Hsp33red (Fig. 2.2F, lanes 5-6). CsgA 
polymerization was also monitored by TEM. Regular, unbranched fibers were observed 
when CsgA was incubated alone or with Hsp33red for 13 hours (Fig. 2.2G, 2H). 
Together, these results demonstrate that oxidized, but not reduced, Hsp33 maintains 
CsgA in a soluble state.  
 
Hsp33ox and DnaK prolong the presence of a transient folding intermediate common to 
amyloids.  
The conformation-specific antibody A11 recognizes a conserved, transient folding 
intermediate that is present during the polymerization of many functional and disease-
associated amyloids (6, 71, 72). Although the exact molecular structure that A11 
recognizes is unresolved, it is proposed to be an ordered intermediate that precedes the 
mature amyloid fiber (71). A11 transiently recognizes freshly purified CsgA during the 
first part of its transition to an amyloid fiber. However, once polymerization reaches 
stationary phase, no A11 reactive species can be observed (6). The A11 antibody was 
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therefore used to test if Hsp33ox and DnaK act on CsgA in a manner that impacts 
progression from an A11-reactive conformation to an amyloid conformation. Freshly 
purified CsgA monomers were incubated with substoichiometric concentrations of DnaK 
or Hsp33ox. Samples were removed at the indicated time points (Fig. 2.3A, arrows) and 
spotted onto a nitrocellulose membrane. An A11-reactive species was detectable up to 
approximately 8 hours when CsgA was incubated in the absence of chaperone (Fig. 
2.3A, 3B). In the presence of DnaK, the lag phase is increased from 2 hours to 10 hours 
and the A11-reactive species was detectable for up to 15 hours (Fig. 2.3A, 3B). When 
CsgA was incubated with Hsp33ox the A11-reactive species did not disappear for more 
than 24 hours after the start of the reaction (Fig. 2.3B). The persistence of the A11 
reactive species was not due to cross-reactivity with Hsp33ox, as the A11 antibody did 
not react with the above assayed concentration of purified Hsp33ox (Figure 2.3C). The 
small amount of cross-reactivity observed for the A11 antibody with DnaK (Fig. 2.3C) is 
consistent with previous findings that the A11 antibody reacts with Hsp70 and 
particularly with the substrate binding domain of Hsp70; however, Lotz et al. did not 
observe reactivity with full-length DnaK (44, 73). 
 
The inhibitory effects of Hsp33 and DnaK are abolished by the addition of CsgA seed.  
CsgA amyloid formation can be accelerated or ‘seeded’ by the addition of 
preformed CsgA fibers.(6) To determine whether DnaK and Hsp33ox alter CsgA 
seeding by preformed fibers, polymerization assays were carried out in the presence of 
different CsgA seed concentrations. CsgA seed concentrations as low as 3% 
(weight/weight relative to soluble monomer) eliminated the lag phase of CsgA amyloid 
formation as has been previously demonstrated (Fig. 2.4A) (6). The inhibitory effects of 
DnaK and Hsp33ox, as well as the lag phase of CsgA fiber formation, were reduced by 
the addition of 3% (w/w) CsgA seed, and abolished by 12% (w/w) CsgA seed for both 
chaperones (Fig. 2.4B, 4C; note the time scales are different in A from B and C). In the 
presence of 3% seed there was an initial burst of fluorescence signal, a phase of 
minimal fluorescence increase and a more rapid growth phase that concluded in a 
stationary phase (Fig. 2.4B, 4C). Hsp33 reduced the maximum ThT fluorescence by a 
similar amount in the presence and absence of CsgA seed (Fig. 2.4C). The observation 
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that the final ThT fluorescence remains reduced in the presence of Hsp33 and 12% 
CsgA seeds suggests that Hsp33 is sequestering a population of CsgA that cannot be 
incorporated into an amyloid (Fig. 2.4C compare solid and dotted lines). 
 
Spy inhibits CsgA Polymerization in vitro. 
 Spy is a periplasmic chaperone that is regulated by the Cpx and Bae 
extracellular stress responses, both of which are induced by conditions that stress the 
proteome (62-65). Spy exists as a homodimer and is structurally homologous to CpxP, 
the adaptor protein of the Cpx two-component stress response system. CpxP has also 
been proposed to act as a chaperone (61, 74, 75). However, Spy has two hydrophobic 
patches in the concave surface of its structure that may be involved in substrate binding 
and chaperone activity; similar hydrophobic patches are less well defined in CpxP (61, 
75). CsgA was tested as a substrate for Spy since CsgA passes through the periplasm 
and, as a functional amyloid, is prone to ordered aggregation. No amyloid aggregates 
have been detected in the periplasm, therefore, we hypothesized that chaperone 
proteins like Spy may help to keep CsgA soluble as it passes through the periplasm to 
the cell surface.  
To test the ability of Spy to prevent CsgA aggregation, purified Spy was mixed 
with freshly purified, monomeric CsgA and monitored polymerization in vitro by ThT 
fluorescence. Spy inhibited CsgA polymerization in a concentration dependent manner 
(Fig. 2.5A). Like DnaK and Hsp33, inhibition by Spy could also be overcome by the 
addition of preformed fibers (Fig. 2.5B). Spy inhibited CsgA polymerization but the 
addition of comparable concentrations of CpxP to soluble CsgA had no effect on the 
polymerization of CsgA (data not shown). Comparison of these seemingly similar 
proteins will likely reveal their distinct functions in envelope stress responses.  
Deletion of spy from the curli-expressing strain BW25113 had no effect on curli 
biogenesis (data not shown). It has been shown that some periplasmic chaperones are 
functionally redundant and can compensate for the loss of a single chaperone (76, 77). 
It is therefore not surprising that the spy deletion did not produce an observable 
phenotype. However, when Spy was overexpressed, cells exhibited reduced Congo red 
binding (Fig. 2.6A) consistent with reduced CsgA protein levels by western blot (Fig. 
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2.6B). One possible explanation for this result is that stabilization of unfolded CsgA by 
Spy in the periplasm allows for more efficient proteolytic degradation of CsgA and 
therefore less secretion and curli assembly. Alternatively, the excessive production and 
secretion of Spy may have titrated resources that are required for the production and 
secretion of curli subunits. CsgG levels are not as dramatically reduced as CsgA levels, 
suggesting that CsgA is more sensitive to Spy overexpression. Because CsgG levels 
remain similar to WT when Spy is overexpressed, it is unlikely that there was not 
competition for secretion or significant feedback repression of the curli operons (Fig. 
2.6B).  
Next, it was tested whether reduced curli assembly was due to an increased 
chaperone capacity in the periplasm. Periplasmic protein extracts (PEs) were harvested 
and added back to freshly purified CsgA monomers, polymerization was monitored by 
ThT fluorescence in vitro (Fig. 2.6C). Periplasmic proteins from WT BW25113 with 
empty vector (vector) or overexpressing Spy (pSpy) were harvested. PEs from cells with 
empty vector showed a minimal effect on CsgA polymerization (Fig. 2.6C, long dashes). 
However, PEs from cells overexpressing Spy inhibited CsgA polymerization (Fig. 2.6C, 
short dashes). After 20 hours, CsgA was found to be in an SDS-insoluble state after 
incubation with periplasmic extracts from WT cells with empty vector only but primarily 
in an SDS-soluble state after incubation with periplasmic extracts from cells 
overexpressing Spy (Fig. 2.6D). These results demonstrate that the periplasmic 
chaperone activity was likely due to an increase in Spy protein in the periplasm.  
 
Discussion 
Amyloidogenesis is an ordered aggregation process. Amyloidogenic proteins, 
such as CsgA, are unstructured prior to their assembly into highly ordered aggregates 
making them likely targets for chaperone proteins. Consistent with this idea, human 
Hsp70 influences amyloid fiber formation of Aβ(1-42) and α-synuclein (42, 43). Also, the 
small heat shock protein (sHsp) αB-crystallin and the sHsp-like clusterin have been 
shown to influence amyloid formation (78-80). Our results demonstrate that the 
endogenous bacterial chaperones DnaK, Hsp33 and Spy are potent inhibitors of CsgA 
fiber formation. 
 51"
Like most amyloidogenic proteins, CsgA polymerizes by a nucleation-
precipitation growth mechanism. Fiber growth is preceded by a lag phase, during which 
nuclei putatively form and subsequently drive fiber formation. Nucleation is the rate-
limiting step of CsgA polymerization, resulting in an approximately 2-hour lag phase 
(Fig. 2.4A) during which “needlelike” protofibers have been observed by TEM (81, 82). 
The presence of DnaK and Hsp33 significantly increased the length of the lag phase of 
CsgA polymerization, apparently by maintaining CsgA in a soluble state. This data 
suggests that both chaperones interfere with CsgA amyloidogenesis. Spy also inhibited 
CsgA but required a 1:1 molar ratio (Spy dimer:CsgA monomer), suggesting either an 
alternative mechanism of inhibition or simply lower affinity for CsgA. 
While DnaK increased the lag phase of CsgA polymerization, it does not appear 
to significantly affect fiber growth. The presence of DnaK did not appreciably change the 
time from the onset of fast polymerization to stationary phase, or the maximum ThT 
fluorescence. The ability of DnaK to inhibit CsgA polymerization required an intact DnaK 
substrate-binding site, as the DnaK V436F mutant, which shows reduced substrate 
affinity, was far less efficient in inhibiting CsgA fiber formation. Therefore, we suggest 
that DnaK most likely interacts transiently with CsgA, preventing an early step in fiber 
formation, while it does not interfere with polymerization after nucleation in the absence 
of ATP. This model is also supported by the observation that the same maximal ThT 
fluorescence is detected in the presence and absence of DnaK.  
In contrast to DnaK, Hsp33 not only lengthened the lag phase of CsgA fiber 
formation but it also altered CsgA fiber elongation kinetics. Hsp33 decreased the rate of 
elongation and reduced the total amount of polymerized CsgA. Fiber formation is 
prevented entirely at an Hsp33 to CsgA molar ratio of 1 to 4. This observation is similar 
to the results of previous studies with the sHsp-like clusterin (78). The inhibitory effect of 
Hsp33 is dependent on its redox state. The reduced form shows little inhibitory activity, 
while the oxidized form is a very potent inhibitor. We propose that Hsp33, like DnaK, 
binds to a folding intermediate, preventing nucleus formation or maturation from the 
“needlelike” oligomers into a fiber-competent conformation. Two models can be 
proposed in order to explain why sub-stoichiometric amounts of Hsp33 are sufficient to 
prevent CsgA fiber formation. Hsp33 could tightly associate with an oligomeric folding 
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intermediate, arresting a large amount of CsgA in an elongation incompetent state, 
leading to a reduced CsgA monomer and amyloid fiber concentration. Such a reduced 
monomer concentration would explain the slower polymerization and overall reduced 
yield of amyloid fibers formed. Alternatively, a transient interaction could lead to the 
release of an altered CsgA molecule with modified amyloid forming potential. Similar 
models have been proposed to explain the inhibition of Aβ fiber formation by Hsp70/40 
and Hsp90 (42).  
Spy may inhibit CsgA polymerization at a step prior to oligomerization. Spy has a 
slight effect on CsgA polymerization at substoichiometric concentrations, but does not 
exhibit full inhibition unless at a 1:1 molar ratio of CsgA to Spy dimer (Fig. 2.5A). 
Seeding assays provide further evidence that Spy inhibits oligomerization given that the 
polymerization kinetics of a seeded reaction in the presence of Spy more closely 
resemble that of a seeded reaction in the absence of chaperone (Fig. 2.5B). These 
results suggest that Spy is stabilizing the soluble monomeric species of CsgA and are 
consistent with the findings of Quan et al demonstrating full aggregation inhibition of 
denatured MDH and aldolase at a 1:1 molar ratio (61).  
It has been proposed that there are two nucleation pathways involved in amyloid 
fiber formation: 1) Fiber independent nucleation is involved in the initial formation of 
amyloid fibers during the lag phase, and 2) fiber dependent nucleation predominates 
after initial fiber formation and is the driving force of seeded polymerization reactions. 
The presence of both pathways has been demonstrated for amyloid formation by Islet 
Amyloid Polypeptide (83). When CsgA monomer is nucleated by preformed fibers, the 
presence of Hsp33, DnaK or Spy no longer prevented the seeding of CsgA into an 
amyloid fiber (Fig. 2.4, Fig. 2.5), suggesting that they interfere with fiber independent 
nucleation, and not with fiber dependent nucleation. The folding step that is inhibited by 
Hsp33, DnaK and Spy might not be necessary for CsgA to be competent for fiber 
dependent nucleation. This would explain the observation that preformed fibers 
circumvent the inhibitory effects of these chaperones. However, even in a seeded 
reaction, Hsp33 reduces the amount of CsgA fibers formed, although no effect on the 
lag phase is observed. This observation suggests again that Hsp33 arrests a fraction of 
CsgA in a state incompetent for fiber formation. DnaK and Spy, on the other hand, 
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appear to act at an earlier stage: possibly stabilizing soluble monomers of CsgA prior to 
oligomerization.  
Disease associated amyloids such as Aβ and PrP form a transient oligomeric 
species, which is recognized by the A11 antibody (71). Freshly purified CsgA is 
recognized by the A11 antibody, while CsgA denatured with guanidine hydrochloride is 
not recognized (6). The CsgA species that is recognized by the A11-antibody has been 
shown to be either monomeric or dimeric, but may be an off-pathway step in amyloid 
fiber formation (6). DnaK and Hsp33 increase the time that the A11-recognized species 
is present during CsgA polymerization, suggesting that CsgA undergoes at least one 
rapid folding step into the A11-recognized species before the chaperones inhibit further 
folding and fiber elongation. Further experiments will have to be carried out to determine 
the relevance of the species recognized by the A11-antibody in the amyloid formation 
pathway of CsgA. Hsp33 may be a suitable tool for these experiments. 
A role for DnaK, Hsp33 and Spy during curli biogenesis in vivo remains to be 
determined. Our data suggest that chaperones could provide a cellular control 
mechanism to protect the cell from premature amyloid formation prior to export of CsgA 
covering different physiological situations and in different subcellular compartments. 
They most likely interfere with fiber independent nucleation, which would be 
predominant in the cytosol after CsgA synthesis and during secretion across the 
periplasmic space. Curli assembly was reduced by increasing the chaperone capacity of 
the periplasm through the overexpression of Spy, suggesting that cells carefully balance 
curli subunit secretion with proteostatic mediators in the periplasm. Curli biogenesis is 
tightly controlled at the level of transcription, export and nucleation (reviewed in ref. 
(84)); chaperone mediated assembly of curli adds another dimension to the controlled 
nature this system. 
 
Materials and Methods 
CsgA Purification. CsgG and CsgA-6XHis were overexpressed in LSR12 (C600::∆csg) 
and CsgA-6XHis was purified from the growth media as previously described (6, 11). To 
remove the imidazole, eluates were run over a gel filtration column (Sephadex G-25 fine, 
Amersham Biosciences), into either 50 mM potassium phosphate buffer pH 7.2 (KPi), or 
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50 mM KPi pH 7.2 that was supplemented with 50 mM potassium chloride (KCl). CsgA-
6XHis polymerizes into an amyloid fiber with similar kinetics to wild type CsgA in vitro, 
and will be referred to as ‘CsgA’ in this paper (11). 
Hsp33 Purification. Hsp33 was purified as previously described (54). The reduction of 
Hsp33 was performed as previously described (58). To oxidize Hsp33, it was treated 
with 2 mM H2O2 at 43oC for 1 hour prior to buffer exchange into 40 mM KPi pH 7.5, as 
previously described (59). 
DnaK purification. Wild type and mutant DnaK (V436F) was purified as previously 
described (85) with slight modifications. Mutant DnaK was created by site-directed 
mutagenesis using the QuikChange kit (Stratagene). 
Spy Purification. Spy was purified as previously described (61). 
Periplasmic Extract Preparation. WT BW25133 cells were made chemically 
competent and transformed with pCDFT (vector) or pCDFTrckanBamHI-spy (pSpy)(61) 
were grown in LB at 37°C overnight and then plated on YESCA plates supplemented 
with kanamycin and grown for 2 days at 26°C. It was unnecessary to induce Spy 
expression as increased Spy levels could be observed by coomassie stained SDS-
PAGE (data not shown). Cells were harvested in 20 mM Tris (pH 8.0). Cells were 
collected by centrifugation at 8,000 rcf for 10 minutes followed by incubation in osmotic 
shock buffer (30 mM Tris, 40% sucrose 2 mM EDTA, pH 7.3) for 10 minutes. Cells were 
pelleted at room temperature and resuspended in 2 mM MgCl, incubated on ice for 3 
minutes and pelleted again. The supernatant was kept as the periplasmic extract (PE). 
ThT Fiber Formation Assay. Each experiment shown is a representative of at least 
three replicates. Freshly purified CsgA was mixed with 20 µM ThT and incubated in the 
presence of DnaK or Hsp33 in a black 96-well flat bottom plate (Corning Inc.), which 
was placed in a Spectramax M2 plate reader (Molecular Devices; Figures 1-4). The 
plate reader was maintained at 25oC for all experiments. 50 mM KPi pH 7.2 was used 
as reaction buffer for all experiments involving Hsp33. For experiments involving DnaK, 
50 mM KPi 50 mM KCl pH 7.2 was used as reaction buffer. Unless stated differently the 
reaction volumes were 100 µl. Molar ratios are reported in terms of monomeric DnaK 
and dimeric Hsp33. Fluorescence was monitored in ten-minute intervals at 495 nm after 
excitation at 438 nm. The cut off of the plate reader was set to 475 nm. The plate was 
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shaken for 5 seconds prior to each read. CsgA polymerization in the presence of Spy 
and periplasmic extracts were conducted in 50uL reaction volumes in 50 mM KPi (pH 
7.3) with 20uM ThT. ThT readings were taken in a Infinite 200 Pro NanoQuant plate 
reader (Tecan Group LTD; Figures 5 and 6) every 10 minutes after 2 seconds of 
shaking at 2.5 mm amplitude with an excitation wavelength of 438 nm and emission 
wavelength of 495 nm. Molar ratios are reported in terms of Spy dimer. At least three 
replicates of each assay were conducted.  
CsgA Solubility Assay. 100 µL CsgA samples supplemented with the respective 
chaperones were incubated in 96-well plates in a Spectramax M2 plate reader at 25oC. 
Identical samples were supplemented with 20 µM ThT to monitor amyloid formation. 
ThT fluorescence was monitored as described above. After 13 hours 30 µL aliquots 
were taken from the CsgA samples and centrifuged at 70,000 x g for one hour at 4oC in 
1.5 ml polyallomer tubes (Beckman Instruments) using a TLA-55 rotor (Beckman 
Coulter) in an Optima TLX ultracentrifuge (Beckman Coulter). After centrifugation, the 
supernatant fractions (~30 µL) were transferred into a fresh tube. Pellet fractions were 
treated with 50 µL 95% (w/w) formic acid (Sigma-Aldrich, F0507), while 95% formic acid 
was added to the supernatant fraction yielding a final formic acid concentration of 76%. 
Immediately after addition of formic acid the samples were placed in a SPD111V 
SpeedVac (Thermo Fisher Scientific) and all solvent was removed. The formic acid 
treated samples were resuspended in 4xSDS sample buffer (125 mM Tris pH 6.8, 10% 
2-Mercaptoethanol, 20% Glycerol, 6% sodium dodecyl sulfate, 0.02% bromophenol 
blue), sonicated for ten minutes in a Solidstate/Ultrasonic FS-14 bath sonicator (Fisher 
Scientific) before incubating at 95oC for 10 minutes. Formic acid treated and untreated 
samples were then analyzed by SDS-PAGE and Coomassie staining. The solubility of 
CsgA after incubation with periplasmic extracts was determined similarly. Soluble and 
insoluble CsgA were separated by centrifugation in an Eppendorf 5415R centrifuge in 
duplicate. Pellets were treated with 40µL 4xSDS sample buffer or 50µL hexafluoro-2-
propanol (HFIP; Sigma Aldrich) for 10 minutes and then dried in a SPD111V SpeedVac 
(Thermo Fisher Scientific) before resuspension in 40µL of 4xSDS sample buffer. 
Supernatants were treated with and equal volume of 4xSDS sample buffer or with a 
final concentration of 80% HFIP for 10 minutes, dried and then resuspended in 40µL 
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4xSDS sample buffer. Samples were boiled for 10 minutes prior to loading on a 15% 
SDS-PAGE gel and analyzed by Coomassie staining. 
Dot-Blot Assay with A11. The blot assay was carried out as previously described.(6) 
CsgA samples were taken from fiber formation reactions in 96 well plates that were 
simultaneously monitored with ThT fluorescence in separate wells at 25oC, as described 
above. 
Whole cell Western Blot. BW25113 with pCDFT (vector) or pCDFTrckanBamHI-spy 
(pSpy) were grown overnight in LB supplemented with kanamycin at 37°C. Cultures 
were diluted to OD=1.0 in 50 mM KPi (pH 7.3) and 4 µL were spotted on a YESCA plate 
and grown for 48 hours at 26°C. Cells were harvested in 1 mL of 50 mM KPi (pH 7.3). 
Two 100µL samples were taken from a 1.0 OD suspension and pelleted at 16,000 rcf 
for 10 minutes. Samples were either treated with 40 µL of 2 x SDS loading buffer or 
50µL of hexafluoro-2-propanol (Sigma-Aldrich, 52512), dried in a Thermo Savant SPD 
SpeedVac (Thermo Fisher Scientific) and then treated with 40 µL of 2x SDS loading 
buffer. 7 µL were loaded in a 15% SDS PAGE gel, transferred to 0.45 µm PVDF 
transfer membrane (Thermo Fisher Scientific), and blocked overnight in TBS-T 5% skim 
milk. Blots were probed with anti-CsgA (1:10,000) and anti-CsgG (1:70,000) polyclonal 
antibodies followed by goat-anti-rabbit (1:10,000; Sigma-Aldrich, A0545). 
Electron Microscopy. Electron microscopy sample preparation and image acquisition 
was carried out as previously described (6). 
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Figures 
 
Figure 2.1. In vitro CsgA fiber formation in the presence of DnaK. (A) Freshly 
purified 20 µM CsgA was incubated with 20 µM ThT alone or with various 
concentrations of DnaK. Fluorescence was measured in 10-minute intervals at 495 nm 
after excitation at 438 nm. Fluorescence is reported in arbitrary units (AU). (B) A 
mutation in the substrate-binding domain significantly reduces DnaK’s inhibitory effect 
on CsgA fiber formation in vitro. Freshly purified 20 µM CsgA was incubated with 20 µM 
ThT alone or with either DnaK or DnaKV436F at a 1:4 molar ratio (DnaK:CsgA). 
Fluorescence was measured as in (A). (A) and (B) are representative data of three 
replicates. (C) After 13 hours samples were taken from the CsgA alone or DnaK+CsgA 
(1:4 molar ratio, DnaK:CsgA) polymerization reactions shown in Fig. 2.1A and 
separated into soluble (S) and polymerized (P) fractions by centrifugation prior to 
treatment with FA. The fractions were run on a 13% SDS-PAGE gel and visualized by 
Coomassie brilliant blue staining. At the same timepoint 10 µL samples containing CsgA 
only (D) or CsgA and DnaK (E) were applied to formvar coated copper grids, stained 
with uranyl actetate and examined by TEM. 
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Figure 2.2. In vitro CsgA fiber formation in the presence of Hsp33. (A) Freshly 
purified 20 µM CsgA was incubated with 20 µM ThT both alone and with various 
concentrations of Hsp33ox. Fluorescence was measured as in Fig. 2.1A. Shown are 
representative data of three replicates. (B) After 13 hours samples were taken from the 
CsgA alone or Hsp33+CsgA at a 1:4 molar ratio (Hsp33:CsgA) polymerization reactions 
shown in (A,) separated into soluble (S) and polymerized (P) fractions and treated as 
described in Fig. 2.1C. At the same timepoint, 10 µL samples containing CsgA only (C) 
or CsgA and Hsp33 (D) were applied to formvar coated copper grids, stained with 
uranyl actetate and examined by TEM. Hsp33red only minimally effects in vitro CsgA 
polymerization. (E) Freshly purified 20 µM CsgA was incubated with 20 µM ThT alone 
or with either Hsp33ox or Hsp33red, each at a 1:4 molar ratio (Hsp33:CsgA). Shown are 
representative data of three replicates. (F) After 13 hours samples were taken from the 
polymerization reactions (1:4Hsp33ox:CsgA and 1:2 Hsp33red:CsgA), separated into 
soluble (S) and polymerized (P) fractions and treated as described in Fig. 2.1C. 
Samples were also analyzed by negative stain TEM. CsgA only (G) or CsgA and 
Hsp33red (H) were applied to formvar coated copper grids, stained with uranyl acetate 
and examined by TEM. 
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Figure 2.3. Hsp33ox and DnaK significantly prolong the presence of a CsgA 
intermediate that is recognized by the A11 antibody. (A) Freshly purified 40 µM 
CsgA was incubated with 20 µM ThT alone or with either DnaK or Hsp33ox. 
Fluorescence was measured as described in Fig. 2.1A. Shown are representative data 
of three replicates. (B) Samples (3 µL) of identical polymerization reactions, containing 
no ThT, were spotted on a nitrocellulose membrane and were probed with the A11 
antibody. Samples were taken at indicated intervals (arrows) over the course of 24 
hours. (C) Freshly purified 40 µM CsgA, 5 µM DnaK and 5 µM Hsp33ox, the same 
concentrations used in parts (A) and (B), were spotted on a nitrocellulose membrane 
and probed with the A11 antibody.  
 
 
 
 
 
 
 
 
 
0
100
200
300
400
500
600
0 10 20 30 40
40 µM CsgA
1:5 DnaK:CsgA
1:5 Hsp33:CsgA
Time (h)
Fl
uo
re
sc
e
n
ce
 
(A
U)
CsgA
CsgA + DnaK
CsgA + Hsp33
0 0:4
0
1:2
5
2:2
0
3:0
5
4:1
0
5:1
5
6:3
0
7:3
5
8:5
0
10
:30
11
:55
13
:30
15
:20
18
:30
21
:00
23
:45
A
B
Time (h:min)
C
α
-
Cs
gA
A1
1
CsgA
DnaK
Hsp33
 60"
Figure 2.4. The addition of preformed fibers abolishes the inhibitory effects of 
Hsp33ox and DnaK on CsgA amyloid formation. (A) Freshly purified 20 µM CsgA 
was incubated with 20 µM ThT and DnaK (B) or Hsp33ox (C). In addition, 3% (w/w 
relative to CsgA monomer) or 12% sonicated, preformed CsgA fibers were added to the 
polymerization reactions as indicated. Fluorescence was measured as described in Fig. 
2.1A. Shown are representative data sets of three replicates. 
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Figure 2.5. In vitro CsgA fiber formation in the presence of Spy. (A) 20µM freshly 
purified CsgA was incubated with 20µM ThT alone or in the presence of various molar 
ratios of Spy. Fluorescence was measured as described in Fig. 2.1A. (B) Freshly 
purified 20 µM CsgA was incubated with 20 µM ThT alone or in the presence of 20µM 
Spy with and without 2% (w/w relative to CsgA monomer) sonicated, preformed CsgA 
fibers. Fluorescence was measured as described in Fig. 2.1A. Shown are 
representative data sets of three replicates. 
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Figure 2.6. Overexpression of Spy reduces curli secretion and assembly. (A) WT 
BW25113 and curli- (csgBAC- csgDEFG-) were transformed with pCDFTrc (vector) or 
pCDFTrckanBamHI-spy (pSpy). Overnight cultures were washed with 50mM KPi (pH 
7.3) and diluted to OD=1.0. 4µL of washed cells were spotted on a YESCA plate 
containing Congo red and grown for 2 days at 26°C. (B) WT BW25113 cells 
transformed with vector control or pSpy were grown on a Congo red containing YESCA 
plate for 2 days at 26°C. Cells were harvested, normalized by OD600 and subjected to 
Western blot using polyclonal antibodies against CsgG (top) and CsgA (bottom) (C) 20 
µM CsgA polymerization was monitored by ThT fluorescence in the presence of 
periplasmic extracts (PEs) from BW25113+vector control or BW25113+pSpy. PEs were 
normalized to 100ug/mL. Fluorescence was measured as described in Fig. 2.1A. Shown 
are representative data of three replicates. (D) Soluble and insoluble CsgA were 
separated by centrifugation after incubation alone, with BW25113+vector control or with 
BW25113+pSpy periplasmic extracts. Samples were either treated with SDS loading 
buffer or first with HFIP, dried and then treated with SDS loading buffer. Samples were 
loaded on an 18% SDS PAGE gel and stained with Coomassie.  
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Chapter 3 
The Bacterial Curli System Possesses a Potent and Selective Inhibitor of Amyloid 
Formation3 
 
Abstract 
Curli are extracellular functional amyloids that are assembled by enteric bacteria during 
biofilm formation and host colonization. An efficient secretion system and chaperone 
network ensures that the major curli fiber subunit, CsgA, does not form intracellular 
amyloid aggregates. We discovered that the periplasmic protein CsgC was a highly 
effective inhibitor of CsgA amyloid formation. In the absence of CsgC, CsgA formed 
toxic intracellular aggregates. In vitro, CsgC inhibited CsgA amyloid formation at low 
substoichiometric concentrations and maintained CsgA in a non-β-sheet rich 
conformation. Interestingly, CsgC inhibited amyloid assembly of human α-synuclein, but 
not Aβ42, in vitro. A common D-Q-Φ-X0,1-G-K-N-ζ motif was identified in CsgC client 
proteins that is not found in Aβ42. CsgC is therefore both an efficient and selective 
amyloid inhibitor. Dedicated functional amyloid inhibitors may be a key feature that 
distinguishes functional amyloids from disease-associated amyloids.  
 
Introduction 
 Maintaining proper cellular proteostasis is essential for all life. Unfolded or misfolded 
___________________ 
3This chapter has been accepted for publication in Molecular Cell. Erik Chorell in Fredrik 
Almqvist’s lab at Umeå University conducted the α-synuclein experiments (Figure 3.9DE 
and 3.10G). Jonathan conducted the sequential NMR experiments (Figure 3.7CDE) and 
Marion Koch and Lea Sefer conducted the cytoplasmic coexpression experiments 
(Figure 3.6G). Fei Li, a former graduate student in the Chapman lab, initiated this entire 
project. Jörgen Åden and Anna Götheson provided the α-synuclein mutants. I 
conducted the experiments presented in Figures 3.1, 3.2, 3.3, 3.4, 3.5, 3.6A-F, 
3.7ABFGH, 3.8, 3.9ABC, 3.10A-F. Daniel Smith, Michelle Barnhart and Yizhou Zhou 
constructed some of the strains and plasmids used in this work. 
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proteins are susceptible to aggregation and can assemble into amyloid fibers. Highly 
ordered, β-sheet rich amyloid fibers are 8-10 nm wide and can be assembled by a 
variety of both native and intrinsically disordered proteins (1, 2). The distinct 
biochemical properties of all amyloids, resistance to protease digestion and chemical 
denaturants, and tinctorial properties when incubated with the dyes Congo red (CR) and 
Thioflavin T (ThT) make identification and characterization of amyloids straightforward 
(3). Amyloid deposits are one of the pathological hallmarks of neurodegenerative 
diseases, including Alzheimer’s, Parkinson’s, Huntington’s and Prion diseases (4).  
 Amyloid formation, however, is not always the result of protein misfolding. 
‘Functional’ amyloids are assembled by dedicated biogenesis systems and amyloid 
polymers participate in various cellular functions ranging from mediating epigenetic 
inheritance, to sequestering toxins, to acting as structural components of biofilms (5, 6). 
Curli are an extracellular functional amyloid produced by enteric bacteria that aid in 
surface attachment and biofilm formation (6-11). Curli biogenesis is exquisitely 
controlled so that curli amyloid fibers are only assembled at the right time and in place 
(12, 13).  
 The csg (curli specific gene) operons encode the major structural and accessory 
proteins that are required for curli production (14). CsgD is a transcription factor that 
positively regulates the csgBAC operon (15, 16). The csgBAC operon encodes the 
major and minor curli fiber components, CsgA and CsgB, respectively (14). CsgA is 
secreted to the extracellular milieu as an unfolded protein and then forms amyloid 
polymers upon interacting with the CsgB nucleator (17, 18). Although CsgA amyloid 
formation in vivo is dependent on CsgB, CsgA can self-assemble into amyloid fibers in 
the absence of CsgB in vitro (19). The csgDEFG operon encodes accessory and 
secretion proteins. CsgG assembles into a nonameric outer membrane pore that is 
required for secretion of CsgA and CsgB (20, 21). CsgE and CsgF are chaperone-like 
accessory proteins (22, 23). CsgE is a small periplasmic protein that is required for 
directing CsgA to CsgG for secretion and CsgE can inhibit amyloid assembly of CsgA in 
vitro (23, 24). CsgF is a surface exposed protein that associates with both CsgG and 
CsgB to tether the curli fiber to the cell surface (22). The csgBAC operon also encodes 
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CsgC, a small β-sheet-rich periplasmic protein (14, 25-27). The role of CsgC during curli 
biogenesis has only been indirectly assessed and remains unknown (25, 27).  
 CsgA is secreted from the cell in an amyloid-competent, yet unpolymerized form in 
vivo (7, 25). Mutations to csgG that prevent secretion do not result in the accumulation 
of intracellular CsgA or CsgB, although csgA and csgB are still expressed (21). This 
suggests that periplasmic CsgA and CsgB are somehow eliminated thereby preventing 
intracellular amyloid formation. We therefore sought to identify periplasmic chaperones 
and/or proteases that may be involved in ridding the cell of mislocalized curli subunits. 
Two general cytoplasmic chaperones, DnaK and Hsp33, and one general periplasmic 
chaperone, Spy, were reported previously to inhibit CsgA amyloid assembly in vitro 
(Chapter 2) (28). Furthermore, CsgE can inhibit CsgA amyloid formation in vitro (23, 
24). These findings implicate an important role for molecular chaperones in inhibiting 
premature CsgA amyloid assembly during transport within the cell. Here we report that 
CsgC inhibits CsgA amyloid formation at substoichiometric molar ratios and in the 
absence of a hydrolysable energy source. Furthermore, we show that this bacterial 
protein inhibits human α-synuclein from forming amyloid fibers in vitro while having no 
effect on human Aβ42 amyloid formation. Together, our results demonstrate that CsgC is 
both a highly efficient and selective inhibitor of amyloid formation.  
 
Results 
Secretion deficient mutants have periplasmic amyloid inhibitory activity.  
 CsgA is secreted across the outer membrane as a predominately unstructured 
protein (19, 25). Furthermore, CsgA is undetectable in the secretion deficient ΔcsgG 
mutant (21). We therefore hypothesized that efficient proteostatic mediators exist within 
the periplasm that prevent CsgA from prematurely forming amyloid aggregates inside 
the cell. To identify amyloid inhibitory factors periplasmic extracts (PEs) from WT and 
curli (csg) mutant strains were analyzed for the ability to prevent purified CsgA from 
aggregating into an amyloid in vitro. The csg mutant strains were grown under curli-
inducing conditions prior to harvesting crude PEs by osmotic shock (modified from (29)). 
PEs were normalized by total protein and added to 20 µM purified, SDS-soluble CsgA. 
CsgA polymerization into amyloid was then monitored by ThT fluorescence for 24 hours 
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as previously described (19). When purified CsgA was incubated alone, ThT 
fluorescence rapidly increased after approximately 2 hours of incubation indicative of 
CsgA amyloid assembly (Fig. 3.1AB, closed squares). The addition of PEs from a 
ΔcsgG mutant to purified CsgA inhibited ThT fluorescence (Fig. 3.1A, open symbols). 
The inhibitory effect of the ΔcsgG PE was titratable: the addition of 100 µg/mL 
periplasmic protein to CsgA prevented ThT fluorescence for the duration of the 
experiment (Fig. 3.1A, open squares), while the addition of 25 µg/mL periplasmic 
proteins only delayed ThT fluorescence for approximately 8 hours (Fig. 3.1A, open 
triangles). In contrast, PEs from a complete curli deletion (Δcsg, deletion of both curli 
operons and the intergenic region) or PEs from a ΔcsgD mutant had little to no effect on 
ThT fluorescence of CsgA (Fig. 3.1B and Fig. 3.2 open triangles). CsgE is important for 
CsgA secretion and that CsgE can inhibit CsgA amyloid formation in vitro (23, 24). To 
test whether the observed inhibitory activity in the ΔcsgG PEs was due to CsgE, csgE 
was deleted in the ΔcsgG mutant background. The ΔcsgGΔcsgE and ΔcsgE PEs both 
strongly inhibited CsgA ThT fluorescence, demonstrating that CsgE was not responsible 
for the observed inhibitory activity (Fig. 3.2B).  
 Inhibition of ThT fluorescence in the CsgA aggregation assay could be due to 
amyloid inhibition, proteolytic degradation of CsgA or the direct inhibition of ThT 
fluorescence. To distinguish between these possibilities, the stability of CsgA was 
assessed in the presence and absence of ΔcsgD (not inhibitory; or Δcsg, data not 
shown) or ΔcsgG (inhibitory) PEs. After 24 hours the samples were separated into 
soluble and insoluble fractions by centrifugation and then analyzed by SDS-PAGE and 
Western blot with or without HFIP treatment to solubilize CsgA amyloid aggregates (Fig. 
3.1C). When incubated alone or in the presence of the ΔcsgD PE, CsgA was found 
predominantly in the pelleted, SDS-insoluble fraction (Fig. 3.1C lanes 4 and 8). In 
contrast, CsgA was still detected in the SDS soluble fractions after incubation with the 
inhibitory ΔcsgG PE (Fig. 3.1C lanes 9 and 10). Therefore, inhibition of ThT 
fluorescence by the ΔcsgG PE was the result of CsgA amyloid inhibition and not 
proteolytic degradation of CsgA or quenching of ThT fluorescence.  
 
Amyloid inhibitory activity is regulated by CsgD 
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 The observation that the ΔcsgD PE did not exhibit an amyloid inhibitory activity 
suggested that CsgD may regulate expression of the factor responsible for the activity. 
The ΔcsgD mutant was then complemented by expressing csgD from a plasmid. 
Expression of csgD was able to restore amyloid inhibitory activity to the ΔcsgD PEs 
(Figs. 3.3A, 3.4A). CsgD positively regulates the csgBAC operon which encodes the 
known major and minor curli subunits, CsgA and CsgB, respectively (7, 14), as well as 
CsgC whose function is poorly understood (25, 27). To determine if the amyloid 
inhibition activity was dependent on csgA, csgB or csgC, PEs from various csg mutants 
were tested for inhibition of CsgA amyloid formation in vitro. PEs from ΔcsgA or ΔcsgB 
mutants inhibited CsgA amyloid formation (Figs. 3.3B, 3.4B). However, deletion of csgC 
alone or in the ΔcsgA or ΔcsgBΔcsgA mutant backgrounds resulted in PEs that had 
less inhibitory activity (Fig. 3.3B). Furthermore, PEs from a ΔcsgGΔcsgC double mutant 
did not inhibit CsgA amyloid formation compared to PEs from a ΔcsgG single mutant 
(Fig. 3.3C). Additionally, when size exclusion chromatography was used to fractionate 
the inhibitory ΔcsgG PEs further, western blot analysis revealed that CsgC was present 
in fractions that retained amyloid inhibitory behavior (Fig. 3.4CD). Together, our genetic 
and biochemical analysis suggested that CsgC was responsible for the amyloid 
inhibition activity. 
 
Cells lacking CsgG and CsgC accumulate intracellular CsgA.  
 Subunits that go off pathway or are unable to be secreted might be prone to forming 
amyloid-like aggregates. We hypothesized that CsgC could discourage CsgA 
aggregation in the periplasm. On CR-indicator plates, curliated cells stain red while curli 
mutants produce white colonies (14). The ΔcsgG mutant forms white colonies on CR-
indicator plates because CsgA and CsgB are not secreted to the cell surface and no 
curli are assembled (Fig. 3.3AB and Fig. 3.6B) (21). Interestingly, a ΔcsgGΔcsgC 
double mutant produced pink colonies (Fig. 3.3A) and could be restored to white by 
expressing csgC from a plasmid (Fig. 3.3A). Cells were harvested from YESCA plates 
and subject them to Western and dot blot analysis. Western blot analysis revealed that 
the ΔcsgGΔcsgC mutant accumulated SDS soluble and insoluble CsgA (Fig. 3.3B). 
CsgA was no longer detected in the ΔcsgGΔcsgC mutant when csgC was 
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complemented on a plasmid (Fig. 3.3B). Furthermore, CsgA produced by the 
ΔcsgGΔcsgC mutant was only detected by dot blot Western after cells were lysed (Fig. 
3.3C), suggesting that the CsgA aggregates were intracellular. Similarly to the ΔcsgG 
mutant, and in contrast to WT and ΔcsgC mutant, no extracellular fibrillar aggregates 
were observed by TEM on the ΔcsgGΔcsgC mutant (Fig. 3.6A-D). Therefore, in the 
absence of CsgC, secretion deficient mutants accumulate intracellular CsgA 
aggregates.  
 
CsgC protects the cell from the toxicity associated with intracellular CsgA accumulation. 
 Amyloid aggregation can be toxic to biological membranes (30, 31). We therefore 
asked whether the accumulation of intracellular CsgA impacted the cellular fitness of the 
ΔcsgGΔcsgC mutant. LIVE/DEAD staining with SYTO 9 and propidium iodide was used 
to assess the proportion of viable cells grown in curli-inducing conditions. The 
ΔcsgGΔcsgC colonies had a larger percentage of dead cells (13.4%) compared to the 
WT colonies (5.8%) (Fig. 3.6E). We also asked whether the Cpx stress response was 
induced in the ΔcsgGΔcsgC mutant. A cpxP promoter lacZ fusion was used to 
investigate induction of the Cpx response. There was 2-fold increase in Cpx induction in 
the ΔcsgGΔcsgC cells at 48 hours compared to the WT (Fig. 3.6F).  
 We also asked whether CsgC could protect against toxicity in the cytoplasm. When 
recombinant CsgA (CsgA22-151 that lacks the Sec secretion signal sequence) was 
overexpressed, the growth of the culture was inhibited (Fig. 3.6G). Interestingly, 
coexpression of CsgA22-151 with CsgC9-110 (Sec minus) in the cytoplasm of BL21(DE3) 
cells improved growth (Fig. 3.6G, closed circles). Cells coexpressing CsgA and CsgC in 
the cytoplasm continued to divide, reaching stationary phase and remaining viable after 
overnight incubation (Fig. 3.6G, closed circles). Expression of CsgC in the periplasm did 
not rescue the CsgA22-151-induced growth arrest (Fig. 3.6G, open circles). Collectively, 
these results demonstrated that CsgC prevented CsgA from forming toxic intracellular 
aggregates. 
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CsgC inhibits amyloid formation 
 Our genetic and in vivo analyses suggested that CsgC has anti-amyloid activity. 
Therefore, purified recombinant CsgC was tested its ability to prevent CsgA 
polymerization in vitro. Purified CsgC inhibited CsgA amyloid formation at molar ratios 
as low as 1:500 (CsgC:CsgA) in vitro as measured by ThT fluorescence (Fig. 3.7A). The 
same molar ratio of BSA:CsgA had little effect on CsgA polymerization (Fig. 3.8A). 
Another fluorescent dye, 8-anilino-1-naphthalenesulfonic acid (ANS), was used to test 
whether CsgC was directing CsgA into non-amyloid aggregates that did not bind ThT. 
Interestingly, CsgC also inhibited ANS fluorescence of CsgA suggesting that CsgC does 
not simply direct CsgA into non-amyloid aggregates (Fig. 3.8C). After 24 hours of 
incubation with CsgC, CsgA ran as a SDS-soluble protein on an SDS-PAGE gel (Fig. 
3.8B); therefore, the inability of CsgA to adopt the SDS-resistant amyloid form in the 
presence of CsgC was again due to chaperone-like inhibition and not due to proteolytic 
degradation (Fig. 3.8B).  
 I then asked whether CsgC prevented CsgA from adopting the β-sheet rich structure 
common to all amyloids (32). CsgA transitions from an unstructured protein to a β-sheet 
rich amyloid fiber as measured by far-UV circular dichroism (CD) (19, 33). As seen in 
previous studies, CsgA was unstructured immediately after purification and by 24 hours 
adopted a largely β-sheet secondary structure (Fig. 3.7B, closed symbols). However, 
when substoichiometric amounts of CsgC (1:10) were added to freshly purified CsgA, 
the CD spectrum of CsgA remained mostly unchanged for 24 hrs (Fig. 3.7B, open 
symbols). CsgC is itself a β-sheet rich protein (Fig. 3.8D); therefore the minimal β-sheet 
contribution from CsgC was subtracted from the CsgA+CsgC reaction. Even at 48 hrs of 
incubation in the presence of CsgC, CsgA remained unfolded and non-amyloidogenic 
as measured by CD and ThT (Fig. 3.8EFG).  
 To better understand how CsgC affects the structural transitions of CsgA over time, 
the 1H NMR spectrum of CsgA alone or CsgA with CsgC was collected. Immediately 
after purification the 1H NMR spectrum of CsgA alone showed the limited peak 
dispersion indicative of a disordered protein (Fig. 3.7C). Over several hours the overall 
peak intensity gradually decreased as CsgA monomers became incorporated into 
aggregates and were lost from the NMR spectrum due to fast transverse relaxation (Fig. 
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3.7C) (33). After approximately 10 hours the CsgA 1H NMR spectrum had essentially 
disappeared, which coincided with maximal fluorescence in the ThT assay (Fig. 3.7A, 
3.8C). When CsgC was mixed with freshly purified CsgA at a molar ratio of 1:150, the 
1H NMR peaks of CsgA remained visible for over 24 hours (Fig. 3.7D). In the presence 
of CsgC the CsgA 1H NMR peaks decreased at a similar rate to the CsgA alone peaks 
during the first three hours, but then was relatively stable between 3-24 hours (Fig. 
3.7E).  
 Given the low molar ratio of CsgC:CsgA required to achieve amyloid inhibition, we 
hypothesized that CsgC may be acting on multimeric species of CsgA. CsgA 
polymerization can be accelerated in vitro by the addition of either sonicated CsgA or 
CsgB preformed fibers in a process called “seeding” (Fig. 3.7F) (18, 19, 34). To address 
the question of whether CsgC inhibits fiber elongation we asked whether CsgC could 
inhibit amyloid assembly of CsgA in the presence of exogenously added CsgA seeds in 
vitro. The addition of 2% CsgA seeds by weight to freshly purified CsgA resulted in 
accelerated CsgA polymerization (Fig. 3.7F, open versus closed squares) while the 
addition of CsgC to CsgA at a 1:10 or 1:100 molar ratio inhibited CsgA polymerization 
(Fig. 3.7F, closed circles and triangles, respectively). Interestingly, the addition of seeds 
to CsgA in the presence of a 1:10 molar ratio of CsgC:CsgA was unable to overcome 
CsgC-mediated amyloid inhibition (Fig. 3.7F, circles). CsgA seeding was still largely 
inhibited even in the presence of CsgC at a 1:100 molar ratio of CsgC:CsgA (Fig. 3.7F, 
triangles. We also asked if CsgC prolonged the transient, pre-amyloid state of CsgA that 
is recognized by the conformational-specific A11 antibody (30). CsgA incubated in the 
absence of CsgC was recognized by the A11 antibody immediately after purification, but 
not after 24 hours (Fig. 3.7G) (19). In contrast, the A11 antibody still recognized CsgA 
after 24 hours of incubation with CsgC (Fig. 3.7G). Together, these results suggest that 
CsgC acts by stabilizing an A11-reactive pre-amyloid intermediate of CsgA.  
 To determine whether CsgC forms a stable complex with CsgA, CsgA was analyzed 
in the absence and presence of CsgC by native gel electrophoresis. Freshly purified 
CsgA ran as a several discrete bands approximately 66kDa and smaller suggesting that 
CsgA begins to self-associate rapidly after purification (Fig. 3.7H, lane 1 and 2). CsgA 
that had been incubated at 25°C for 24 hours no longer migrated into the gel (Fig. 3.7H, 
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lanes 3). However, CsgA that had been incubated for 24 hours with a 3-fold 
substoichiometric concentration of CsgC had a similar banding pattern as CsgA 
immediately after purification (Fig. 3.7H, lanes 5). The migration of CsgA and CsgC 
proteins in native gels suggested 1) that CsgC stabilizes CsgA in a heterogeneous 
mixture of homo-oligomeric species, and 2) that CsgA and CsgC do not form a stable 
hetero complex.  
 Next, we sought to identify the domain(s) of CsgA through which CsgC acts. CsgA is 
comprised of five imperfect repeating units (R1-R5). R1, R3 and R5 are amyloidogenic 
while R2 and R4 contain gatekeeper residues that temper amyloid formation (19, 35, 
36). Deletion of R1, R3 or R5 in CsgA does not significantly abrogate CsgA amyloid 
assembly and synthetic peptides corresponding to each of the amyloidogenic repeating 
units can self-assemble into amyloid fibers (19, 35). The ability of CsgC to inhibit 
amyloid assembly of the CsgA ΔR1, ΔR3 and ΔR5 mutants in vitro was tested. CsgC 
was still capable of inhibiting amyloid formation of each CsgA repeating unit deletion 
mutants at substoichiometric molar ratios (Fig. 3.10A-C). CsgC also inhibited amyloid 
assembly of synthetic peptides corresponding to CsgA R1 and R5 at substoichiometric 
molar ratios (Fig. 3.10DE). Together, our results suggest that CsgC can interact with 
multiple domains of CsgA to inhibit amyloid assembly.  
 
CsgC displays client protein selectivity.  
 Finally, we next sought to explore the specificity of CsgC-mediated amyloid inhibition. 
Salmonella enterica and Citrobacter koseri both produce curli and CsgA from both 
bacteria share approximately 75% sequence identity with E. coli CsgA (34). E. coli 
CsgA can be cross-seeded in vitro and in vivo by S. enterica and C. koseri CsgA (34). 
E. coli CsgC was capable of inhibiting amyloid formation of CsgA molecules from S. 
enterica, C. koseri and E. coli at the same molar ratios (Fig. 3.9A and Fig. 3.10F). The 
minor curli subunit, CsgB, shares 30% sequence identity with CsgA and can also 
assemble into an amyloid-like aggregate in vitro (18, 37). Furthermore, CsgB can seed 
CsgA polymerization both in vivo and in vitro (18, 35, 37). we tested a truncated version 
of CsgB (CsgBtrunc, lacking the 5th repeating unit) as a client for CsgC in vitro. Although 
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CsgA and CsgBtrunc share a large degree of similarity, a higher molar ratio (1:10, 
CsgC:CsgBtrunc) was required to achieve CsgB amyloid inhibition (Fig. 3.9B).  
 I then asked if CsgC could act as a general amyloid inhibitor and inhibit human 
amyloid-forming proteins. The Alzheimer’s disease-associated amyloid protein Aβ42 and 
the Parkinson’s disease-associated protein α-synuclein were tested as potential CsgC 
clients. Even at a 1:1 molar ratio (CsgC: Aβ42), CsgC did not inhibit Aβ42 amyloid 
assembly (Fig. 3.9C). In contrast, CsgC inhibited α-synuclein amyloid formation at 1:3 
and 1:10 ratios and, to a lesser degree, at a 1:100 molar ratio (Fig. 3.9D). Sequence 
alignments revealed a D-Q-Φ-X0,1-G-K-N-ζ motif (Φ=W/L, ζ=S/E) in α-synuclein 
(residues 98-104) and CsgA (residues 104-112) (Fig. 3.9F). CsgC was able to inhibit 
amyloid formation by CsgA lacking residues 88-110 and synthetic peptides 
corresponding the N- and C-terminal repeats of CsgA that contain similarly spaced 
glutamine and asparagine residues (Fig. 3.10). However, the D-Q-Φ-X0,1-G-K-N-ζ motif 
only exists once in α-synuclein (Fig. 3.9F). Residues 98-104 in α-synuclein were either 
mutated to alanine residues (α-synuclein6ala) or a scrambled sequence (α-synucleinscram) 
and asked whether CsgC could still inhibit amyloid assembly. Interestingly, CsgC only 
modestly affected the polymerization of α-synuclein variants that were missing the D-Q-
Φ-X0,1-G-K-N-ζ motif (Fig. 3.9E and 3.10G). Together, these results suggest a common 
CsgC interaction motif in CsgA and α-synuclein. 
 
Discussion 
 Protein misfolding and amyloid aggregation are hallmarks of many degenerative 
human diseases (4). Modulating the protein folding environment as a means to 
ameliorate amyloid-associated diseases is an area of intense research focus (38-40). 
Molecular chaperones have been shown to be important for inhibiting disease-
associated amyloid assembly and amyloid-related cytotoxicity in vitro and in vivo (41). 
The heat shock protein Hsp70 inhibits amyloid assembly of the Alzheimer’s Disease-
associated protein Aβ and the Parkinson’s Disease-associated protein α-synuclein in 
vitro (42-44). Overexpression of Hsp70 has also been found to reduce disease 
pathology in a murine model of Alzheimer’s Disease (45). Similarly, overexpression of 
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the small heat shock protein Hsp16.2 in a Caenorhabditis elegans model of Alzheimer’s 
Diseases resulted in decreased amyloid deposits and toxicity (46).  
 Functional amyloids, while sharing all of the biophysical characteristics of disease-
associated amyloids, are distinguished from disease-associated amyloids by their 
dedicated and controlled biogenesis (47). Curli functional amyloid biogenesis is highly 
coordinated to ensure that curli fibers are assembled exclusively on the bacterial cell 
surface (12). Secretion of soluble curli subunits is, in part, facilitated by specific 
secretion (CsgE and CsgG) and nucleation (CsgB and CsgF) factors as well as general 
cytoplasmic and periplasmic molecular chaperones (7, 17, 18, 20, 22, 23, 28, 37). We 
therefore asked whether the curli biogenesis system also encoded specific molecular 
inhibitors of intracellular CsgA amyloidogenesis.  
 Mislocalized curli subunits in the periplasm are unstable and degraded when 
outer membrane secretion is disrupted (21). We therefore hypothesized that periplasmic 
proteostatic mediators existed to efficiently inhibit mislocalized, intracellular CsgA from 
aggregating. Our in vitro analysis of periplasmic extracts from curli mutants revealed an 
amyloid inhibitory activity in the periplasm of several mutant strains with curli gene 
deletions (Figs. 3.1-3.4). The addition of WT PEs accelerated or seeded CsgA 
polymerization in vitro likely due to extracellular curli fibers that copurified with the crude 
periplasmic extracts (Fig. 3.2A and data not shown). Expression of csgD was required 
for the observed amyloid inhibitory activity (Fig. 3.3.2A). Further genetic analysis 
revealed that expression of csgC was required for CsgA amyloid inhibition in all of our 
inhibitory PEs (Figs. 3.1-3.4).  
 CsgC could also inhibit intracellular CsgA amyloid assembly. Deletion of csgC in the 
ΔcsgG background results in the accumulation of intracellular CsgA aggregates (Fig. 
3.3BC). The CsgA trapped in these intracellular aggregates migrated on an SDS PAGE 
gel with a size consistent with that of processed CsgA (lacking the Sec-secretion signal 
sequence), suggesting that the CsgA aggregates were in the periplasm. CsgC does not 
appear to possess proteolytic activity itself (Fig. 3.1C and Fig. 3.8B). It is likely that the 
CsgC maintains CsgA in a state that is competent for secretion or in a state that is 
sensitive to periplasmic proteases. In addition to CsgC, there may be other periplasmic 
proteins that can also discourage CsgA amyloid formation. Compared to a ΔcsgG 
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mutant, PEs from a ΔcsgGΔcsgC mutant exhibited greatly reduced amyloid inhibitory 
activity; however, the ΔcsgGΔcsgC PEs still slightly impaired CsgA polymerization (Fig. 
3.3C). Interestingly, the Cpx stress response system, which positively regulates 
periplasmic chaperones and proteases, is induced approximately two fold in the 
ΔcsgGΔcsgC mutant compared to WT (Fig. 3.6F) (48, 49). The weak inhibitory activity 
of the ΔcsgGΔcsgC PEs may therefore be due to an increased abundance of Cpx 
regulated periplasmic chaperones, which include Spy, a chaperone-like protein that has 
previously been shown to inhibit CsgA amyloid formation (28, 50, 51).  
 When grown under curli-inducing conditions the ΔcsgGΔcsgC mutant formed mucoid 
colonies, while WT, ΔcsgG or ΔcsgC were non-mucoid (data not shown). Additionally, 
the ΔcsgGΔcsgC cells clumped together when scraped off the agar surface and 
required vigorous vortexing to resuspend (data not shown). As amyloid intermediates 
can be toxic to membranes (30, 31), we hypothesized that the increase viscosity of the 
ΔcsgGΔcsgC colonies was due to an increase in cell death. Indeed, the ΔcsgGΔcsgC 
mutant had an increased number of dead cells per colony relative to the WT (Fig. 3.6E). 
Although the growth defect of the ΔcsgGΔcsgC mutant was only modest, this was not 
unexpected. There are two distinct cell populations within curli-dependent biofilms: one 
encased in a protective matrix of curli fibers and another that is not (52, 53). 
Furthermore, only about 30% of the cells in a biofilm express and assemble curli fibers 
(54). It is therefore likely that Cpx induction occurs in a subpopulation of curli expressing 
cells, and only when secretion across the outer membrane fails. Furthermore, Cpx 
induction likely helps protect the cells by both down-regulating the curli operons and up-
regulating periplasmic proteases and chaperones (49, 55). When a truncated allele of 
CsgA that remained in the cytoplasm was expressed growth arrest was induced that 
was apparently linked to CsgA aggregation (Fig. 3.6G). The CsgA-induced growth 
arrest was ameliorated when CsgC was coexpressed along with CsgA in the cytoplasm 
(Fig. 3.6G).  
 CsgA amyloid formation can be inhibited by both protein and chemical “chaperones” 
acting via distinct mechanisms (23, 24, 28, 33, 56). Protein chaperones that inhibit 
CsgA polymerization at molar ratios close to 1:1, such as Spy and CsgE, likely exert 
their inhibitory activity during early stages of aggregation by interacting with monomers 
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of CsgA (23, 28). DnaK and Hsp33, on the other hand, inhibit CsgA polymerization at 
substoichiometric molar ratios by interacting with early oligomers or inhibiting fiber 
elongation, respectively (28). Small, heteroycyclic 2-pyridones designed as 
peptidomimetic compounds can inhibit CsgA amyloid assembly by diverting CsgA into 
“off-pathway” oligomers that are unable to assemble or nucleate amyloid formation (33).  
  CsgC is a unique proteinaceous inhibitor of CsgA amyloid formation because it 
discourages amyloid assembly at much lower molar ratios (1:500) than any other 
previously reported CsgA amyloid inhibitor (Fig. 3.7A) (23, 24, 28, 56). Our biophysical 
and biochemical evidence (CD, NMR, ThT, seeding analysis, conformation-specific 
antibody analysis, gel electrophoresis) demonstrate that CsgC prevents CsgA from 
adopting the β-sheet rich, SDS insoluble, fibrous polymers (Figs. 3.7, 3.8). In the 
presences of CsgC, CsgA remains in an unstructured conformation (Fig. 3.7B and Fig. 
3.8F) which can be distinguished from the off-pathway oligomers formed when CsgA is 
incubated with amyloid-inhibiting 2-pyridones (33). The potency of CsgC inhibition at 
substoichiometric concentrations suggests that it does not form stable 1:1 complexes 
with individual CsgA monomers to block amyloid formation. Instead it appears that 
CsgC acts somewhere further along the pre-amyloid folding pathway to stabilize an 
A11-reactive, non-amyloid species and inhibit transition into a fibrillar species (Fig. 
3.7FGH, Fig. 3.11). It is possible that CsgC binds dynamically to a soluble but 
oligomeric pool of CsgA, and prevents its escape from this ‘molten oligomer’ to form 
seeds for nucleation into an amyloid (Fig. 3.11). Alternatively, CsgC may induce a 
structural change within a sub-population of CsgA, which biases the whole population 
away from forming amyloid. Both explanations are consistent with our data.  
 Unlike previously reported general molecular chaperones that can inhibit CsgA 
amyloid formation, CsgC appears to have client protein selectivity (Figs. 3.9, 3.10A) 
(28). E. coli CsgC inhibited the aggregation of CsgA proteins from closely related 
bacterial species, C. koseri and S. enterica, each of which shares 75% sequence 
identity with E. coli CsgA (Fig. 3.9A, 3.10F). Furthermore, CsgC inhibited a truncation 
mutant of the E. coli minor curli subunit CsgB from assembling into an amyloid (Fig. 
3.9B). Although CsgB is closely related to CsgA, sharing ~30% sequence identity with 
CsgA and β-sheet-rich secondary structure, a higher molar ratio of CsgC:CsgB was 
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required to achieve amyloid inhibition over 24 hours (Fig. 3.9B). This implies that while 
CsgC is able to recognize CsgB at some stage during amyloidogenesis, the sites where 
CsgB differs from CsgA allow it to escape the action of CsgC more easily.  
 CsgC also inhibited amyloid formation of the human Parkinson’s disease-associated 
protein α-synuclein, but not the Alzheimer’s disease-associated protein Aβ42 (Fig. 
3.9CD). Although Aβ42 does not share recognizable sequence homology with CsgA, an 
alignment of α-synuclein with CsgA revealed a shared D-Q-Φ-X0,1-G-K-N-ζ motif that 
maps to R3 of CsgA and residues 98-104 of α-synuclein (Fig. 3.9B). The D-Q-Φ-X0,1-G-
K-N-ζ motif is less well conserved in CsgB (Fig. 3.9F). Remarkably, mutagenesis of 
residues 98-104 of α-synuclein to alanine residues (6ala) reduced the ability of CsgC to 
inhibit α-synuclein amyloid assembly (Fig. 3.9EF). α-synuclein contains three domains: 
an N-terminal amphipathic domain, a hydrophobic “non-amyloid component of 
Alzheimer’s Disease” (NAC) and a C-terminal domain sometimes referred to as the 
solubilizing domain (Fig. 3.10A) (57-60). Interestingly, the D-Q-Φ-X0,1-G-K-N-ζ motif 
shared with CsgA R3 maps to the C-terminal/solubilizing domain of α-synuclein 
suggesting that CsgC may be modulating the solubilizing activity of the α-synuclein C-
terminal domain. The presence of the D-Q-Φ-X0,1-G-K-N-ζ motif in α-synuclein is 
important for CsgC-mediated amyloid inhibition; however, it appears that CsgA possess 
multiple domains through which CsgC can mediate amyloid inhibition (Fig. 3.9). CsgA is 
comprised of five imperfect repeating units that have distinct propensities to form 
amyloid. R1, R3, and R5 are highly amyloidogenic, while R2 and R4 are not (19, 35). 
R2 and R4 contain specific “gatekeeper” residues that temper amyloid formation and 
that are not present in repeating units R1, R3 or R5 (36). CsgC can inhibit amyloid 
assembly of CsgA R1, R3 and R5 deletion mutants as well as synthetic peptides 
corresponding to R1 and R5 (Fig. 3.10A-E). CsgB is similarly comprised of five 
imperfect repeating units with R1, R2 and R4 being the most amyloidogenic (37). While 
the exact sequence motif in CsgA R3 that is shared with α-synuclein is not found in the 
other repeating units of CsgA or CsgB, a second similar motif, Q-X-G-X1,2-N-X5-Q, can 
be found in all the CsgA and CsgB repeating units as well as in α-synuclein (Fig. 
3.10H). The observation that there may be multiple CsgC recognition domains in CsgA 
explains why CsgC was able to inhibit the polymerization of CsgA R1, R3, and R5 
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deletion mutants in addition to synthetic peptides corresponding to R1 and R5 (Fig. 
3.10A-E). Collectively, these data suggest that CsgC client protein selectivity is dictated 
by a short, 8-10 amino acid, sequence that is repeated several times in CsgA and CsgB 
but only once in α-synuclein (Figs. 3.9E, 3.10A).  
 Specific amyloid inhibition by proteins at substoichiometric molar ratios is not 
unprecedented. Grafted Amyloid Motif Antibodies (gammabodies) have been 
engineered to contain amyloid domains of various amyloid-forming proteins. 
Gammabodies specifically recognize the amyloid conformation of the target protein and 
can in some instances inhibit amyloid formation of the target protein at 10-fold 
substoichiometric molar ratios (61, 62). In another report, the monomeric form of 
transthyretin (M-TTR) has been shown to inhibit Aβ and HypF-N amyloid oligomer 
toxicity in vitro at molar ratios comparable to that of CsgC and CsgA (1:100 to 1:500) 
(63). Although not completely understood, the protein-protein interactions that prevent 
amyloid formation in the case the gammabodies are hypothesized to be mediated 
through intermolecular amyloid-like contacts (61, 62). CsgC is non-amyloidogenic under 
all of the conditions tested, but it is a beta-sheet rich protein that might mimic the 
amyloid form of CsgA, leaving open the possibility that CsgC interacts with CsgA via an 
amyloid-like interaction. Clarifying how these amyloid inhibitors interact with their client 
amyloid-forming proteins awaits high-resolution biophysical studies.  
  
Materials and Methods 
Bacterial Growth. All overnight cultures were grown in LB at 37°C with shaking at 
220rpm. Cultures were normalized to OD600=1.0, 4 µL were spotted YESCA agar (yeast 
extract casamino acids) plates and grown for 48 hours at 26°C to induce curli 
production. For Congo red analysis YESCA plates were supplemented with 50 µg/mL 
Congo red and 1 µg/mL Brilliant Blue G250. When necessary, plates were 
supplemented with ampicillin or kanamycin at 5 µg/mL. 
Periplasmic Extract Preparation. Overnight cultures were plated as a lawn on a 
YESCA plate and grown for 48 hours at 26°C. Cells were scraped off the plate with 3 
mL of 20 mM Tris (pH 8.0). 40 OD600 nm units for each strain were harvested by 
centrifugation at 8,000xg, resuspended in 500 µL of osmotic shock buffer (30 mM Tris 
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pH 7.2, 40% sucrose, 2 mM EDTA) and incubated at room temperature for 10 minutes. 
Cells were pelleted for 10 min at 16,000xg, resuspended in 500 µL of cold 2 mM MgCl2, 
incubated on ice for 3 minutes and pelleted at 16,000xg for 10 minutes at 4°C. The 
supernatant was kept as the periplasmic fraction. All experiments were performed in 
BW25113 and MC4100 backgrounds at least three times and yielded very similar 
results.  
Strains and Plasmids.  
Individual mutants in BW25113 obtained from the Keio collection (64). The ΔcsgG 
mutant was constructed by expressing the FLP recombinase from pCP20 at 37°C to 
remove the kan cassette from the Keio collection csgG::kan mutant (65). Additional 
mutations in BW25113 were constructed using lambda red recombination as described 
previously (See Table 3.1 and 3.3) (66). Mutations in MC4100 were generated using P1 
transduction from BW25113. P1 phage were propagated on BW25113 mutants in LB 
supplemented with 100 mM CaCl2 until the culture cleared. Remaining cells were killed 
by the addition of chloroform. Suspensions were pelleted for 10 min at 3,000xg and the 
supernatant was removed as the P1 lysate. MC4100 was transduced with P1 phage in 
10 mM MgSO4 5 mM CaCl2 for 30 min at 30°C. LB supplemented with 100 mM sodium 
citrate was added to the reactions and the cells were allowed to recover shaking at 
37°C for 1 hour. Cells were pelleted and plated on LB supplemented with kanamycin. 
Strains were verified by PCR with either outside flanking primers or with a flanking 
primer and primer k1 (66). Plasmid pcsgD (pD10) was constructed by amplifying csgD 
from the chromosome with primers MMB116 and MMB117 by PCR followed by 
digestion and ligation into the EcoRI/BamHI site of pTrc99A. Plasmid pcsgC was 
constructed by amplifying csgC with primers KpnI-csgC and csgC-XbaI by PCR 
followed by digestion and ligation into the KpnI/XbaI site of pCKR101. Plasmid pCpx1 
was constructed by amplifying 249 nucleotides upstream of the cpxP start codon from 
the chromosome with primers MMB92 and MMB93 followed by PCR followed by 
digestion and ligation into the EcoRI/BamHI site of pRJ800. 
Protein Purification. CsgA, CsgB and variants of CsgA were purified as described 
previously (34). CsgC was purified as described previously (26). His-tagged human a-
synuclein was expressed from pt77/434HK in BL21(DE3)pLysS cells. The cells were 
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grown in 5X LB containing 40 mg/L ampicillin at 36 °C. Protein expression was induced 
at OD of 0.6 by addition of IPTG (100 mg/L culture) and incubated for three hours 
before harvest. The pelleted cells were lysed by re-suspension in 8 M Urea, 20 mM Tris 
pH 8.0, and 20 mM imidazole. The solution was sonicated on ice for repeated cycles of 
5s sonication followed by 30s resting for a total of 5-10 min (until non-viscous). The 
mixture was centrifuged at 20,000 rpm for 20 min and the supernatant was collected. A 
Ni-NTA (20 mL) column was charged using three column volumes (CV) of 100 mM 
NiSO4, followed by five column volumes of water before being equilibrated with two CV 
of 8 M urea, 20 mM Tris pH 8.0, and 20 mM imidazole. The bacterial lysate was loaded 
on the column and washed with 10 CV of 20 mM imidazole, 50 mM NaCl, 20 mM Tris 
pH 7.5, and 5% glycerol. The protein was eluted with five CV of 250 mM imidazole, 50 
mM NaCl, 20 mM Tris pH 7.5, and 5% glycerol. β-mercaptoethanol was added to a 
concentration of 20 mM followed by Caspase-7 (1:100 w:w) to cleave off the His-tag 
and the solution was incubated over night at 4°C. The protein solution was diluted two 
times with water and loaded on two serially connected Q-sepharose columns. Washed 
with 10 CV of 20 mM Tris pH 8.0 and eluted using a gradient of from 0-1 M NaCl over 
10 CV. Gel filtration (superdex 75) was used to remove aggregated protein or minor 
contaminants. Pure fractions were dialyzed against 50 mM ammonium carbonate buffer 
and lyophilized. 
Peptide Preparation. CsgA R1 and R5 peptides (Proteintech Group Inc.) and Aβ42 
(Biosource) was dissolved in 1:1 trifluoroacetic acid (TFA): 1,1,1,3,3,3-hexafluoro-2-
propanol (HFIP) to a concentration of 1 mg/mL and sonicated for 10 minutes. The 
TFA/HFIP were removed using a SpeedVac. The pellets were dissolved a second time 
in HFIP and dried again. HFIP treated (Aβ42) was dissolved in 20 µL dimethylsulfoxide 
and then quickly diluted to 25µM with cold KPi (pH 7.3) and sonicated for 30 seconds. 
Amyloid Inhibition Assays. Monomeric CsgA, CsgAΔR1, CsgAΔR3, CsgAΔR5, 
CsgBΔR5, Aβ42 or α-synuclein were added to 10 uL of 50 mM KPi (pH 7.3) 100 mM 
NaCl or CsgC in a black flat-bottom 96-well plate with 20 µM thioflavin T (ThT). The 
samples were incubated either in a Molecular Devices SpectraMax M2 or a Tecan 
Infinite M200 microtitre plate reader at 25°C. The plate was shaken linearly for 3 
seconds prior to taking fluorescence readings (exication: 438nm, emission: 495nm, 
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cutoff: 475nm) every 10 or 20 minutes. α-synuclein polymerization assays were 
conducted at 37°C with constant agitation with a 2 nm glass bead in each well. Seeding 
experiments were conducted by adding 2% (by weight) CsgA fibers that had been 
sonicated with a probe sonicator 3x10sec to each reaction. Graphs are representative 
of at least 3 independent experiments. Values are reported as normalized ThT 
fluorescence: buffer or CsgC alone values were subtracted from sample values and 
were divided by the maximum ThT reading for each sample and smoothed in 
KaleidaGraph (Synergy Software).  
Circular Dichroism. CsgA (20 µM in 20 mM KPi pH 7.3) or CsgA with CsgC (2 µM in 
KPi pH 7.3) were analyzed using a Jasco J-810 spectropolarimeter from 190 to 250nm 
at 25°C immediately after purification and every 24 hours. The buffer or 2 µM CsgC 
spectra were subtracted from the samples.  
Nuclear magnetic resonance spectroscopy. One-dimensional proton NMR 
experiments were performed on 10 µM CsgA alone, or with CsgC in a 150:1 molar ratio, 
in a buffer containing 50 mM potassium phosphate pH 7.4, 5% (v/v) D2O. Sequential 
spectra (800 scans each) were recorded every 30 minutes over a period of ~24 hours. 
Spectra were processed within BioSpin (Bruker) and plotted in ORIGIN. 
Denaturing Gel Electrophoresis and Western Blot. Overnight cultures were diluted to 
OD600=1.0 and 4 µL were spotted on a YESCA plate and incubated at 26°C for 2 days. 
The cells were harvested and resuspended in 50 mM KPi pH 7.3. 0.1 OD600 nm units for 
each strain were harvested in duplicate by centrifugation. One duplicate was 
resuspended in 2X SDS loading buffer while the other was treated with HFIP for 10 min 
at room temperature, dried in a SpeedVac and then resuspended in 2X SDS loading 
buffer. Samples were run on a 15% SDS PAGE gel and transferred to a PVDF 
membrane. Blots were probed with antibodies against CsgA (1:12,000), CsgG 
(1:50,000), CsgC (1:4,000), Sigma70 (1:5,000) or A11 (1:10,000).  
Native Gel Electrophoresis. Samples were mixed with 3X Native loading buffer (15 
mM Tris, 144 mM glycine, 30% glycerol, 1% bromophenol blue) and loaded on a 7.5% 
nondenaturing Tris-glycine gel at 150V at 4°C and then transferred to a PVDF 
membrane for western blot.  
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Live/Dead Staining. Live/Dead staining was conducted using a LIVE/DEAD BacLight 
Bacterial Viability Kit (Molecular Probes). Briefly, 100 µL of overnight culture of were 
spread on a YESCA plate as a lawn and grown at 26°C for 48 hours. Cells were 
harvested with 5 mL 0.85% NaCl and normalized to OD600 nm= 0.06. 100 µL of 
SYTO9/Propidium Iodide (10 µM/60 µM) were added to 100 µL of cell suspension and 
incubated in the dark for 15 minutes. Fluorescence was read in a Molecular Devices 
SpectraMax M2 microtitre plate reader with an excitation wavelength of 485 nm and 
emission wavelength of 530 nm and 630 nm. Experiments were performed on 
BW25113 and MC4100 three times and yielded similar results in each strain 
background. 
β-galactosidase Assay. Cells were transformed with pRJ800 empty vector or pCpx1 
(with the cpxP promoter cloned upstream of lacZ in pRJ800) and grown on YESCA 
plates at 26°C for 48 hours and harvested in cold 50 mM potassium phosphate buffer 
(pH 7.3). Cells were permeablilized by detergent and assayed for β-galactosidase 
activity as described previously (67). Experiments were performed on BW25113 and 
MC4100 three times and yielded similar results in each strain background. 
Transmission Electron Microscopy. MC4100 cells were prepared as a 1.0 OD600 nm 
suspension in 50 mM KPi (pH 7.3) and mounted on formvar-coated grids. Grids were 
imaged using a Philips CM100 transmission electron microscope. 
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Figures and Tables 
 
Figure 3.1. Secretion deficient mutants induce an amyloid inhibitory activity in the 
periplasm. Periplasmic extracts (PEs) were harvested from BW25113 ΔcsgG (A) or 
complete curli deletion (Δcsg; B) and incubated with soluble CsgA for 24 hours. CsgA 
amyloid formation was monitored by ThT fluorescence. C) Soluble and insoluble CsgA 
were separated by centrifugation after 24 hours of incubation alone or in the presence 
of periplasmic protein extracts from a ΔcsgD or ΔcsgG mutant. Samples were 
suspended in SDS loading buffer with or without HFIP pretreatment. Samples were 
separated on a 15% SDS PAGE gel and stained with Coomassie (top panel) or 
analyzed by western blot for CsgA (lower panel).  
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Figure 3.2. csg mutants exhibit varying degrees of amyloid inhibitory activity. PEs 
were harvested from WT BW25113 E. coli or various gene deletion mutants of curli 
biogenesis genes (A) or from a ΔcsgGΔcsgE double deletion strain (B) and assayed for 
CsgA amyloid inhibition in vitro. Polymerization of CsgA was monitored by ThT 
fluorescence. (C) Cells were analyzed by western blot and Congo red binding.  
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Figure 3.3. Amyloid inhibition requires expression of csgC. A) PEs from a 
BW25113 ΔcsgD mutant with pTrc99A (vector) or pTrc99A-csgD (pcsgD) were assayed 
for CsgA amyloid inhibition in vitro. BC) PEs from BW25113 mutants (ΔcsgA, ΔcsgB, 
ΔcsgC) or BW25113 combination mutants (ΔcsgBΔcsgA; ΔcsgAΔcsgC; 
ΔcsgBΔcsgAΔcsgC) were assayed for CsgA amyloid inhibition. CsgA amyloid formation 
was monitored by ThT fluorescence.  
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Figure 3.4. Amyloid inhibitory activity is regulated by CsgD and requires 
expression of csgC. A) BW25113 cells were spotted on YESCA-CR and grown for two 
days at 26°C to induce curli expression. WT cells were transformed with empty vector 
(pTrc99A, ev) and ΔcsgD cells were transformed either with empty vector (ev) or 
pTrc99A-csgD. Whole cell extracts were analyzed by SDS-PAGE and Western blot with 
anti-CsgA and anti-CsgG antibodies with or without HFIP treatment. B) BW25113 
deletion mutants in csgA, csgB, csgC or the indicated combination mutants were grown 
on YESCA-CR plates at 26°C for 2 days prior to analysis by SDS-PAGE, western blot 
and evaluation of Congo red binding. C) Size exclusion chromatography was used to 
fractionate PEs from a BW25113 ΔcsgG mutant. Each fraction was assayed for CsgA 
amyloid inhibition in vitro. Polymerization of CsgA was monitored by ThT fluorescence. 
D) ΔcsgG mutant PEs fractions were separated on a 15% SDS PAGE gel and analyzed 
by western blot with a CsgC antibody.  
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Figure 3.5. ΔcsgGΔcsgC mutants accumulate intracellular CsgA aggregates. A) 
BW25113 cells were grown on Congo red indicator plates at 26°C for 48 hrs to assess 
curli production in vivo. B) Cells grown under curli-inducing conditions were subject to 
western blot analysis with CsgG, CsgA, CsgC and Sigma70 antibodies. C) Intact or 
lysed cells were analyzed by dot blot western using CsgA antibodies.  
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Figure 3.6. ΔcsgGΔcsgC cells do not produce extracellular curli fibers but exhibit 
a decrease in cellular fitness. A-D) MC4100 cells were grown for 2 days on YESCA 
plates at 26°C prior to being harvested, mounted on formvar coated grids, stained with 
uranyl acetate and imaged by transmission electron microscopy. E) Live-Dead stain of 
MC4100 cells grown on YESCA plates at 26C. The percent dead cells was calculated 
relative to a WT standard curve. * p<0.001, ** p<0.0002. F) β-galactosidase activity was 
measured after MC4100 cells containing a cpxP promoter lacZ fusion construct were 
grown on YESCA plates at 26°C for 48 hours. * p<0.00008. G) Overexpression of 
cytoplasmic CsgA (closed squares) alone causes growth arrest measured by OD600 nm 
over time. Coexpression of ev (pBAD33A, open squares) or periplasmic CsgC (open 
circles) failed to alleviate growth arrest. Coexpression of cytoplasmic CsgC (closed 
circles) improved cell growth and division.  
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Figure 3.7. Purified CsgC inhibits CsgA amyloid formation at substoichiometric 
molar ratios. A) Polymerization of CsgA was monitored by ThT fluorescence over time 
in the presence or absence of purified CsgC. B) The secondary structure of CsgA was 
monitored by CD every 24 hours for 4 days in the absence (closed symbols) or 
presence (open symbols) of CsgC (1:10, CsgC:CsgA). Sequential 1H NMR spectra of 
10 µM CsgA alone (C) or in 150-fold molar excess over CsgC (D). The methyl proton 
spectral region is shown for clarity. E) The amplitude of the strongest methyl peak in the 
CsgA (C) and CsgA+CsgC (D) spectra (0.83 ppm) plotted over time. F) Polymerization 
of CsgA was seeded by the addition of 2% (by weight) CsgA seeds in the absence of 
CsgC (open squares) or the presence of CsgC (open circles and triangles). G) Dot blot 
analysis of CsgA alone, CsgC alone or CsgA+CsgC (1:3, CsgA:CsgC) immediately after 
purification (t=0h) or after 24 hours of incubation (t=24) with anti-CsgA, anti-CsgC and 
A11 antibodies. H) Native gel electrophoresis and Western blot of 20 µM soluble CsgA 
without and with 5 min of boiling, 20 µM CsgA that has been incubated at 25°C for 24h, 
6.7 µM CsgC alone, or 20µM CsgA that has been incubated with 2 µM CsgC for 24h.  
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Figure 3.8. CsgA amyloid inhibition in vitro. A) CsgA was incubated with 
substoichiometric molar ratios of BSA for 24 hours. Polymerization of CsgA was 
monitored by ThT fluorescence. B) CsgA was separated into soluble and pelleted 
fractions by centrifugation after 24 hours of incubation alone or in the presence of CsgC 
(1:10, CsgC:CsgA). Samples were either treated with SDS loading buffer or pretreated 
with HFIP prior to being run on a 15% SDS PAGE gel and Western blot with anti-CsgA 
antibody. C) CsgA was incubated with CsgC at a 1:10 molar ratio and aggregation was 
monitored by ThT and ANS fluorescence over time. D) The CD spectrum of CsgC alone 
demonstrates that CsgC remains β-sheet rich over time. The secondary structure of 
CsgA alone (E) or in the presence of CsgC (F) at a 1:10 (CsgC:CsgA) molar ratio was 
monitored by CD every 24 hours for 4 days. ThT fluorescence of CsgA in the presence 
and absence of CsgC was monitored in parallel with CD (G).  
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Figure 3.9. Amyloid inhibition by CsgC is specific. Using the ThT assay, E. coli 
CsgC was tested for amyloid inhibition against CsgA from S. enterica (A), E. coli CsgB 
(B), Aβ42 (C), α-synuclein (DE). F) Sequence alignment of E. coli CsgA, CsgB, human 
α-synuclein and the α-synuclein alanine variant used in panel E.  
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Figure 3.10. CsgC inhibits CsgA repeating unit deletion mutants and synthetic 
peptides. CsgC was tested for amyloid inhibition in vitro with purified repeating unit 
deletion mutants of CsgA (A) ΔR1, (B) ΔR3, (C) ΔR5 and synthetic peptides 
corresponding to R1 (D) and R5 (E). Polymerization was monitored by ThT 
fluorescence. F) C. koseri CsgA was purified and allowed to polymerize in the presence 
or absence of E. coli CsgC. G) Residues 98-104 or α-synuclein were scrambled 
(DQLGKNEE mutated to SQGAYGNTA). The purified α-synucleinscram was purified and 
allowed to polymerize in the presence and absence of CsgC. Polymerization was 
monitored by ThT fluorescence. H) Alignment of α-synuclein with CsgA.  
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Figure 3.11. Model of CsgC-mediated amyloid inhibition. A predicted energy 
landscape of CsgA amyloidogenesis where CsgA forms dynamic, amorphous 
aggregates before assembling into amyloid-like, prefibrillar oligomers. Our data support 
a model where CsgC inhibits CsgA amyloid formation by transiently interacting with a 
prefibrillar CsgA species that results in keeping CsgA in an amorphous conformation. 
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Table 3.1. Strains used in Chapter 3 
Strains Relevant Genotype References 
BW25113 F- Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, 
Δ(rhaD-rhaB)568, hsdR514 
(66) 
Δcsg BW25113 ΔcsgDEFG…ΔcsgBAC This study 
ΔcsgA BW25113 csgA::kan (64) 
ΔcsgB BW25113 csgB::kan (64) 
ΔcsgC BW25113 csgC::kan (64) 
ΔcsgD BW25113 csgD::kan (64) 
ΔcsgE BW25113 csgE::kan (64) 
ΔcsgG BW25113 ΔcsgG This study 
ΔcsgBcsgA BW25113 csgBcsgA::kan This study 
ΔcsgAcsgC BW25113 csgAcsgC::kan This study 
ΔcsgBcsgAcsgC BW25113 csgBcsgAcsgC::kan This study 
ΔcsgGcsgE BW25113 ΔcsgG csgE::kan This study 
ΔcsgGcsgC BW25113 ΔcsgG csgC::kan This study 
MC4100 F- araD139 Δ(argF-lac) U169 rpsL150(strR) relA1 
fibB5301 deoC1 ptsF25 rbsB 
(68) 
ΔcsgG (LSR1) MC4100 csgG::Tn105 (14) 
ΔcsgC MC4100 csgC::kan This study 
ΔcsgGcsgC MC4100 csgG::Tn105 csgC::kan This study 
NEB3016 MiniF lacIq(CamR) / fhuA2 lacZ::T7 gene1 [lon] ompT 
gal sulA11 R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10 
New England 
Biolabs 
BL21(DE3) F–, ompT, hsdSB (rB–, mB–), dcm, gal, λ(DE3) New England 
Biolabs 
BL21(DE3)pLysS F–, ompT, hsdSB (rB–, mB–), dcm, gal, λ(DE3), 
pLysS, Cmr. 
Promega 
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Table 3.2. Plasmids used in Chapter 3 
Plasmids Relevant Characteristics References 
pTrc99A IPTG inducible expression vector Pharmacia Biotech 
pcsgD (pD10) csgD cloned into the EcoRI/BamHI site in 
pTrc99A 
This study 
pCKR101 IPTG inducible expression vector (69) 
pcsgC csgC cloned into KpnI/XbaI site in pCKR101 This study 
pET11d IPTG inducible expression vector New England 
Biolabs 
pNH11 C-terminal His6 tagged E. coli csgA cloned into 
NcoI/BamHI site in pET11d 
(37) 
pET11d-
CsgAΔR1 
C-terminal His6 tagged E. coli csgAΔR1 was PCR 
amplified out of pΔR1 (35) and cloned into 
NcoI/BamHI site in pET11d 
This study 
pET11d-
CsgAΔR3 
C-terminal His6 tagged E. coli csgAΔR3 was PCR 
amplified out of pΔR3 (35) and cloned into 
NcoI/BamHI site in pET11d 
This study 
pET11d-
CsgAΔR5 
C-terminal His6 tagged E. coli csgAΔR5 was PCR 
amplified out of pΔR5 (35) and cloned into 
NcoI/BamHI site in pET11d 
This study 
pET11d-
CsgAST 
C-terminal His6 tagged S. typhimurium csgA 
cloned into NcoI/BamHI site in pET11d 
(34) 
pET11d-
CsgACK 
C-terminal His6 tagged C. koseri csgA cloned into 
NcoI/BamHI site in pET11d 
(34) 
pNH28 C-terminally His6 tagged csgBΔR5 cloned into 
NcoI/BamHI site in pET11d 
(37) 
pET28a IPTG inducible expression vector New England 
Biolabs 
pC3 C-terminal His6 tagged csgC cloned into pET28a (26) 
pCsgA22-151 C-terminal LEHHHHHH tagged csgA lacking the 
Sec-secretion signal sequence was cloned into 
NcoI/XhoI site in pET28a 
This study 
pBAD/Myc-
his C 
Arabinose inducible expression vector Invitrogen 
pCsgC1-110 C-terminal VEHHHHHH tagged csgC was cloned 
into the NcoI/SalI site of pBAD/Myc-his  
This study 
pCsgC9-110 C-terminal VEHHHHHH tagged csgC lacking the 
Sec-secretion signal sequence was cloned into 
the NcoI/SalI site of pBAD/Myc-his  
This study 
pt77/434HK  IPTG inducible expression of Caspase-7 
cleavable His6-tagged α-synuclein  
AlexoTech AB 
(www.alexotech.co
m, Umeå, Sweden) 
pRJ800 Promoterless lacZ construct (70) 
pCpx1 cpxP promoter cloned into the EcoRI/BamHI site This study 
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in pRJ800 
pCP20 Flp recombinase expressing vector (65) 
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Table 3.3. Primers used in Chapter 3 
Primer Primer sequence Constructs 
CsgGH2P2 5’-CCGGATGATAATTCCGGCTTTTTTATCTGTCAGGATTC 
CGGTGGAACCGAGTGTAGGCTGGAGCTGCTTC-3’ 
Δcsg 
CsgEH1P1 5’-CGCATTGCAGCCTCCGAACAATTTTTTATTTAGAATTCA 
TCATGCGCCAACATATGAATATCCTCCTTAG-3’ 
ΔcsgGcsgE 
CsgEH2P2 5’-GACACAAGCGGTTTCCTGGGCAAACGATAACCTCAGG 
CGATAAAGCCATGGTGTAGGCTGGAGCTGCTTC-3’ 
ΔcsgGcsgE 
CsgCH1P1 5’-TATTACAGAAACAGGGCGCAAGCCCTGTTTTTTTTCGG 
GAGAAGAATATGGTGTAGGCTGGAGCTGCTTC-3’ 
ΔcsgGcsgC 
CsgCH2P2 5’-ATTCATCTTATGCTCGATATTTCAACAAATTAAGACTTT 
TCTGAAGAGGGCATATGAATATCCTCCTTAG-3’ 
Δcsg 
ΔcsgGcsgC  
ΔcsgAcsgC  
ΔcsgBcsgA
csgC 
CsgBH1P1 5’-GAAATGATTTAATTTCTTAAATGTACGACCAGGTCCAG 
GGTGACAACATGGTGTAGGCTGGAGCTGCTT-3’ 
ΔcsgBcsgA  
ΔcsgBcsgA
csgC 
CsgAH1P1 5’-ACGTTAATTTCCATTCGACTTTTAAATCAATCCGATGG 
GGGTTTTACATGGTGTAGGCTGGAGCTGCTTC-3’ 
ΔcsgAcsgC 
CsgAH2P1 5'-CGCCCTGTTTCTGTAAATACAAATGATGTATTAGTACT 
GATGAGCGGTCGCCATATGAATATCCTCCTTAG 
ΔcsgBcsgA  
 
MMB116 5’-CGGAATTCATGTTTAATGAAGTCCATAG-3’ pD10 
MMB117 5’-CGGGATCCTTATCGCCTGAGGTTATCG-3’ pD10 
KpnI-csgC 5’-GCGGGTACCATGAATACGTTATTACTC-3’ pcsgC 
csgC-XbaI 5’-GCGAGATCTTTAAGACTTTTCTGAAGA-3’ pcsgC 
MMB92 5’-CGGAATTCATCGTGGGCAACAATCACG-3’ pCpx1 
MMB93 5’-CGGGATCCTTGCTCCCAAAATCTTTCTG-3’ pCpx1 
NH55 5'-GCGTTTCCATGGGTGTTGTTCCTCAGTACGGCGGC-3’ pET11d-
CsgAΔR1, 
pET11d-
CsgAΔR3, 
pET11d-
CsgAΔR5 
NH56 5'-GTTTAAAGCTTGGATCCTTAGTGATGGTGATGGTGATG 
GTACTGATGAGCGGTCGCGTTGTT-3’ 
pET11d-
CsgAΔR1, 
pET11d-
CsgAΔR3, 
pET11d-
CsgAΔR5 
CsgA2F 5’-CGTTCCATGGGTGTTGTTCCTCAGTACGG-3’ pCsgA22-151 
CsgA2R 5’-TATTCTCGAGGTACTGATGAGCGGTCGCGTTG-3’ pCsgA22-151 
CsgCK12F 5’-TATTCCATGGGCACGTTATTACTCCTTGCGGC-3’ pCsgC1-110 
CsgCcoli10
R 
5’-TATTCTCGAGTTAAGACTTTTCTGAAGAGGGCGGC-3’ pCsgC1-110 
 105"
CsgCcoli3F 5’-TCTTCCATGGGCTCCAGTCAGATAACCTTTAATACGACC-
3’ 
pCsgC9-110 
CsgCcoli3R 5’-TATTCTCGAGAGACTTTTCTGAAGAGGGCGGCCATTG-3’ pCsgC9-110 
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Chapter 4 
CsgE is Required for Efficient Translocation of Curli Subunits  
Across the Outer Membrane4 
 
 
Abstract 
Protein localization is essential for protein function. Enteric bacteria, including 
Escherichia coli, assemble curli, functional amyloid fibers on the cell surface that share 
structural and biochemical properties with disease-associated amyloids. The major curli 
subunit, CsgA, is secreted across the outer membrane as an unstructured protein. The 
outer membrane pore protein CsgG mediates secretion with the assistance of the 
accessory protein CsgE. CsgE is required for CsgA secretion and we have 
demonstrated that CsgE can inhibit CsgA amyloid assembly in vitro. In this chapter I 
report that CsgE directly interacts with E. coli CsgA and the minor curli subunit CsgB. 
CsgE can arrest actively polymerizing CsgA amyloid formation in vitro. Directed 
mutational analysis revealed several residues in CsgE that are important for proper 
function in vivo. Finally, the metalloprotease YfgC was identified in a mutagenesis 
screen for mutations that restore Congo red binding to a ΔcsgE mutant. Deletion of yfgC 
in secretion mutants stabilized CsgC protein levels suggesting that CsgC may be a 
substrate of YfgC. Futhermore, cells deleted for csgG, csgC and yfgC accumulated 
increased levels of intracellular CsgA. Together, these findings suggest that YfgC may 
be involved in preventing the accumulation of intracellular amyloid assembly by CsgA.  
___________________ 
4Portions of this chapter (Figure 4.1ABC, experiments that I conducted) are published in 
Chemistry and Biology (37). Sarah Kang cloned all of the CsgE mutants for the ΔcsgE 
mutant complementation assays and erythromycin sensitivity assays. Sarah also 
conducted all the original ΔcsgE complementation experiments (Figure 4.2) and 
contributed the erythromycin sensitivity data (Figure 4.3). Dr. Matt Badtke and Michael 
O’Conner conducted the Mariner transposon mutagenesis and first identified YfgC. I 
contributed the data presented in Figure 4.4. 
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Introduction 
Protein localization is important for proper to protein folding and function. There 
are two secretion mechanisms that facilitate proteins translocation across the inner 
membrane of Gram-negative bacteria: the Twin Arginine Translocation (Tat) and Sec 
pathways. The Tat secretion system secretes folded or partially folded substrates (1). 
On the other hand, the Sec translocation system secretes unfolding polypeptides"(2). 
SecB is a chaperone-like protein that assists in maintaining peptides in an unfolded 
conformation and delivering them to the SecYEG pore for secretion across the inner 
membrane (3-6). Additional cytoplasmic proteins and chaperones, including the 
ribosome-associated protein Trigger Factor (TF) and the heat shock protein DnaK, 
assist in preventing inappropriate protein folding"(6). Secreted proteins from Gram-
negative bacteria present a additional protein folding challenges to the cell as these 
proteins must traverse two biological membranes. There are at least eight unique 
secretion systems in Gram-negative bacteria for delivering proteins outside the cell (7). 
One of the most intriguing secretion systems is the Type8SS, better known as 
nucleation precipitation, responsible for the assembly the functional amyloid curli on the 
bacterial cell surface. Curli are extracellular fibers produced by Escherichia coli and 
Salmonella species that are important for adhesion to inert surfaces, adhesion to host 
cells during infection, during biofilm formation, and other community behaviors (8-11). 
Secretion of the curli subunits presents additional challenges to the cell as curli 
rapidly assemble in amyloid fibers"(12). Amyloid proteins are commonly associated with 
neurodegenerative disorders such as Alzheimer’s, Huntington’s, and Parkinson’s 
diseases (13). Unrelated proteins of various size and primary amino acid sequences 
can assemble into amyloids that share the same biophysical properties (14): amyloids 
are 4–12 nm wide fibers, have a cross β-sheet structure, are highly resistant to 
denaturation, and bind amyloid-specific dyes such as Congo red and thioflavin T (ThT) 
(12, 15). A growing number of ‘‘functional’’ amyloids can be assembled by many cell 
types to fulfill normal physiological processes, including regulation of melanin synthesis, 
information transfer, or as structural materials (8, 16, 17). 
Curli biogenesis is a highly regulated process and requires the products of two 
divergently transcribed operons (csgBAC and csgDEFG) (18). The major subunit 
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protein of curli is CsgA. CsgA is secreted to the cell surface as an unstructured protein 
and then templated into amyloid fibers by the minor curli subunit CsgB (19-23). The 
amyloid core of CsgA consists of five imperfect repeating units (R1–R5). R1 and R5 are 
highly amyloidogenic, whereas R2, R3, and R4 contain gatekeeper residues that reduce 
their ability to form amyloids (24-26). The secretion of CsgA and CsgB is dependent on 
CsgG, which forms an oligomeric pore in the outer membrane (27-29). CsgC is a 
periplasmic protein that specifically and efficiently inhibits amyloid formation of CsgA 
(Chapter 3 and (30, 31)). The chaperone-like CsgF assists the CsgB-CsgA interaction 
and aids the nucleation of CsgA polymerization in vivo (32). CsgE interacts with CsgG 
in a cap-like structure in the periplasm (29). CsgE is a putative chaperone of CsgA that 
also functions as a specificity factor in the periplasm to facilitate efficient curli subunit 
secretion (28, 32).  
In this chapter, I report that CsgE directly interacts with CsgA and CsgB amyloid 
fibers and is capable of arresting polymerization of actively elongating fibers. I also 
report mutants in CsgE that influence CsgE function in vivo. Finally, YfgC was identified 
in a screen for mutation that restore Congo red binding to a ΔcsgE mutant. YfgC is a 
periplasmic metalloprotease that may play a role in degrading curli subunits and 
accessory factors when secretion fails.  
 
Results 
CsgE interacts with CsgA to inhibit amyloid assembly in vitro 
Molecular chaperones can inhibit CsgA amyloid formation (Chapter 2; (9)). CsgE 
is a putative periplasmic chaperone and has been shown to prevent CsgA self-
assembly into amyloid fibers in vitro (Fig 4.1A) (32). To test whether the interaction 
between CsgE and CsgA fibers could prevent further CsgA fiber elongation, an order of 
addition experiment was conducted where CsgE was added at different times after the 
start of CsgA polymerization. CsgA was allowed to polymerize for 1, 2, 7, and 8 hr prior 
to the addition of CsgE. CsgE arrested CsgA polymerization at every time point tested 
(Fig 4.1A). These results are consistent with the idea that CsgE prevents fiber 
elongation, possibly by sequestering soluble CsgA.  
Surface Plasmon Resonance (SPR) was then used to test whether CsgE directly 
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interacts with CsgA amyloid fibers. Purified CsgA was allowed to polymerize for 24 hr. 
Fibers were then sonicated and immobilized on a GE Sensor-Chip and CsgE was 
injected over the chip. A rapid increase in resonance units was observed upon addition 
of CsgE indicating a direct interaction between CsgE and CsgA fibers (Fig. 4.1B black 
line). Injection of a mock purification of CsgE to control for possible copurified proteins 
did not result in a large increase in resonance units (Fig 4.1B, gray line). CsgE also 
interacted with CsgB fibers immobilized on the SPR chip (Fig 4.1C). CsgE did not 
interact with the control protein BSA (Fig 4.1D). SPR experiments using mature CsgA 
fibers suggest that not only can CsgE stabilize CsgA monomers but can also interact 
with CsgA and CsgB fibers that may also inhibit monomer addition to fiber ends and 
nucleation.  
 
Mutational analysis of CsgE in vivo 
CsgE is required for curli biogenesis in vivo"(12, 32). CsgE interact with CsgG 
and forms a cap-like structure on the periplasmic side of the CsgG pore (29). A csgE 
mutant can be complemented by expression of csgE from a plasmid or overexpression 
of csgG (32). The ability to complement the csgE mutant allowed us to investigate the 
effect of specific mutants on CsgE function in vivo. In collaboration with Dr. Christiane 
Ritter at the Helmholtz Centre for Infection Research in Braunschweig, Germany, and 
with the help of Sarah Kang, an undergraduate in the Chapman Lab, we have begun to 
investigate the molecular details of CsgE function.  
The Ritter Lab has a preliminary solid-state NMR structure of CsgE (unpublished 
data) and has identified several residues that, when mutated, increase CsgE stability in 
vitro. We cloned three of the identified mutants (W49S, W52S and F68S) into an 
expression vector under control of the csgBAC promoter. The csgE mutant-containing 
plasmids were transformed into BW25113 ΔcsgE and assayed for the ability to restore 
CR binding and CsgA protein levels. Expression of the W49S and W52S mutants fully 
restored CR binding to WT levels while expression of the F68S mutant only partially 
restored CR binding (Fig. 4.1A). Although CR binding was restored, WT CsgE protein 
was undetectable by western blot and complementation with either WT or the W49S 
mutant did not result in detectable levels of CsgE (Fig. 4.2B). Complementation with the 
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W52S and F68S mutants resulted in detectable levels of CsgE with the F68S mutant 
yielding the highest level of expression (Fig. 4.2B). The increased expression, and 
stability, of the F68S mutant is consistent with observations in the Ritter Lab that the 
F68S mutant has increase stability in vitro. CsgG protein levels remained unchanged 
when any of the mutants were used to complement the ΔcsgE mutant (Fig. 4.2C). WT 
levels of CsgA were restored when WT, or the W49S and W52S mutants were used to 
complement the ΔcsgE mutant (Fig. 4.2C). Consistent with the CR binding results, 
expression of the F68S mutant resulted in lower levels of CsgA protein by western blot 
(Fig. 4.2C).  
 
CsgE gates CsgG 
 The observation that the CsgE F68S mutant was stably expressed but unable to 
complement the ΔcsgE mutant suggested this variant of CsgE may still be capable of 
gating the CsgG pore. We therefore used an erythromycin sensitivity assay developed 
previously for investigating CsgG pore activity (32). Briefly, a complete curli deletion 
strain was grown in broth culture with empty vector (ev), expressing csgG alone or 
expressing both csgG and csgE from an IPTG-inducible promoter. After an hour, 30 
µg/mL erythromycin was added to the culture. Cells transformed with empty vector 
continued to grow whereas cells overexpressing csgG arrest growth (Fig. 4.3A-C, 
compare black squares with open squares) (32). Cells continued to grow in the 
presence of 30 µg/mL erythromycin when both csgG and WT csgE are expressed (Fig. 
4.3A-C, black circles). Overexpression of either the W49S or W52S mutant of CsgE did 
not block erythromycin sensitivity (Fig. 4.3A and B, respectively). On the other hand, 
overexpression of the F68S mutant of CsgE rescued growth to the same degree as WT 
CsgE (Fig. 4.3C). 
 
Identification of a protease in the ΔcsgE mutant 
 The fate of mislocalized CsgA and CsgB in the ΔcsgE mutant is unknown. The 
curli genes are still expressed in the ΔcsgE mutant (Elisabeth Ashman Epstein, 
unpublished results) and overexpression of csgG in a ΔcsgE mutant restores CsgA 
secretion and CR binding. Together, these observations suggest that CsgA stability is 
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dependent on the ability of cells to secrete CsgA outside the cell before periplasmic 
proteases are able to degrade CsgA. To try to identify periplasmic proteases that may 
degrade CsgA and CsgB in a ΔcsgE mutant, we conducted a transposon mutagenesis 
of ΔcsgE and screened for mutants that restored CR binding. A post-doctoral 
researcher, Dr. Matthew Badtke, and an undergraduate researcher, Michael O’Conner 
in the Chapman Lab, conducted the initial mutagenesis and screening. The screen 
yielded yfgC (BepA), a metalloprotease involved in maintaining outer membrane 
integrity (33). 
 Deletion of yfgC in a ΔcsgE mutant partially restored CR binding (Fig. 4.4A). 
However, increased CR binding relative to the ΔcsgE mutant was not due to restored 
CsgA protein levels (Fig. 4.4B). To verify that this was not due to loss of a general 
periplasmic protease, the canonical periplasmic serine protease DegP was deleted. 
Unlike the ΔcsgEΔyfgC mutant, deletion of degP in the ΔcsgE mutant did not restore 
CR binding (Fig. 4.4A). CsgG protein levels were also investigated since YfgC is 
important for outer membrane protein (OMP) assembly and degradation (33). The 
absence of yfgC also does not influence CsgG protein levels (Fig. 4.4B). YfgC is 
important for maintaining outer membrane integrity; therefore, the observed rescue of 
CR binding in the ΔcsgEΔyfgC mutant relative to the ΔcsgE mutant may be due to loss 
of outer membrane integrity and an influx of CR into the periplasmic space.  
 To better investigate the possibility that CsgA is a substrate of YfgC, yfgC was 
deleted in a mutant background known to accumulate intracellular CsgA, the 
ΔcsgGΔcsgC mutant (Chapter 2). There was a very modest increase in CR binding of 
the ΔcsgGΔcsgCΔyfgC mutant compared to the ΔcsgGΔcsgC mutant (Fig. 4.4C). There 
was no apparent difference in CR binding of the ΔyfgC mutant compared to WT, the 
ΔcsgGΔyfgC mutant compared to ΔcsgG or the ΔcsgCΔyfgC mutant compared to 
ΔcsgC (Fig. 4.4C). However, unlike the ΔcsgEΔyfgC mutant, the ΔcsgGΔcsgCΔyfgC 
mutant accumulated slightly more SDS insoluble CsgA compared to the ΔcsgGΔcsgC 
(Fig. 4.4D, lower panel). CsgC levels are reduced in a ΔcsgG mutant (Chapter 3; Fig. 
4.4E, lower panel). Interestingly, deletion of yfgC in the ΔcsgG mutant restores CsgC 
back to WT levels suggesting that CsgC may be a substrate of YfgC (Fig. 4.4E, lower 
panel compare lane 6 to lane 2).  
 117"
Discussion 
Bacterial protein secretion is a controlled event. Most secreted proteins traverse 
the inner membrane of Gram-negative bacteria via the Sec translocon with SecB 
playing an important role inhibiting aggregation and directing peptides to the SecYEG 
inner membrane pore (2). In Gram-negative bacteria there are at least eight secretion 
systems for transporting proteins outside the cell (7). The curli system possesses a 
dedicated outer membrane secretion system (sometimes referred to as Type 8 
secretion) (7). Secretion of the curli subunits presents additional challenges to the cell 
since curli rapidly assembly into amyloid fibers (12). Amyloid can be toxic to 
membranes; therefore, the curli secretion system must be both efficient and specific to 
avoid inappropriate intracellular amyloid aggregation (34).  
The outer membrane curli secretion pore is composed of nine CsgG monomers 
arranged in a β-barrel imbedded in the membrane with a largely α-helical periplasmic 
domain. The inner diameter of the CsgG pore is approximately 2 nm wide, 
accommodating only largely unfolded polypeptides (28, 29, 35, 36). The diameter of the 
CsgG pore requires that periplasmic factors exist that keep CsgA from folding prior to 
secretion. CsgE interacts with CsgG and is required for CsgA secretion in vivo (12, 32). 
Expression of CsgE gates CsgG pore activity and client protein specificity in vivo (28, 
32). CsgE also inhibits CsgA amyloid formation and interacts directly with CsgA and 
CsgB in vitro (Fig. 4.1ABC) (32, 37). I predict that CsgE maintains CsgA is a 
conformation that is presumably competent for secretion by inhibiting CsgA amyloid 
assembly (Fig. 4.4A; (32)). It is possible that CsgE plays a similar role during curli 
subunit secretion to that of SecB during secretion across the inner membrane. Both 
proteins appear to have dual functions: 1) inhibit protein aggregation and 2) to deliver 
client proteins to a dedicated secretion apparatus. Our observations support a SecB-like 
mechanism for CsgE during secretion and also suggest that CsgE can disrupt on-going 
fiber formation (Fig. 4.1A). 
Dr. Christiane Ritter at the Helmholtz Centre for Infection Research has solved a 
preliminary structure of CsgE and has identified mutations within CsgE that improve 
CsgE stability in vitro (Fig. 4.2A). To gain a better understanding on the molecular 
details of CsgE function in vivo we expressed Dr. Ritter’s CsgE mutants in vivo and 
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asked whether they could compliment a ΔcsgE mutant. The mutation that was most 
stabilizing in vitro, F68S, was also the mostly stably expressed mutant in vivo (Fig. 
4.2C). However, the F68S mutant did not complement CR binding or CsgA protein 
levels when expressed in a ΔcsgE mutant (Fig. 4.2BD). Interestingly, overexpression of 
the CsgEF68S mutant with CsgG protected cells in the erythromycin sensitivity assay 
suggesting that the F68S mutant can still gate CsgG pore function (Fig. 4.3C). The two 
other mutations in CsgE, W49S and W52S, could complement CR binding and CsgA 
protein levels in a ΔcsgE mutant but were erythromycin sensitive and therefore likely 
unable to gate CsgG in the erythromycin sensitivity assay (Fig. 4.2BCD and Fig. 4.3AB). 
Together, these results suggest that the F68 residue of CsgE may be more important 
for interaction with CsgA while the W49 and W52 residues may be more important for 
interacting with and gating CsgG.  
In the absence of CsgE very little CsgA is secreted in vivo. CsgA also does not 
accumulate within the periplasm of ΔcsgE cells (12, 32). Together with the observation 
that csgA expression is only modestly effected in a ΔcsgE mutant (Elisabeth Ashman 
Epstein, unpublished results) suggests that CsgA is degraded in the periplasm if it 
cannot be secreted. A transposon screen for mutations that restored CR binding to a 
ΔcsgE mutant was conducted to try to identify periplasmic proteases that may degrade 
CsgA. One protease that was identified was YfgC (Fig. 4.4A). YfgC is a periplasmic 
metalloprotease that plays a role in outer membrane β-barrel protein folding and 
insertion (33). yfgC is regulated by the SigmaE alternative sigma factor and deletion of 
yfgC in a ΔsurA or ΔdegP backgrounds is lethal under some conditions (38, 39). SurA 
assists in folding and inserting a several outer membrane β-barrel proteins (35). If SurA 
and YfgC are functionally redundant then would not be unexpected to observe that the 
double deletion is a synthetic lethal mutant. The ΔsurA mutant has decreased CR 
binding and decreased CsgG protein levels (Daniel Smith, unpublished data). The 
crystal structure of CsgG revealed the protein to be a β-barrel outer membrane protein 
(29). It is likely that CsgG is a client of SurA. CsgG levels are unchanged in a ΔyfgC 
mutant (Fig. 4.4BD).  
The ΔyfgCΔdegP mutant was also synthetic lethal at 37°C on SDS/EDTA 
suggesting a severe defect in outer membrane integrity (39). Interestingly, while loss of 
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yfgC in the ΔcsgE mutant restored some CR binding, CsgA protein levels were not 
restored (Fig. 4.4AB). The restored CR binding when yfgC was deleted may have been 
due to CR leaking across the compromised outer membrane.  
 Finally, we asked whether YfgC could act on CsgA when CsgA was forced to 
accumulate in the periplasm. To do this yfgC was deleted from a ΔcsgGΔcsgC mutant 
that accumulates SDS-insoluble intracellular CsgA (Fig. 3.5). Deletion of yfgC in the 
ΔcsgGΔcsgC mutant slightly increased CR binding and CsgA protein levels (Fig. 
4.4CD). The only modest increase in CsgA protein levels may be accounted for by the 
approximately 2-3-fold feedback repression of the csgBAC operon when csgG is 
deleted (Appendix A). Together, these results suggest that a small pool of CsgA may be 
degraded by YfgC in the periplasm. What is more interesting is the effect the yfgC 
deletion has on CsgC. CsgC protein levels are reduced in a ΔcsgG mutant likely due to 
feedback repression of the csgBAC promoter (Appendix A). Deletion of yfgC in the 
ΔcsgG mutant restored CsgC back to WT levels (Fig. 4.4E). YfgC has only been 
reported to degrade outer membrane β-barrel proteins (33). These findings suggest that 
CsgC, while not an outer membrane β-barrel protein, may also be a substrate of YfgC. 
Together, the data presented here represent the first molecular dissection of the 
multiple functions of CsgE and new insights into periplasmic proteostasis during curli 
biogenesis.  
 
Materials and Methods 
Bacterial Strains and Plasmids. BW25113 ΔdsbA (dsbA::kan) and ΔdsbB (dsbB::kan) 
obtained from the Keio collection (40). Additional mutations in BW25113 were 
constructed using lambda red recombination as described previously (41). 
Soluble CsgA Purification. C-terminal His6-tagged CsgA (12) was, with some 
modifications, purified as previously described (42). Briefly, NEB3016 slyD::kan 
pET11d-sec-csgA-6xhis cells were grown to OD600 0.9, induced with IPTG, and 
incubated at 37C for 1 hr. Cells were pelleted by centrifugation and stored at -80C. Cells 
were lysed by incubation with stirring in an 8 M guanidine hydrochloride, 50 mM 
potassium phosphate solution pH 7.3 for 24 hr at 4C. The insoluble portion of the lysate 
was removed by centrifugation and the remaining supernatant was incubated with 
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NiNTA resin (Sigma-Aldrich) for 1 hr at room temperature. The nickel affinity beads 
were washed with 50 mM potassium phosphate pH 7.3 and a 12.5 mM imidazole, 50 
mM potassium phosphate solution. His6-tagged CsgA was eluted with a 125 mM 
imidazole, 50 mM potassium phosphate solution. Protein concentration was determined 
by the BCA assay (Thermo Scientific).  
CsgE Purification. CsgE-His was, with some modifications, expressed and purified as 
previously described (32). Briefly, CsgE-His was expressed from pNH27 (gene 
encoding cytoplasmic CsgE inserted into the NcoI-BamHI sites of pET11d) in strain 
NEB 3016 with 100 mg/ml ampicillin. Cells were grown to OD600 0.9 and induced for 1 
hr with IPTG. Cells were pelleted by centrifugation and resuspended in lysis buffer. 
Cells were lysed using a French press and after centrifugation the supernatant was 
incubated with NiNTA resin (Sigma- Aldrich) at 4°C overnight. The nickel affinity beads 
were washed with lysis buffer, followed by a 12.5 mM Imidazole, 50 mM potassium 
phosphate solution pH 7.3. His-tagged CsgE was eluted with a 250 mM Imidazole, 50 
mM potassium phosphate solution pH 7.3. The protein buffer was exchanged to 50 mM 
potassium phosphate, 200 mM sodium chloride pH 7.3 with 1 mM PMSF on a Zeba 
Desalt Spin Column (Thermo Scientific).  
In Vitro CsgA Polymerization Inhibition. Equimolar concentrations of CsgE and CsgA 
or equal volumes of compound and CsgA were mixed in a 96-well black plate (Corning). 
Control experiments were performed with 0.5% DMSO. Thioflavin T was added to a 
final concentration of 20 mM and fluorescence was measured at 480 nm (excitation 440 
nm) for 18 hr at 20C with agitation every 15 min on a Tecan Infinite 200i to monitor 
amyloid formation.  
Surface Plasmon Resonance. Interaction studies between CsgA amyloid fibers and 
CsgE were conducted as previously described with some modification (43). 40 µL of 1 
mM CsgE or an equivalent volume of a mock purification (NEB3013 with pET11d) was 
injected over the sensor chip at 20 mL/min. The injection was stopped at 120 s, and the 
flow of 50 mM potassium phosphate, 200 mM sodium chloride buffer was resumed. The 
response was recorded in resonance units.  
Bacterial Growth. All overnight cultures were grown in LB at 37°C with shaking at 
220rpm. Cultures were normalized to OD600=1.0, 4 µL were spotted YESCA agar (yeast 
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extract casamino acids) plates and grown for 48 hours at 26°C to induce curli 
production. For Congo red analysis YESCA plates were supplemented with 50 µg/mL 
Congo red and 1 µg/mL Brilliant Blue G250. When necessary, plates were 
supplemented with ampicillin or kanamycin at 5 µg/mL. 
Western Blot Analysis. Overnight cultures were diluted to OD600=1.0 and 4 µL were 
spotted on a YESCA plate and incubated at 26°C for 2 days. The cells were harvested 
and resuspended in 50 mM KPi pH 7.3. 0.1 OD600 nm units for each strain were 
harvested in duplicate by centrifugation. One duplicate was resuspended in 2X SDS 
loading buffer while the other was treated with HFIP for 10 min at room temperature, 
dried in a SpeedVac and then resuspended in 2X SDS loading buffer. Samples were 
run on a 15% SDS PAGE gel and transferred to a PVDF membrane. Blots were probed 
with antibodies against CsgA (1:12,000), CsgG (1:50,000), CsgC (1:4,000) or YfgC 
(1:5000; the YfgC antibody was a generous gift from Dr. Jean Francoise Collet).  
Erythromycin Sensitivity. An E. coli MC4100 complete curli deletion strain was 
transformed either with empty vector, pMC1 (expressing csgG only), pLR12 (expressing 
csgG and WT csgE), pSK1, pSK2 or pSK3 (expressing csgG and csgE W49S, W52S or 
F68S, respectively). Overnight cultures were diluted in duplicate 1:100 in LB 
supplemented with ampicillin and grown shaking for 30 min at 37°C in Klett flasks. IPTG 
was added to the cultures to a final concentration of 0.5mM and cultures were incubated 
again for 30 min at 37°C. Erythromycin was added to one of each duplicate to a 
concentration of 30 µg/mL, cultures were returned to the shaking incubator and grown 
at 37°C. Optical density was measured at t=0h and every 30 min during growth using a 
Klett Calorimeter.  
Mariner Transposon Mutagenesis. Overnight cultures of E. coli BW1951 transformed 
with pFD1 (described previously (44)) and MC4100 ΔcsgE (StrepR) were mixed, rinsed 
once with YESCA media and grown for 2.5 hours at 37°C on a cellulose filter disc on a 
YESCA plate. The cells were then rinsed from the filter disc with 10 mL YESCA 
supplemented with streptomycin and IPTG and incubated for another 5 hours at 37°C to 
select again the donor strain and induce expression of the mariner transposase. Cells 
were pelleted and resuspended in 10mL YESCA supplemented with streptomycin and 
kanamycin and incubated for 1 hr at 37°C. Mutants were selected for on YESCA kan 
 122"
plates and screened for CR binding at 26°C after 48 hr of growth. The location of the 
transposon in candidates with restored CR binding was determined with random-primer 
sequencing using primers 5’-GGCCACGCGTGCACTAGTACNNNNNNNNNNTACNG-3’ 
and 5’-ATCCATTTAATACTAGCGACGC-3’ for the first round of PCR and primers 5’-
GGCCACGCGTGCACTAGTAC-3’ and 5’-GCCATCTATGTGTCAGACCGG-3’ for the 
second found of PCR. Candidates that yielded a PCR product were sent for sequencing 
using primer 5’-GCCATCTATGTGTCAGACCGG-3’.  
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Figures and Tables 
 
Figure 4.1. CsgE interacts with CsgA and CsgB. A) CsgE added to freshly purified 
CsgA or CsgA incubated for 1 hr inhibits CsgA polymerization. CsgE added to CsgA 
incubated for 7 hr or 8 hr efficiently inhibits further polymerization. B-D) Surface 
plasmon resonance sensograms of 1 mM purified CsgE (solid line) or a mock 
purification (dotted line) were injected over immobilized sonicated CsgA fibers (B), CsgB 
fibers (C) or BSA control (D) on a CM5 sensor chip. Flow of phosphate buffer was 
resumed after 120 s.  
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Figure 4.2. csgE mutants exhibit different curli biogenesis phenotypes in vivo. A) 
CR binding of ΔcsgE complemented with WT or mutant versions of CsgE. B) Western 
blot analysis of CsgE levels in a ΔcsgE mutant complemented with WT or mutant 
versions of CsgE. C) Western blot analysis of CsgG and CsgA levels in a ΔcsgE mutant 
complemented with WT or mutant versions of CsgE.  
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Figure 4.3. csgE mutants exhibit differential CsgG gating phenotypes in vivo. E. 
coli cells with empty vector (ev), overexpressing csgG alone (CsgG), csgG and WT 
csgE (CsgEWT) or csgG and the indicated csgE mutants. Expression was induced by 
the addition of IPTG at 0.5h and erythromycin was added at 1 h.  
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Figure 4.4. Analysis of yfgC function in vivo. A) CR binding of E. coli BW25113 
showing partially restored CR binding of ΔcsgEΔyfgC compared to ΔcsgE. B) Western 
blot analysis of CsgG and CsgA. C) CR binding of E. coli BW25113 and western blot 
analysis of CsgG, CsgA (D), YfgC and CsgC (E).  
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Table 4.1 Strains used in Chapter 4 
Strains Relevant Genotype References 
NEB3016 MiniF lacIq(CamR) / fhuA2 lacZ::T7 gene1 [lon] 
ompT gal sulA11 R(mcr-73::miniTn10--TetS)2 
[dcm] R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-
mrr)114::IS10 
New England 
Biolabs 
BW25113 F- Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-
1, Δ(rhaD-rhaB)568, hsdR514 
(41) 
ΔcsgC BW25113 csgC::kan (40) 
ΔcsgE BW25113 csgE::kan (40) 
ΔcsgG BW25113 ΔcsgG Chapter 3 
ΔcsgGΔcsgC BW25113 ΔcsgG csgC::kan Chapter 3 
ΔdegP BW25113 degP::kan (40) 
ΔyfgC BW25113 yfgC::kan (40) 
ΔcsgEΔdegP BW25113 ΔcsgE degP::cm This work 
ΔcsgEΔyfgC BW25113 ΔcsgE yfgC::cm This work 
ΔcsgGΔyfgC BW25113 ΔcsgG yfgC::cm This work 
ΔcsgCΔyfgC BW25113 ΔcsgC yfgC::cm This work 
ΔcsgGΔcsgCΔyfgC BW25113 ΔcsgGΔcsgC yfgC::cm This work 
C600 F- tonA21 thi-1 thr-1 leuB6 lacY1 glnV44 rfbC1 
fhuA1 λ- 
(45) 
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Table 4.2 Plasmids used in Chapter 4 
Plasmids Relevant Characteristics References 
pTrc99A IPTG inducible expression vector Pharmacia Biotech 
pNH11 C-terminal His6 tagged E. coli csgA cloned into 
NcoI/BamHI site in pET11d 
(22) 
pNH27 C-terminal His6 tagged E. coli csgA cloned into 
NcoI/BamHI site in pET11d 
(32) 
pLR1 The csgBAC promoter cloned into BamHI/PstI 
site in pACYC177 
(28) 
pLR70 WT csgE cloned into pLR1 (32) 
pSK1 W49S csgE mutant cloned into pLR1 This work 
pSK2 W52S csgE mutant cloned into pLR1 This work 
pSK3 F68S csgE mutant cloned into pLR1 This work 
pLR12 csgG and csgE cloned into pTrc99A This work 
pSK4 WT csgE replaced with W49S csgE mutant in 
pLR12 
This work 
pSK5 WT csgE replaced with W52S csgE mutant in 
pLR12 
This work 
pSK6 WT csgE replaced with F68S csgE mutant in 
pLR12 
This work 
pKD3 Cm resistance flanked by FRT sites (41) 
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Table 4.3 Primers used in Chapter 4 
Primer Primer sequence Constructs 
csgE F Kpn-RBS-Nco 5'-GTTTGGTACCACACAGGAAACAGACC pSK1, 
pSK2, pSK3 
csgE R 3xS-Pst 5'-GTTTCTGCAGTTATTAGATCCTTAGAA pSK1, 
pSK2, pSK3 
csgE_W49S_f 5'-GGCCCAGTGCACGAAGCGGAAGCTG pSK1, pSK4 
csgE_W49S_r 5'-CGTTATAGTGATCCAGCTTCCGCTTC pSK1, pSK4 
csgE_W52S_f 5'-CCAGTGCACGATGGGGAAGCAGCAT pSK2, pSK5 
csgE_W52S_r 5'-GATTGACCGTTATAGTGATGCTGCTT pSK2, pSK5 
csgE_F68S_f 5'-GGACGTTATTTTCCAGACTTTTTTAAG pSK3, pSK6 
csgE_F68S_r 5'-CTCGAAGTCTCTTTTCAACGGGCTTA pSK3, pSK6 
DegPH1P1 5’-GAAGAACACAGCAATTTTGCGTTATCTGTTAAT 
CGAGACTGAAATACATG 
ΔdegP 
DegPH2P2 5’-TCCCGTTTTCAGGAAGGGGTTGAGGGAGATTA 
CTGCATTAACAGGTAGAT 
ΔdegP 
YfgCH1P1 5’-CACAGTATCGGTCAAATGACTATCTCCAGAAA 
TACAGGATAGAGGTTATG 
ΔyfgC 
YfgCH2P2 5’-TTTGGTCATTGTTCTTCCTTTAATGCGAATTAC 
ATCTTGGTATAAGGCTT 
ΔyfgC 
degP fwd 5'-ATT ATA TCA GCG GTA ΔdegP 
degP rev 5'-CCA CGA TAT CCT GCG ΔdegP 
yfgC fwd 5'-TGA ACC TCA AGA GCG ΔyfgC 
yfgC rev 5'-CAA TTC ACG GGC GCT ΔyfgC 
 "
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Chapter 5 
Discussion and Future Directions 
 
The classification of curli as an amyloid transformed the amyloid field by 
introducing a new class of what are now referred to as functional amyloids. Functional 
amyloids have now been discovered in all areas of life. The diversity of the functions 
performed by amyloids is staggering (1-3). Curli, and several other bacterial functional 
amyloids, serve as adhesive and structural components during biofilm formation (4-6). 
In mammalian cells, amyloid assembly by Pmel17 and peptide hormones serve as 
storage granules and are cytoprotective (7, 8). The translation termination factor Sup35 
in Saccharomyces cerevisiae assembles into an amyloid and mediates epigenetic 
inheritance (9). Molecular chaperones are important modulators of amyloid formation 
and disaggregation of Sup35 amyloid aggregates (10, 11). In most cases, little is known 
about how inappropriate amyloid assembly is avoided. In this dissertation, I have 
demonstrated that controlled and directed secretion of curli subunits involves a 
multitude of factors, including general and dedicated molecular chaperones, amyloid 
inhibitors, secretion proteins, stress response induction and feedback repression of the 
curli genes. Together, these systems ensure proper localization and assembly of curli 
amyloid fibers.  
 
Curli Biogenesis 
Curli gene expression is subject to an extensive degree of transcriptional and 
post-transcriptional regulation (12). The curli operons, csgBAC and csgDEFG, encode 
the amyloid fiber subunits and the dedicated secretion and accessory factors required 
for assembly (13). At least 300 other genes are involved in curli biogenesis further 
supporting the claim that the curli system is one of the most extensively and precisely 
controlled systems in E. coli [(12) and Daniel Smith, unpublished findings]. CsgD is a 
major biofilm regulatory protein that positively regulates expression of the csgBAC 
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operon encoding the major and minor curli fiber subunits CsgA and CsgB, respectively 
(13). A third gene, csgC, is located downstream of csgA and encodes a potent and 
selective amyloid inhibitor (Chapter 3) (13-15). The csgE, csgF and csgG genes encode 
the necessary proteins required for curli secretion. With the exception of CsgD, the the 
curli proteins are secreted across the innermembrane via the Sec translocon.  
The accessory periplasmic protein CsgE interact with both CsgA and CsgG and 
is required for CsgA secretion in vivo (4, 16, 17). CsgE also possesses chaperone-like 
activity and can inhibit the assembly of CsgA into an amyloid in vitro (Chapter 4) (17, 
18). CsgF is an accessory protein that interacts with CsgG on the cell surface (19). 
CsgG assembles into a nonameric pore in the outer membrane and is required for 
secretion of CsgA and CsgB (16, 20, 21). The inner diameter of the CsgG pore is only 2 
nm accommodating largely unfolding CsgA client proteins (14, 16). Once outside the 
cell the minor subunit, CsgB interacts with CsgF and assembles into a templating 
surface that nucleates the polymerization of CsgA into an amyloid on the cells surface 
(19, 22-24). CsgA can assemble into an amyloid in the absence of CsgB in vitro; 
however, CsgB is required for CsgA polymerization and surface localization in vivo (23, 
25).  
Reports that CsgA is secreted in a soluble, non-amyloid conformation across the 
outer membrane and yet CsgA does not accumulate within the cell when secretion is 
disrupted guided the major questions asked of my dissertation (14, 20). Namely, how 
bacterial cells ensure that CsgA only assembles into amyloid fibers on the cell surface? 
During secretion, the major amyloid fiber subunit CsgA and the minor templating 
subunits CsgB may encounter general chaperones and anti-aggregation factors. The 
ability of general aggregation inhibitors from both the cytoplasm and the periplasm to 
act on CsgA in vitro was therefore investigated in Chapter 2 of this dissertation. A 
second question that remained in the curli field prior to this dissertation was whether E. 
coli possesses dedicated and specific inhibitors of CsgA amyloid formation. A combined 
genetic and biochemical approach was used in Chapter 3 to identify the highly efficient 
and specific curli amyloid inhibitor CsgC. Finally, further investigations into the function 
and molecular details of CsgE-directed secretion of CsgA were conducted in Chapter 4. 
Together, the work presented in this dissertation has revealed important amyloid 
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inhibitory mechanisms in the E. coli curli biogenesis system and identified CsgC a new 
and unique inhibitor of amyloid formation. 
 
General Protein Folding Factors Inhibit CsgA Amyloid Formation 
 Molecular chaperones are important for cellular proteostasis for several reasons. 
First, chaperones assist folding of newly synthesized polypeptides into their correct, 
functional conformation. In the event that a protein unfolds or misfolds chaperones 
redirect proteins back towards their native conformation and inhibit inappropriate intra- 
and intermolecular interactions that might lead to protein aggregation and potentially 
cytotoxic effects. Finally, chaperones deliver damaged or misfolded proteins to 
proteases to be degraded. Molecular chaperones that reside in both the bacterial 
cytoplasmic and periplasmic spaces were selected for analysis.  
In Chapter 2 I report that the general cytoplasmic chaperones DnaK and Hsp33 
inhibit CsgA amyloid formation at substoichiometric molar ratios (Chapter 2 and (26)). 
The addition of DnaK to CsgA only extended the lag phase of CsgA polymerization 
while the addition of Hsp33 extended the lag phase and decreased the final amount of 
ThT fluorescence (26). Furthermore, the addition of CsgA preformed fibers or seeds 
could more easily overcome CsgA amyloid inhibition by DnaK than Hsp33. Taken 
together, these findings support a model where DnaK acts primarily during early stages 
of CsgA polymerization while Hsp33 may also interact with CsgA protofibrils or 
oligomers to inhibit fiber elongation (26). Interestingly, DnaK inhibited CsgA 
polymerization in that absence of the cofactors DnaJ and GrpE and in the absence of 
ATP demonstrating that DnaK can function as a holdase or holding chaperone to inhibit 
CsgA amyloid assembly (26).  
The periplasmic environment is distinct from the cytoplasmic environment in 
many ways; most notably, the periplasmic space is devoid of a hydrolysable energy 
source. Therefore, many periplasmic chaperones act as holdases. Spy is one such 
holdase that is regulated by the Cpx two-component and the Bae two-component 
systems (27-29). Spy can also inhibit CsgA amyloid formation in vitro but requires closer 
to a 1:1 molar ratio to achieve inhibition over a 24-hour experiment (Chapter 2) (26). 
The addition of CsgA seeds to a reaction with Spy and soluble CsgA could overcome 
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Spy-mediated inhibition (26). These results are again consistent with the model that Spy 
inhibits CsgA amyloid formation by interacting with soluble CsgA during early stages of 
polymerization. Furthermore, I found that overexpression of Spy in WT cells resulted in 
decreased detectable CsgA but not CsgG suggesting that when Spy is in large 
abundance in the periplasm it can retain CsgA in a protease-sensitive conformation 
(Chapter 2) (26).  
 
Identification of CsgC as a Curli Amyloid Inhibitor 
Curli are secreted by a dedicated secretion pore and assembled on a dedicated 
platform (12). I therefore hypothesize that there exist dedicated inhibitors to prevent 
intracellular amyloid formation (12). I used a combined biochemical and genetic 
approach to try to identify either curli-specific or curli-induced amyloid inhibitors in the 
periplasm of E. coli. These efforts ultimately revealed that CsgC is an extraordinarily 
efficient and selective CsgA amyloid inhibitor. In the experiments that lead to the 
discovery of CsgC as an amyloid inhibitor, periplasmic extracts (PEs) were harvested 
from various curli mutants that had been grown under curli-inducing conditions. PEs 
were added to newly purified CsgA and assays for inhibitory activity using the ThT 
assay. I found that mutants that were disrupted for secretion (ΔcsgG or ΔcsgE) or 
localization (ΔcsgB, ΔcsgF, or ΔcsgFΔcsgB) of CsgA exhibited an inducible chaperone-
like activity. PEs from WT cells accelerated polymerization when added to newly 
purified CsgA likely due to seeding by co-purified CsgA fibers in the crude extracts. 
Loss of csgA or csgB in the ΔcsgG mutant, loss of csgA in the ΔcsgFΔcsgB mutant or 
deletion of both csgB and csgA simultaneously relieved the CsgA amyloid inhibitory 
activity in PEs likely do to feedback repression of the csgBAC operon coupled with a 
polar effect on csgC expression in either csgA or csgB mutant (Fig. 3.2C and Fig. 3.4A). 
Size exclusion chromatography and western blotting combined with our observation that 
deletion of csgC in curli mutant backgrounds relieved the CsgA amyloid inhibitory 
activity in PEs lead us to conclude that the observed amyloid inhibitory activity was due 
to CsgC.  
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CsgC is a Potent and Selective Amyloid Inhibitor 
CsgC inhibits CsgA amyloid formation at very low substoichiometric 
concentrations (1:500, CsgC:CsgA) and maintains the majority of CsgA in an 
unstructured conformation that can still be recognized by the oligomer-specific antibody 
A11 (Fig. 3.7). The remarkable ability of CsgC to prevent amyloid formation at very low 
substoichiometric levels (1:500; Fig. 3.7A), and in the absence of ATP hydrolysis, is 
unique among anti-amyloid, chaperone-like proteins. CsgC can still inhibit CsgA 
amyloid formation at substoichiometric concentrations even in the presence of CsgA 
seeds suggesting that CsgC functions during later stages of CsgA aggregation or 
directs CsgA into an off pathway species (Fig. 3.7F).  
The molecular details of CsgC chaperone activity on CsgA are still not well 
understood and should the investigated in future biochemical and biophysical 
experiments. I found that purified CsgC interacts directly with CsgA in a by far Western 
dot blot analysis (Fig. 5.1). More detailed analysis of the direct interaction between 
CsgA and CsgC is needed. Surface Plasmon Resonance may be used to better 
investigate the dynamic of an interaction between CsgA and CsgC. Sequence and 
conformation specific CsgA gammabodies can be used to test whether CsgC is 
directing CsgA into a conformation that can be recognized by one of these 
conformation-specific antibodies. Given the observation that very low molar ratios of 
CsgC to CsgA can inhibit amyloid formation over several days, CsgC may be directing 
CsgA into a large, off-pathway oligomeric species. CD, size analysis, TEM and 
conformation-specific antibodies will enable further biochemical definition of the CsgA-
CsgC complex. The characteristics of CsgA incubated with CsgC can further be probed 
by asking if CsgA incubated with CsgC is protease sensitive. CsgA incubated alone 
adopts a highly protease-resistant, SDS-insoluble form, typical of all amyloids (19, 25, 
26). When CsgC is incubated with CsgA at substoichiometric concentrations, CsgA 
remains completely SDS soluble suggesting that CsgC maintains CsgA in a non-
amyloid conformation. I predict that CsgA incubated with CsgC will also be sensitive to 
proteolysis.  
The efficiency of CsgC-mediated amyloid inhibition is only one facet of what 
makes CsgC such a remarkable amyloid inhibitor. CsgC does not appear to act as a 
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general amyloid inhibitor but instead exhibits a high degree of client protein selectivity 
(Fig. 3.9 and 3.10). E. coli CsgA shares approximately 30% sequence identity with E. 
coli CsgB, and over 70% sequence identity with both Salmonella enterica and 
Citrobacter koseri CsgA (30). CsgC inhibited S. enterica, C. koseri and E. coli CsgA 
polymerization at the same molar ratios while inhibition of CsgB amyloid formation 
required a higher molar ratio compared to CsgA (1:10 CsgC:CsgB and 1:500 
CsgC:CsgA; Fig. 3.7 and 3.9). Intriguingly, CsgC inhibited α-synuclein, but not Aβ42 
amyloid formation. I identified an 8-9 amino acid motif (D-Q-Φ-X0,1-G-K-N-ζ) that is 
present in the loop region between R3 and R4 of CsgA and in the solubilizing domain of 
α-synuclein. There is a high degree of sequence similarity shared by all of the CsgA 
repeating units. CsgC inhibited amyloid formation by ΔR1, ΔR3 and ΔR5 CsgA mutants 
as well as synthetic peptides corresponding to R1 and R5. CsgC likely has multiple 
interaction sites within CsgA, but only one in α-synuclein. CsgC was unable to inhibit 
amyloid formation by the α-synuclein motif mutants supporting my hypothesis that the 
D-Q-Φ-X0,1-G-K-N-ζ motif is required for CsgC interaction (Fig. 3.9E and 3.10G). 
There are still many questions to be asked about the client protein selectivity of 
CsgC and the importance of the D-Q-Φ-X0,1-G-K-N-ζ motif in client proteins. Additional 
amyloid candidate client proteins that do not contain the motif should also be evaluated 
such as IAPP, Sup35, tau and TTR. It would also be of great interest to create Aβ42 
peptides that have been amended with the D-Q-Φ-X0,1-G-K-N-ζ motif and ask whether 
CsgC can now inhibit amyloid formation by these chimeric peptides. The possibility that 
CsgC can inhibit the aggregation of non-amyloidogenic proteins, such as citrate 
synthase (CS) and luciferase, should also be addressed. CS and luciferase are well-
characterized general chaperone substrates. Chimeric versions of CS and luciferase 
with the D-Q-Φ-X0,1-G-K-N-ζ motif can be used to ask whether CsgC can inhibit general 
aggregation if the motif is present on the client protein. Altogether, these additional 
experiments will definitively establish the substrate specificity of CsgC, and whether it is 
a general amyloid inhibitor, a general protein folding inhibitor or a specific inhibitor of 
CsgA and the importance of the D-Q-Φ-X0,1-G-K-N-ζ motif in client proteins. 
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A Putative Substrate-Binding Domain in CsgC  
When the crystal structure of CsgC was first reported it was predicted to act as a 
redox active protein in the periplasm. CsgC contains a conserved CxC motif and the 
structure of CsgC aligned very closely to the N-terminal domain of the oxidoreductase 
DsbD. CsgC was found to have a reduction potential similar to that of DsbC and DsbG. 
Under reducing conditions CsgC was less thermodynamically stable suggesting that 
disulfide bond formation of the CxC motif was important for protein stability (15). I found 
that disulfide bond formation is not important for the amyloid inhibitory activity of CsgC. 
Reduced CsgC has similar inhibitory activity against CsgA as oxidized CsgC and 
mutation of cysteine 29 to a serine yielded a CsgC protein that inhibited CsgA amyloid 
formation at molar ratios similar to that of WT CsgC (Fig. 5.2AB). I was unable to detect 
stable expression of the C29S mutant of CsgC in vivo; therefore, to evaluate the roll of 
disulfide bond formation of the CxC motif in CsgC in vivo genes encoding the disulfide 
bond catalyzing protein dsbA or dsbB were deleted and CsgC was detected by Western 
blot. Not unsurprisingly, CsgC protein levels were reduced in both the ΔdsbA and 
ΔdsbB mutants indicating that disulfide bond formation of the CxC motif in CsgC is 
important for protein stability both in vitro and in vivo (Fig. 5.2CDE). 
Chaperones often work by presenting structurally disordered or aggregation 
prone regions. The substrate binding domains of molecular chaperones are typically 
hydrophobic, aggregation prone regions that become solvent-exposed under conditions 
that activate chaperone activity (31). Interestingly, a few molecular chaperones have 
substrate binding domains that have amyloid-like properties (32, 33). It is possible that 
CsgC might be functioning to inhibit CsgA amyloid formation by making amyloid-like 
interactions with the growing CsgA fiber. I identified a single region in CsgC that is 
predicted to be aggregative or amyloidogenic using the programs PASTA or TANGO 
and the ZipperDB, respectively (Fig. 5.3BCD) (34-37). The predicted 
aggregative/amyloidogenic region of CsgC is highlighted in red (Fig. 5.3E) Mutation 
analysis of residues within the predicted aggregative domain and in other domains of 
CsgC will be useful in determining the important regions or residues for client protein 
interaction. Dr Steve Matthews lab at the Imperial College of London has begun 
mutational analysis of CsgC. The Matthews lab has identified several mutations that 
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disrupt charged patches on the surface of CsgC and result in decreased CsgA amyloid 
inhibition activity but not CsgC protein folding or stability (unpublished results). Further 
characterization of mutations in CsgC that reduce amyloid inhibition or specificity are 
likely to yield important insights into how CsgC functions.  
It is possible that amyloid inhibition by CsgC requires steric hindrance by the 
remainder of the CsgC protein. Inhibition of amyloid formation by gammabodies 
developed in Dr. Tessier’s lab is mediated by homotypic interactions between similar 
amyloid domains in each protein. For example, gammabodies that contain grafted 
portions of Aβ specifically recognize and inhibit Aβ amyloid assembly at 
substoichiometric molar ratios (38, 39). Once domains of CsgC are identified that 
dictate the specificity or activity of CsgC these domains can be grafted into the 
gammabody scaffold. The gammabody may be able to recognize and inhibit CsgA 
amyloid assembly if the antibody portion can mimic the steric hindrance of CsgC. I 
hypothesize that a direct interaction between CsgA and CsgC grafted within the 
gammabody will inhibit CsgA amyloid formation.  
 
CsgE is a Critical Curli Secretion Protein 
Transporting proteins across membranes is a significant challenge to cells. The 
transport of aggregation-prone and amyloidogenic proteins presents an even greater 
challenge because inappropriate interactions between membranes and amyloids can 
compromise membrane function (7, 40-42). Our model for CsgA secretion posits that 
CsgE binds to CsgA in the periplasm and chaperones it to the CsgG secretion complex 
in the outer membrane. Consistent with this model, CsgE interacts with both CsgG and 
CsgA and is required for efficient CsgA secretion (16-18, 43). Furthermore CsgE can 
inhibit amyloid assembly of CsgA even after polymerization is initiated in vitro (Chapter 
4) (17, 18). The domain in CsgA that CsgE recognizes is still unknown. Investigating 
whether CsgE can inhibit amyloid formation by CsgA repeating unit deletion mutants 
and repeating unit synthetic peptides will be the first step towards identifying the CsgE 
interaction domain(s) in CsgA. The N-terminal 22 amino acids of CsgA are not 
necessary for in vitro CsgA amyloid formation but are required for targeting peptides for 
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secretion through CsgG (44, 45). The N-terminal 22 amino acids of CsgA should also 
be evaluated as a potential CsgE interaction site.  
The specificity of CsgE amyloid inhibition is unknown. The CsgA amyloid inhibitor 
protein CsgC exhibits a high degree of selectivity that is dictated by the presence of a 
D-Q-Φ-X0,1-G-K-N-ζ motif in client protein. It is possible that CsgE can inhibit amyloid 
formation by other proteins. Future studies on CsgE chaperone activity should involve 
an investigation into a panel of proteins, as described above for CsgC. Dr. Pernilla 
Wittung-Stafshede and Dr. Fredrik Almqvist’s labs already have evidence that CsgE can 
modulate α-synuclein amyloid formation (unpublished data). The ability of CsgC and 
CsgE to modulate CsgA and α-synuclein amyloid formation are reminiscent of strikingly 
different results obtained when the small peptidomimetic 2-pyridone molecule FN075 is 
incubated with CsgA compared to α-synuclein (46). FN075 inhibits CsgA amyloid 
formation and accelerates α-synuclein amyloid formation by directing both proteins into 
oligomers. Interestingly, the oligomers of CsgA that assemble in the presence of FN075 
are “off-pathway” while the oligomers of α-synuclein that assemble in the presence of 
FN075 are “on-pathway” (46).  
 
Understanding CsgE Function in vivo 
CsgE is required for curli biogenesis in vivo but the molecular details of CsgE 
function are unknown (4, 17). The clear CsgE mutant phenotype in vivo and the 
chaperone activity of CsgE in vitro make mutation-function analysis relatively easy. In 
collaboration with Dr. Christiane Ritter we have begun to analyze mutations in CsgE 
that impact its several functions in distinct ways. The W49S and W52S mutations can 
complement a ΔcsgE mutant in vivo but cannot gate CsgG pore activity (Fig. 4.2BD and 
Fig. 4.3AB). In contrast, the F68S mutant cannot complement a ΔcsgE mutant but can 
still gate CsgG pore activity (Fig. 4.2BD and Fig. 4.3C). These results suggest that the 
W49 and W52 residues are located on a surface of CsgE that are important for 
interacting with CsgG and gating the pore but not necessarily important for interacting 
with CsgA or delivering CsgA to CsgG. On the other hand, the F68 residue is likely 
located on a surface of CsgE that is more important either for interacting with CsgA or 
for delivering CsgA to CsgG, not for gating CsgG. Alternatively, the F68S mutation 
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could alter the dynamics of the CsgE-CsgG interaction such that CsgG is always gated 
or occupied and is no longer accessible to CsgA. WT CsgE is associated with outer 
membrane fractions in a CsgG-dependent manner and coimmunoprecipitates with 
CsgG (21). It is possible that for CsgE and CsgG to function properly the interaction 
between CsgG and CsgE must dynamic. The domains and specific residues of CsgE 
that are important for its multiple functions as a secretion and gating factor should be 
further investigated.  
 
Amyloid Cytotoxicity and Designing Therapeutics 
Oligomers formed early during amyloidogenesis are considered to be the toxic 
species (41, 47). Toxicity is not only associated with disease amyloids. Microcin E492 is 
a functional amyloid produced by Klebsiella pneumoniae that forms a soluble toxic 
oligomer as a defense against neighboring bacteria. Once Microcin E492 polymerizes 
into amyloid fibers it becomes inert (48, 49). The ability of CsgC and CsgE to modulate 
α-synuclein amyloid formation begets the question of whether CsgC and CsgE change 
the cytotoxicity associated with disease-associated amyloids like α-synuclein. Early 
oligomers and amyloids that are arrested at early stages of polymerization might be 
more cytotoxic to cultured cells whereas toxicity may be reduced if amyloid formation is 
accelerated. Future studies focusing on the mechanism and molecular details of 
amyloid modulation by proteins like CsgC and CsgE will help guide the rational design 
of amyloid therapeutics.  
 
Concluding Remarks 
 Curli are a bacterial functional amyloid that serves as an excellent model for 
studying bacterial biofilm formation, protein secretion and amyloid biology. Curli gene 
expression and fiber assembly are beautifully coordinated and controlled events. 
Bacteria have evolved many mechanisms that work in concert in preventative measures 
and as fail-safe mechanisms to 1) ensure that curli subunits are secreted prior to 
amyloid assembly and 2) rapidly eliminate mislocalized and potentially dangerous 
subunits in the even that secretion fails. The multitiered mechanisms employed by E. 
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coli underscore the importance of controlled amyloidogenesis and hold the key to 
understanding both disease-associated and functional amyloid biology.  
 
Materials and Methods 
Strains and Plasmids.  
BW25113 ΔdsbA (dsbA::kan) and ΔdsbB (dsbB::kan) obtained from the Keio collection 
(50). 
Protein Purification. CsgA was purified as described previously (30). CsgC was 
purified as described previously (51). CsgC was reduced with by the addition of 10 mM 
dithiothreitol (DTT) at 37°C for 30 min. 
CsgA Polymerization. CsgA was diluted to a final concentration of 20 µM and 
incubated with CsgC and 20 µM Thioflavin T (ThT). Readings were taken in either a 
Molecular Devices SpectraMax M2 or a Tecan Infinite M200 microtitre plate reader at 
25°C. The plate was shaken linearly for 3 seconds prior to taking fluorescence readings 
(exication: 438nm, emission: 495nm, cutoff: 475nm) every 10 or 20 minutes. 
Western Blot. Cells were grown on YESCA agar plates at 26°C for either 24 or 48 
hours. They were then scraped from the plate and normalized to OD600=1.0 in 50mM 
potassium phosphate buffer (pH 7.3). 100 µL of cell suspension were pelleted in 
duplicate. One duplicate was treated with 50 µL 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFIP) for 10 minutes, dried and then resuspended in 40 µL SDS loading buffer while 
the other sample was only resuspended in SDS loading buffer. Samples were 
separated on a 15% acrylamide gel and transferred to PVDF with α-CsgA (1:15,000), α-
CsgG (1:50,000) or α-CsgC (1:4000).  
Far Western Blot. Freshly purified soluble CsgA (25 µM), 25 µM CsgA that had been 
allowed to polymerize into fibers for 24 hours, or fibers that had been sonicated 3 times 
20 sec on ice were spotted as 4 µL dots on 0.22 µm nitrocellulose membrane and 
allowed to dry. Blots were blocked in 2% BSA in TBS-T. Blots were then either probed 
with α-CsgA (1:15,000), α-CsgC (1:4000) or incubated for 1 hour with 1 mg/mL purified 
CsgC protein prior to incubation with α-CsgC antibody (1:4000). 
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Figure 5.1 CsgC interacts directly with CsgA. Far western dot blot analysis was used 
to detect a direct interaction between CsgA and CsgC. CsgA monomers (mono), fibers 
or sonicated fibers (seeds) were spotted on a nitrocellulose membrane in triplicate and 
then blocked with 2% BSA. One blot was probed with an α-CsgA antibody, another blot 
was probed with an α-CsgC antibody and the last blot was incubated with CsgC protein 
at 1 mg/mL and then probed with an α-CsgC antibody.  
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Figure 5.2 Intramolecular disulfide bond formation and CsgC stability. 
A) The CxC disulfide bond in CsgC was reduced with 10 mM DTT for 30 minutes at 
37°C and then assayed for CsgA amyloid inhibition in a ThT assay. B) WT CsgC and 
C29S mutant CsgC were purified and tested for CsgA amyloid inhibition in a ThT assay. 
C) Congo red binding of WT, ΔcsgC, ΔdsbA and ΔdsbB E. coli. D) Western blot 
analysis of CsgG and CsgA protein levels in WT, ΔcsgC, ΔdsbA and ΔdsbB cells. E) 
Western blot analysis of CsgC protein levels in WT, ΔcsgC, ΔdsbA and ΔdsbB cells.  
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Figure 5.3 CsgC contains a predicted aggregative domain. A) CsgC sequence 
shown with the location of the β-sheets indicated. The primary sequence of CsgC was 
analyzed using the aggregation prediction algorithm PASTA (B), the amyloid prediction 
algorithm TANGO (C) or the ZipperDB (D). The predicted aggregative/amyloidogenic 
region of CsgC (residues 86-91) are highlighted in red (E).  
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Appendix A: Investigating Feedback Repression of the Curli Operons 
Loferer and colleagues (1997) reported that CsgA and CsgB protein levels are below 
the level of detection by Western blot in a ΔcsgG mutant; however, they showed that 
csgA and csgB were both still expressed using translational fusion to each gene. I 
attempted to repeat these results using a lacZ transcriptional reporter under control of 
the csgDEFG or csgBAC promoter and qRT-PCR with either csgD or csgB primers. In 
contrast to the Loferer et al. (1997) result, I found that there is approximately a 3-fold 
decrease in expression from the csgBAC promoter while the csgDEFG promoter activity 
was unchanged in a ΔcsgG mutant (Fig. A.1AB). The qRT-PCR results showed a 
similarly modest repression of csgB (Fig. A.1C). The CpxAR two-component system is 
one of the negative regulators of curli expression. I therefore asked whether CpxR was 
responsible for the observed feedback repression in the ΔcsgG mutant by examining 
expression of the csgDEFG-lacZ and csgBAC-lacZ fusion constructs in a ΔcsgGΔcpxR 
mutant. Expression of csgDEFG-lacZ increased approximately 2-fold when cpxR was 
deleted while expression of cpxR along, but not in the ΔcsgG mutant resulted in a 
dramatic increase in csgBAC-lacZ expression. Together, these results demonstrate that 
there is feedback repression of the csgBAC promoter in a ΔcsgG mutant but that the 
repression is not mediated by the Cpx two-component system.  
 
Materials and Methods 
Bacterial Strains. Described in Chapter 3. 
β-galactosidase Assay. Described in Chapter 3. 
qRT-PCR. Cells were grown on YESCA plates for 24h at 26C. Cells were harvested 
with YESCA media containing RNase Protect (QIAGEN) and incubated for 5 min. Cells 
were pelleted at 5,000xg for 10 min and resuspended in Tris-EDTA containing 1 mg/mL 
lysozyme and incubated for 5 min before RLT (QIAGEN) was added. The cells were 
pelleted and the supernatant removed to a new tube with Molecular Biology Grade 
ethanol and inverted several times to mix. The RNA solution was transferred to a 
QIAGEN spin column and centrifuged for 15 sec. The column was washed RW1 buffer, 
RDD buffer containing DNase, and RPE buffer twice before eluting with 31 µL of DNase 
free water. cDNA was synthesized using ImPrompII reverse transcriptase. SYBR Green 
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qPCR MasterMix was used for the quantitative PCR using primers 5’-
GGTGCAAGCGTTAATCGGAA-3’ and 5’-CTTCCGTGGATGTCAAGACC-3’ for 16S, 5’-
GCGGCGAATGCTACTTTACG-3’ and 5’-CGCTGATGAACAACGAACGA-3’ for csgD 
and 5’-TAGCAACCGGGCAAAGATTG-3’ and 5’-CGTTGTGTCACGCGAATAGC-3’ for 
csgB. Values are reported as ΔΔCt and normalized to 16S. 
 
 
Figure A.1. Transcription analysis of curli operons 
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Appendix B: One and Two Dimensional Gel Analysis of Periplasmic Extracts to 
Identify Amyloid Inhibitory Factors.  
Mass spectrometry analysis of one and two dimensional gel electrophoresis of PEs from 
E. coli k-12 MC4100 revealed upregulation at 48 hours of growth of the substrate 
binding subunit of two ABC transporters: OppA and DppA. The Opp and Dpp systems 
are involved in recycling oligo- and dipeptides, respectively, back into the cell. OppA 
and DppA have both been reported to have general chaperone activity in vitro 
(Richarme and Caldas, 1997). However, deletion of both oppA and dppA in 
backgrounds that exhibited amyloid inhibitory PEs did not relieve the inhibitory activity. 
Consistently, neither OppA nor DppA were induced in isogenic curli mutants of E. coli k-
12 BW25113, however, the inhibitory activities associated with the specific curli mutant 
PEs were the same as in MC4100. Why OppA and DppA are induced in some curli 
mutants in MC4100 but not BW25113 is unclear. Therefore, to simplify our investigation 
we selected BW25113 for the remainder of our studies. 
 
Materials and Methods 
Two-Dimensional Gel Electrophoresis. 
Periplasmic extracts were collected as described in Chapter 3. Proteins were 
precipitated with 10% trifluoroacetic acid on ice for 30 min. The precipitated protein was 
centrifuged for 30 min at 16,000rpm at 4°C and the supernatant removed. Proteins were 
separated by isoelectric point using a 24 cm GE Healthcare Immobiline dry strip. The 
Immobiline strip was then placed at the top of a 13% acrylamide gel pH 8.6 and then 
stained with colloidal coomassie stain. Gels were analyzed using Delta 2D software and 
all spot intensities were normalized by the sum of the intensities for a given gel. Spots 
with intensities greater than 3-fold over WT were excised and set to the University of 
Michigan Proteomics Core for MS/MS analysis.  
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Figure B.1. Two-dimensional gel electrophoresis of periplasmic extracts 
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Appendix C: The Effect of Polyphosphate on Curli in vivo and in vitro.  
Michael Gray, a post-doc in Ursula Jakob’s lab, was studying the effect of 
polyphosphate on protein folding and approached me about investigating a potential roll 
for polyphosphate during curli biogenesis and CsgA amyloid assembly. I found that 
deletion of the polyphosphate kinase, ppk, resulted in delayed CR binding of MG1655 
relative to WT (24 h) while loss of the exopolyphosphatase, ppx, bound WT amounts of 
CR (Fig. D1A, left panel). All strains bound the same amount of CR after 48 h of growth 
(Fig. D1A, right panel). Interestingly, Western blot analysis revealed that the Δppk 
mutant produced similar amounts of total CsgA protein compared the WT; however, a 
larger proportion of the CsgA protein was SDS soluble in the Δppk mutant at 24 and 
48h of growth (Fig. D1B). I then asked whether the Δppk or Δppx mutants had a curli-
dependent biofilm phenotype. To do this I chose to use the uropathogenic E. coli isolate 
UTI89. UTI89 makes curli-dependent wrinkled or rugose colonies on YESCA agar 
plates and curli-dependent pellicle biofilms. Will DePas in the Chapman lab had 
constructed the Δppk mutant in UTI89 in a candidate approach to identify mutants with 
increased biofilm. Figure D1C is a photograph taken by Will DePas. Will observed that 
the Δppk mutant had a slightly larger colony diameter and appear to wrinkle less than 
the WT (Fig. D1C). When the Δppk mutant was grown in a pellicle biofilm the mutant 
formed a smooth pellicle compared to the wrinkled pellicle produced by the WT (Fig. 
D1D).  
Next, I asked whether polyphosphate directly effected CsgA amyloid formation. I 
purified CsgA and diluted it to 10 µM in the presence of 10 mM, 1 mM or 0.1 mM 
polyphosphate and monitored polymerization by ThT fluorescence. Polyphosphate 
alone did not result in ThT fluorescence. The addition of any concentration of 
polyphosphate to CsgA accelerated CsgA amyloid formation: decreasing the lag phase 
from approximately 4 hours to 20 minutes (Fig. D2). Together, these results suggest 
that ppk plays a role in the timing of curli biogenesis and the development of curli-
dependent biofilms. 
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Figure C.1. Polyphosphate production curli biogenesis and curli-dependent 
biofilm formation in vivo.  
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Figure C.2. Polyphosphate accelerates CsgA amyloid formation in vitro. 
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